Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3004248	s-shbg	nmol/l (nmol/l)	12452	21083	0.00%
3004248	p-shbg	nmol/l (nmol/l)	465	788	0.00%
3004248	p-shbg	— (—)	379	704	100.00%	Distribution not available
3004248	shbg	nmol/l (nmol/l)	18	26	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Hypogonadotropic hypogonadism

706

756

23.63

307.65

3.6

1.8

26.97

36.20

nmol/l

22.28

669

735

Sleep apnoea

2866

7809

2.45

307.65

2.0

1.7

34.09

42.55

nmol/l

70.01

2782

7626

Testicular dysfunction

820

893

20.20

307.65

3.1

1.6

30.13

37.75

nmol/l

17.59

808

866

Sleep apnoea, including avohilmo

2918

7898

2.35

307.65

2.0

1.6

34.59

43.00

nmol/l

62.91

2837

7717

Hypopituitarism

958

1086

12.53

307.65

3.3

1.6

29.50

38.60

nmol/l

26.51

916

1055

Testicular hypofunction

733

797

20.56

307.65

3.1

1.6

29.92

37.99

nmol/l

17.12

724

774

Exclusions for E4_PCOS_BROAD

1256

1967

7.39

307.65

3.0

1.7

34.38

40.45

nmol/l

10.05

1209

1916

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

1335

2890

4.93

307.65

2.9

1.6

34.59

42.06

nmol/l

18.74

1283

2816

Polycystic ovarian syndrome, consortium definition

932

881

6.39

307.65

1.2

1.1

49.87

62.70

nmol/l

8.74

926

871

Polycystic ovarian syndrome, broad definition

633

417

17.11

307.65

1.2

49.48

60.49

nmol/l

3.63

628

412

Disorders of other endocrine glands

2468

4105

6.49

307.65

2.6

1.5

34.86

43.07

nmol/l

32.33

2406

4006

Sleep disorders (combined)

3045

7662

2.13

275.01

1.9

1.6

36.60

43.66

nmol/l

43.07

2961

7496

Other antidepressants

3071

7661

2.10

265.30

2.0

1.6

38.48

41.88

nmol/l

10.75

2983

7498

Depression or dysthymia

2036

4814

2.40

243.99

1.9

1.6

38.69

42.16

nmol/l

7.59

1976

4700

Exclusions for E4_PCOS_CONSORTIUM

1566

3758

2.67

243.70

2.7

1.5

38.46

43.66

nmol/l

7.30

1508

3691

Endocrine, nutritional and metabolic diseases

2639

6394

2.14

238.09

2.0

1.5

36.63

43.07

nmol/l

25.33

2578

6281

Selective serotonin reuptake inhibitors

2862

7674

1.99

215.09

1.9

1.6

38.88

41.87

nmol/l

7.60

2786

7510

Benign neoplasm: Pituitary gland, craniopharyngeal duct

329

532

7.16

200.12

2.8

1.8

40.73

39.91

nmol/l

0.16

324

510

Recurrent or chronic depression

1260

3619

2.52

179.38

2.0

1.6

37.01

40.64

nmol/l

5.93

1229

3556

Episodal and paroxysmal disorders

2756

7851

1.82

158.25

1.9

1.6

36.78

43.27

nmol/l

31.32

2688

7687

Medical observation and evaluation for suspected diseases and conditions

2008

5182

2.03

158.10

2.0

1.6

38.95

40.07

nmol/l

1.15

1910

5106

Depression medications

1217

2588

2.45

147.05

2.0

1.6

36.58

42.00

nmol/l

9.06

1185

2567

Behavioural syndromes associated with physiological disturbances and physical factors

2386

9641

1.79

139.68

1.9

1.7

39.77

40.38

nmol/l

0.52

2345

9429

Mood disorders, excluding more controls

2451

8402

1.77

134.69

1.9

1.7

38.97

41.04

nmol/l

3.21

2381

8232

Hypothyroidism (congenital or acquired)

983

2316

2.48

126.77

2.2

1.5

38.33

43.22

nmol/l

5.45

963

2297

Mood [affective] disorders

2609

10111

1.70

126.14

1.9

1.7

38.82

40.98

nmol/l

3.72

2538

9898

Mood disorders

2610

10112

1.70

125.51

1.9

1.7

38.82

40.99

nmol/l

3.75

2539

9899

Benign neoplasm of other and unspecified endocrine glands

423

1211

3.70

125.45

2.5

1.7

41.01

41.91

nmol/l

0.24

416

1165

Hypothyroidism and >3 levothyroxin purchases

969

2297

2.47

123.63

2.2

1.5

38.37

43.22

nmol/l

5.34

949

2278

Hypothyroidism, levothyroxine purchases

969

2297

2.47

123.63

2.2

1.5

38.37

43.22

nmol/l

5.34

949

2278

Used for control exclusion in common control thyroid runs

2872

8878

1.66

120.47

2.0

1.6

40.02

40.88

nmol/l

0.90

2796

8688

Sleep disorders

2211

9415

1.73

115.42

1.9

1.7

39.87

40.30

nmol/l

0.31

2171

9212

Codeine

2408

7763

1.71

115.34

1.9

1.6

37.95

42.09

nmol/l

12.59

2347

7605

Depression

2429

9927

1.69

114.86

1.9

1.7

39.17

40.80

nmol/l

2.16

2368

9723

Codeine or tramadol medication

2753

9334

1.64

111.75

1.9

1.7

38.13

42.07

nmol/l

13.36

2680

9127

Neurological diseases

2189

6406

1.74

109.83

1.9

1.6

37.10

43.18

nmol/l

23.02

2129

6298

Medical treatment for female infertility

313

807

3.94

105.53

1.2

60.77

56.15

nmol/l

0.82

313

796

Diseases of male genital organs

2414

7457

1.69

103.91

1.9

1.8

36.90

37.86

nmol/l

1.42

2345

7305

Opioids

2479

7918

1.65

102.60

1.9

1.6

38.66

42.06

nmol/l

8.66

2419

7756

Insomnia

2120

9339

1.68

100.74

1.9

1.7

39.69

40.34

nmol/l

0.51

2081

9140

Impotence

331

952

3.93

100.53

2.2

1.8

39.44

40.16

nmol/l

0.23

321

914

Anxiety disorders, excluding more controls

2063

8033

1.70

99.72

1.9

1.7

38.74

40.56

nmol/l

2.47

2006

7881

Genitourinary diseases

2169

6514

1.71

99.56

1.9

1.8

37.99

38.03

nmol/l

0.02

2109

6396

Coxibs

727

1551

2.53

96.86

2.0

1.5

38.15

44.81

nmol/l

8.66

710

1525

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1369

7296

1.86

96.82

1.9

1.7

37.89

40.67

nmol/l

4.33

1328

7132

Obesity and other hyperalimentation

1435

7694

1.83

96.29

1.9

1.7

32.64

43.72

nmol/l

47.86

1387

7516

Obesity

1429

7676

1.83

95.79

1.9

1.7

32.64

43.71

nmol/l

47.48

1381

7499

Other nutritional deficiencies

1493

7991

1.79

92.87

1.9

1.7

33.63

43.56

nmol/l

37.91

1446

7804

Anxiety (asthma-related co-morbidities)

1634

7319

1.76

92.46

1.9

1.7

38.75

39.79

nmol/l

0.84

1590

7205

Tramadol

1845

6709

1.72

91.76

2.0

1.7

38.56

41.75

nmol/l

6.72

1794

6561

General examination and investigation of persons without complaint and reported diagnosis

1717

5182

1.76

89.52

1.9

1.6

40.01

40.07

nmol/l

0.03

1660

5106

Neurotic, stress-related and somatoform disorders

2198

9665

1.62

88.89

1.9

1.7

38.66

40.32

nmol/l

2.22

2141

9480

Anxiety disorders

2208

9735

1.60

86.77

1.9

1.7

38.73

40.37

nmol/l

2.19

2151

9545

Any death

279

6074

0.32

82.64

1.6

1.7

46.51

42.54

nmol/l

1.60

262

5881

Abnormalities of breathing

2156

7962

1.59

80.04

2.0

1.7

37.46

41.64

nmol/l

12.15

2115

7798

All anxiety disorders

1643

7865

1.68

79.07

1.9

1.7

38.79

39.81

nmol/l

0.83

1599

7741

Use of hypnotics and sedatives

2454

9250

1.54

78.80

1.9

1.7

39.76

41.05

nmol/l

1.80

2376

9044

Other dorsopathies, not elsewhere classified

2455

8405

1.55

78.57

1.9

1.7

39.98

41.29

nmol/l

1.56

2390

8227

Neurological diseases, wide definition

901

2218

2.08

76.62

2.0

1.5

35.81

43.45

nmol/l

14.52

878

2192

Obesity due to excess calories

1046

5694

1.87

76.20

2.0

1.7

32.07

43.90

nmol/l

38.60

1002

5554

Other diseases of upper respiratory tract

2422

8329

1.53

74.35

1.8

1.7

41.15

41.60

nmol/l

0.36

2347

8147

Symptoms and signs involving the circulatory and respiratory systems

2432

8056

1.53

73.43

1.8

1.7

38.67

41.54

nmol/l

6.52

2378

7891

Hypertrophy of breast in women and men

310

1020

3.11

72.54

2.0

1.6

46.75

44.19

nmol/l

0.84

293

996

Psychiatric diseases

2286

7491

1.55

72.36

1.9

1.6

40.47

41.19

nmol/l

0.68

2211

7335

Oxicams

503

1134

2.57

71.60

2.0

1.5

40.79

45.65

nmol/l

3.76

488

1110

Pain in throat and chest

1988

7713

1.57

69.40

1.9

1.7

39.26

41.08

nmol/l

2.45

1931

7549

Other special examinations and investigations of persons without complaint or reported diagnosis

1665

5183

1.65

68.85

1.9

1.6

40.81

40.07

nmol/l

0.55

1619

5106

Dorsalgia

2338

8365

1.51

68.35

1.9

1.7

40.18

41.33

nmol/l

1.25

2279

8187

Deviated nasal septum

1008

5625

1.84

68.31

1.9

1.8

37.82

40.33

nmol/l

3.54

970

5481

Obesity related asthma

792

4100

1.98

67.65

2.0

1.7

33.82

41.59

nmol/l

22.51

769

3977

Mouth breathing

1120

6479

1.77

66.85

2.0

1.8

36.22

40.74

nmol/l

9.35

1104

6296

Exposure to other specified factors

1824

10900

1.56

66.43

1.9

1.7

38.96

40.73

nmol/l

2.64

1769

10668

Obesity, other/unspecified

719

3629

2.02

65.90

1.8

1.7

34.07

44.15

nmol/l

15.99

696

3547

Diarrhoea and gastroenteritis of presumed infectious origin

2241

9988

1.50

64.34

1.8

1.7

40.14

41.21

nmol/l

1.03

2199

9746

Parasetamol

2111

7089

1.53

63.51

1.9

1.7

36.96

41.58

nmol/l

15.06

2048

6965

Special screening examination for infectious and parasitic diseases

901

3640

1.87

61.44

1.7

1.6

40.07

38.23

nmol/l

1.31

867

3604

Acetic acid derivatives and related substances

622

1498

2.20

61.31

1.9

1.5

38.55

45.15

nmol/l

7.80

605

1472

Other anxiety disorders

1186

6143

1.70

61.26

1.8

1.7

40.14

40.39

nmol/l

0.10

1154

6046

Dorsopathies

2418

8434

1.47

61.20

1.9

1.7

40.09

41.23

nmol/l

1.24

2353

8256

Exposure to unspecified factor

2212

10878

1.48

61.18

1.8

1.7

40.04

41.14

nmol/l

1.33

2151

10643

Nonorganic sleeping disorders, excluding more controls

507

2333

2.24

59.88

2.2

1.6

41.77

41.70

nmol/l

0.02

500

2296

Acute upper respiratory infections of multiple and unspecified sites

1662

7988

1.56

59.45

1.8

1.7

38.27

41.80

nmol/l

7.56

1630

7800

Soft tissue disorders

2414

8602

1.46

58.68

1.9

1.7

39.74

41.23

nmol/l

1.97

2346

8433

Other joint disorders

2206

7963

1.48

57.22

1.9

1.6

39.19

41.36

nmol/l

3.84

2135

7816

Other intervertebral disc disorders

1830

7302

1.53

57.03

2.0

1.7

38.80

41.15

nmol/l

4.35

1785

7137

Chronic rhinitis, nasopharyngitis and pharyngitis

669

3477

1.96

56.41

1.9

1.7

39.66

41.55

nmol/l

1.01

661

3397

Pain (limb, back, neck, head abdominally)

1802

5953

1.53

55.33

1.9

1.7

39.21

41.04

nmol/l

2.40

1755

5827

Injuries to the wrist and hand

2193

10581

1.45

54.64

1.8

1.7

40.71

41.19

nmol/l

0.38

2132

10348

Persons encountering health services for examination and investigation

1603

5183

1.57

54.44

1.9

1.6

39.79

40.07

nmol/l

0.17

1551

5106

Benign neoplasms

2464

9632

1.43

53.40

1.9

1.7

40.42

40.77

nmol/l

0.25

2402

9426

Lumbar disc prolapse

1407

6931

1.58

53.03

2.0

1.7

38.78

41.00

nmol/l

3.22

1379

6770

Disorders of skin appendages

1069

6498

1.67

52.68

1.7

42.26

40.82

nmol/l

0.66

1047

6341

Shoulder lesions

1606

6408

1.54

51.68

1.9

1.7

40.55

41.19

nmol/l

0.44

1544

6259

General symptoms and signs

2519

9035

1.41

50.65

1.9

1.7

39.82

40.74

nmol/l

0.98

2459

8838

Oter anti-inflammatory and antirheumatic agents, non-steroids

370

832

2.50

49.60

1.8

1.5

41.50

47.07

nmol/l

4.05

353

812

Any mental disorder

2373

8455

1.42

49.34

1.9

1.7

40.27

41.11

nmol/l

0.86

2294

8282

Inflammatory diseases of prostate (prostatitis)

468

2279

2.15

48.75

2.0

1.8

39.97

40.69

nmol/l

0.32

449

2198

Other headache syndromes

682

3736

1.85

48.49

1.9

1.6

40.20

44.96

nmol/l

5.12

663

3650

Diseases of the musculoskeletal system and connective tissue

1406

4560

1.57

47.28

1.8

1.6

38.67

41.28

nmol/l

3.33

1368

4497

Dislocation, sprain and strain of joints and ligaments of knee

1500

9322

1.50

46.57

1.8

1.7

38.72

40.21

nmol/l

1.77

1466

9121

Hyperkinetic disorders, excluding more controls

376

1656

2.25

44.47

2.0

1.6

36.27

40.29

nmol/l

2.07

361

1645

Antihypertensive medication - note that there are other indications

1593

5706

1.50

44.38

1.9

1.6

36.50

42.86

nmol/l

16.90

1555

5633

Propionic acid derivatives

613

1605

1.95

44.31

1.7

1.5

38.93

44.51

nmol/l

5.84

594

1579

Transport accidents

1108

6082

1.59

43.98

1.9

1.7

40.58

41.48

nmol/l

0.54

1083

5977

Pain in joint

1378

5821

1.53

43.81

2.0

1.7

39.42

41.15

nmol/l

1.85

1340

5698

Sexual dysfunction

112

273

4.81

43.64

2.3

1.7

36.29

38.47

nmol/l

0.56

112

264

Chronic sinusitis

817

4876

1.70

43.26

1.9

1.7

39.23

41.59

nmol/l

1.64

803

4760

Polyuria

461

2335

2.02

42.24

1.8

1.7

44.19

43.51

nmol/l

0.23

442

2241

Nonorganic sleeping disorders

507

2661

1.95

42.02

2.2

1.7

41.77

40.40

nmol/l

0.59

500

2597

Injuries to the shoulder and upper arm

1837

10528

1.42

41.96

1.9

1.7

39.28

40.08

nmol/l

0.81

1787

10288

Intestinal infectious diseases

2375

9971

1.37

41.88

1.8

1.7

40.89

41.34

nmol/l

0.30

2329

9727

Benzodiazepine use

2094

10468

1.39

41.20

2.0

1.7

40.19

41.30

nmol/l

1.20

2026

10244

Rotator cuff syndrome

1196

5617

1.55

41.03

1.9

1.7

40.03

41.47

nmol/l

1.33

1147

5475

Anti-inflammatory and antirheumatic products, non-steroids

600

1605

1.91

40.78

1.8

1.5

38.95

44.51

nmol/l

5.81

581

1579

Other diseases of intestines

2356

9909

1.36

40.01

1.8

1.7

39.74

40.90

nmol/l

1.48

2290

9715

Persons encountering health services in other circumstances, wide

2551

9801

1.35

40.00

1.8

1.7

40.23

40.67

nmol/l

0.36

2501

9564

Arthropathies

2163

7974

1.39

39.79

1.9

1.6

39.34

41.33

nmol/l

3.04

2098

7827

Abdominal and pelvic pain

2390

8874

1.37

39.79

1.8

1.7

39.61

40.58

nmol/l

1.13

2326

8683

Male infertility

316

1463

2.37

39.12

2.5

1.8

30.99

34.89

nmol/l

4.06

311

1441

Intracranial trauma

1221

5708

1.52

38.81

1.8

1.6

39.60

42.86

nmol/l

4.57

1191

5610

Acute upper respiratory infections

1938

8618

1.40

38.70

1.8

1.7

39.03

42.51

nmol/l

8.58

1890

8395

Continuous positive airway pressure

489

2183

1.93

38.22

2.0

1.6

34.74

42.16

nmol/l

13.43

465

2144

Other specific joint derangements/joint disorders

1684

7722

1.42

37.74

1.9

1.6

39.47

41.48

nmol/l

2.72

1641

7579

Chronic diseases of tonsils and adenoids

1712

7698

1.42

37.61

1.8

1.7

39.40

40.78

nmol/l

1.46

1675

7552

Examination and observation for other reasons

1316

5143

1.50

37.44

1.9

1.6

41.13

40.13

nmol/l

0.75

1287

5067

Disease of hard tissues of teeth, NOS

1215

4211

1.53

37.19

1.8

1.7

39.70

40.97

nmol/l

1.07

1151

4135

Low back pain

1570

7944

1.43

37.15

1.9

1.7

39.51

41.58

nmol/l

2.41

1533

7772

Non-selective monoamine reuptake inhibitors

522

2756

1.85

37.14

2.0

1.6

41.30

42.84

nmol/l

0.74

510

2664

Spondylopathies

1523

6356

1.45

36.59

1.9

1.7

41.09

nmol/l

0.00

1478

6200

Irritable bowel syndrome

463

2463

1.91

36.53

2.0

1.6

40.93

42.54

nmol/l

0.74

454

2409

Abnormalities of heart beat

588

3301

1.77

36.23

1.9

1.7

42.35

43.95

nmol/l

0.79

568

3207

Other soft tissue disorders, not elsewhere classified

1958

8390

1.38

36.03

1.9

1.7

39.97

41.43

nmol/l

1.63

1905

8222

Symptoms and signs involving the digestive system and abdomen

2362

8874

1.35

35.85

1.8

1.7

39.53

40.58

nmol/l

1.30

2297

8683

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

1038

3361

1.57

35.47

1.9

1.6

36.50

40.20

nmol/l

5.91

1009

3315

Migraine

789

3960

1.63

35.14

1.7

1.5

41.74

45.18

nmol/l

2.39

778

3889

Headache

1369

7621

1.45

35.06

1.9

1.7

39.45

41.06

nmol/l

1.50

1339

7452

Acute sinusitis

1113

6937

1.50

34.95

1.9

1.7

38.94

41.22

nmol/l

2.35

1092

6780

Intestinal infectious diseases

1945

10932

1.36

34.41

1.8

1.7

40.35

40.92

nmol/l

0.33

1910

10677

Artrosis, including avohilmo

1824

7259

1.39

34.35

2.0

1.7

38.31

40.66

nmol/l

4.44

1768

7092

Paracetamol or NSAID medication

422

1064

2.03

34.31

1.8

1.4

38.41

43.56

nmol/l

3.82

409

1047

Bronchitis

2106

9910

1.35

34.09

1.8

1.7

38.86

41.99

nmol/l

7.42

2062

9672

Concussion

1036

5614

1.52

34.07

1.9

1.6

38.71

42.79

nmol/l

6.23

1011

5516

Hernia

1915

9480

1.37

33.88

1.8

40.08

39.66

nmol/l

0.30

1866

9270

Lower back pain or/and sciatica

2146

10527

1.34

33.78

1.9

1.7

39.84

41.46

nmol/l

2.19

2099

10283

Monoamine oxidase A inhibitors

228

963

2.43

33.20

2.0

1.7

40.70

42.64

nmol/l

0.61

222

934

Persistent mood disorders

385

1996

1.97

33.07

2.0

1.7

40.12

41.45

nmol/l

0.43

368

1949

Neoplasms

2093

8289

1.35

33.05

1.9

1.7

38.86

40.05

nmol/l

1.15

2048

8136

Personality disorders, excluding more controls

632

3813

1.69

32.62

1.9

1.7

39.44

40.45

nmol/l

0.43

617

3755

Vasomotor and allergic rhinitis

775

4816

1.60

32.62

1.9

1.7

39.72

40.72

nmol/l

0.50

757

4731

Diseases of the skin and subcutaneous tissue

2203

8330

1.34

32.26

1.8

1.7

40.93

40.56

nmol/l

0.23

2136

8154

Restless leg syndrome

238

1047

2.33

31.58

2.0

1.7

39.70

41.82

nmol/l

0.68

233

1011

Sciatica+with lumbago

948

5801

1.52

31.56

1.9

1.7

39.55

41.87

nmol/l

2.42

930

5658

Cervical disc disorders

654

4040

1.64

30.62

1.9

1.7

40.61

41.77

nmol/l

0.61

630

3926

Mycoses

1739

11266

1.35

30.36

1.8

1.7

41.96

40.73

nmol/l

1.03

1695

11015

Arthrosis

1473

5801

1.41

30.09

2.0

1.7

38.80

41.13

nmol/l

3.53

1429

5668

Myalgia

403

2186

1.87

30.07

2.0

1.6

38.84

42.34

nmol/l

2.29

386

2135

Generalized anxiety disorder

374

1990

1.92

29.87

2.0

1.6

39.81

42.57

nmol/l

1.28

359

1959

Hyperplasia of prostate

1079

4181

1.49

29.69

1.9

1.7

41.18

41.75

nmol/l

0.36

1032

4061

Use of pramipexole

326

1656

2.00

29.67

2.0

1.7

40.40

43.05

nmol/l

1.23

318

1589

Disturbance of activity and attention

363

1884

1.95

29.59

2.0

1.6

36.45

39.59

nmol/l

1.49

348

1867

Injury of muscle and tendon at shoulder and upper arm level

807

5292

1.55

29.46

1.9

1.8

38.43

41.46

nmol/l

4.11

781

5132

Hypothyroidism, other/unspecified

1458

6933

1.39

29.34

2.0

1.6

42.96

43.69

nmol/l

0.40

1422

6737

Gastro-oesophageal reflux disease

1255

7710

1.42

28.97

1.8

1.7

42.07

41.45

nmol/l

0.36

1209

7524

Other disorders of penis

352

1872

1.96

28.81

1.9

1.8

39.19

38.88

nmol/l

0.09

340

1814

Viral hepatitis, IBD co-morbidity

191

805

2.47

28.40

2.2

1.6

49.31

39.45

nmol/l

5.02

179

792

Disorders of the thyroid gland

1657

8017

1.36

28.11

1.9

1.6

43.40

43.10

nmol/l

0.14

1619

7798

Diseases of the ear and mastoid process

2473

9693

1.29

28.07

1.8

1.7

41.18

40.63

nmol/l

0.39

2404

9500

Other pulmonary diagnosis

1711

6359

1.36

27.99

1.9

1.7

39.80

41.73

nmol/l

2.43

1665

6220

Hypothyreosis and Thyroxine purchase for inclusion criteria

1466

7021

1.38

27.83

2.0

1.6

42.93

43.78

nmol/l

0.50

1430

6827

Spondylosis

907

4987

1.50

27.75

1.9

1.7

41.55

42.11

nmol/l

0.28

877

4846

Type 2 diabetes, definitions combined, including avohilmo

1859

8207

1.33

27.06

1.8

1.7

32.52

42.74

nmol/l

66.77

1802

8027

Internal derangement of knee

797

5280

1.52

26.94

1.9

1.7

39.36

41.58

nmol/l

2.35

760

5163

Other disorders of adrenal gland

292

3.45

26.89

2.3

1.5

49.43

42.53

nmol/l

0.76

280

Osteoporosis

231

996

2.19

26.75

1.6

1.8

51.07

43.08

nmol/l

3.50

220

962

Hyperkinetic disorders

376

2042

1.85

26.52

2.0

1.6

36.27

39.19

nmol/l

1.39

361

2023

Injuries to the knee and lower leg

2356

10246

1.28

26.50

1.7

39.99

41.43

nmol/l

2.05

2292

10019

Spinal stenosis

743

3678

1.55

26.41

1.9

1.7

41.79

43.71

nmol/l

1.43

726

3551

Factors influencing health status and contact with health services

889

2978

1.52

26.36

1.9

1.6

38.07

38.99

nmol/l

0.56

857

2936

Other disorders of male genital organs

184

799

2.47

26.24

2.0

1.8

35.57

36.65

nmol/l

0.29

174

776

Type 2 diabetes, strict (exclude DM1)

1834

8188

1.32

26.19

1.8

1.7

32.75

42.76

nmol/l

61.96

1774

8005

Any gastric operation

1811

6876

1.33

25.93

1.8

1.7

40.24

40.30

nmol/l

0.03

1766

6764

GASTRO-related operations

1811

6876

1.33

25.93

1.8

1.7

40.24

40.30

nmol/l

0.03

1766

6764

Type 2 diabetes, definitions combined

1829

8174

1.32

25.92

1.8

1.7

32.61

42.75

nmol/l

64.36

1769

7992

Type 2 diabetes

1954

8770

1.31

25.90

1.8

1.7

34.44

42.42

nmol/l

34.37

1894

8585

Other extrapyramidal and movement disorders in other diseases

361

1991

1.84

25.65

2.0

1.7

41.42

42.26

nmol/l

0.29

348

1917

Visual disturbances

783

5246

1.51

25.60

1.9

1.7

41.67

42.52

nmol/l

0.40

757

5102

Persons encountering health services for other counselling and medical advice, not elsewhere classified

2297

9797

1.28

25.49

1.9

1.7

40.76

40.66

nmol/l

0.05

2253

9560

Panic disorder

349

1915

1.86

25.41

1.9

1.6

37.21

41.85

nmol/l

2.55

337

1886

Impingement syndrome of shoulder

442

2598

1.73

25.27

1.8

1.7

41.34

42.47

nmol/l

0.45

418

2521

Pain, not elsewhere classified

507

3092

1.66

25.11

1.9

1.7

40.39

42.33

nmol/l

0.76

498

3015

Statin medication

1486

6196

1.36

25.08

1.9

1.7

35.43

41.14

nmol/l

13.84

1444

6082

Excluding asthma or asthma-COPD overlap

1685

6359

1.34

24.97

1.9

1.7

39.82

41.73

nmol/l

2.34

1638

6220

Symptoms and signs involving the urinary system

1400

7905

1.36

24.92

1.8

1.7

42.30

41.08

nmol/l

1.10

1345

7709

Other arthrosis

983

4746

1.45

24.85

1.9

1.7

40.46

41.58

nmol/l

0.83

956

4626

Gonarthrosis

1184

4829

1.41

24.81

1.9

1.7

40.28

41.93

nmol/l

1.69

1138

4706

Certain infectious and parasitic diseases

1509

5616

1.36

24.50

1.8

1.6

40.20

41.01

nmol/l

0.59

1466

5500

Diarrhoea and gastroenteritis of presumed infectious origin

1473

9976

1.34

24.42

1.8

1.7

39.50

40.51

nmol/l

0.75

1447

9751

ILD differential diagnosis

1671

6322

1.33

24.35

1.8

1.7

39.77

41.81

nmol/l

2.57

1627

6184

Meniscus derangement

1120

5403

1.41

24.27

1.9

1.7

39.98

41.06

nmol/l

0.81

1090

5276

Bipolar affective disorders

435

2581

1.72

24.17

2.1

1.7

37.07

41.01

nmol/l

2.49

424

2532

Cardiovascular diseases

1541

6213

1.35

24.01

1.8

1.6

37.30

41.01

nmol/l

6.88

1508

6122

COPD differential diagnosis

1669

6328

1.33

23.97

1.8

1.7

39.75

41.81

nmol/l

2.63

1625

6189

Tinnitus

417

2458

1.72

23.64

1.8

1.7

40.78

41.38

nmol/l

0.20

406

2384

Visual disturbances and blindness

815

5591

1.47

23.63

1.9

1.7

42.36

42.40

nmol/l

0.01

788

5433

Diabetes, varying definitions

2052

9419

1.29

23.60

1.8

1.7

35.62

42.11

nmol/l

26.04

1992

9227

Asthma, excluding more controls

1560

6122

1.34

23.54

1.9

1.7

37.93

41.69

nmol/l

7.50

1529

5993

Diabetes mellitus

2057

9427

1.28

23.38

1.8

1.7

35.82

42.10

nmol/l

21.75

1997

9235

Other/unspecified dorsalgia

618

3981

1.56

23.36

1.9

1.7

39.89

42.02

nmol/l

1.48

603

3881

Cough

605

3702

1.56

23.15

1.9

1.6

43.34

43.50

nmol/l

0.05

590

3594

Benign neoplasm of colon, rectum, anus and anal canal

937

5741

1.43

22.91

1.8

1.7

42.20

43.06

nmol/l

0.54

902

5558

Somatoform disorder

280

1486

1.92

22.60

1.9

1.7

39.58

41.42

nmol/l

0.63

275

1452

Asthma

1579

6281

1.33

22.54

1.9

1.7

38.04

41.82

nmol/l

7.65

1548

6145

Other (not insulin) diabetes medications

1833

8445

1.30

22.54

1.8

1.7

32.94

42.66

nmol/l

50.46

1767

8259

Other and unspecified tonsillitis

1049

6380

1.40

22.52

1.8

1.7

36.71

40.19

nmol/l

4.84

1032

6265

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

574

3305

1.57

22.15

1.9

1.6

38.13

39.89

nmol/l

0.70

557

3268

Disorders of adult personality and behaviour

685

4618

1.51

22.07

1.9

1.7

39.06

40.15

nmol/l

0.51

670

4528

Postprocedural endocrine and metabolic disorders, not elsewhere classified

167

738

2.30

21.99

2.0

1.6

44.34

43.19

nmol/l

0.18

162

721

Asthma (mode)

1553

6322

1.32

21.98

1.9

1.7

38.10

41.81

nmol/l

7.30

1525

6184

Diabetes medication

2047

9592

1.27

21.91

1.8

1.7

35.92

42.08

nmol/l

20.79

1981

9396

Malaise and fatigue

825

4616

1.45

21.70

1.9

1.6

43.44

43.04

nmol/l

0.15

809

4479

Other reaction to severe stress, and adjustment disorders

730

5012

1.47

21.31

1.8

1.7

41.54

40.60

nmol/l

0.34

712

4931

Biguanides

1781

8468

1.29

21.28

1.8

1.7

32.88

43.13

nmol/l

54.90

1718

8280

Adrenocortical insufficiency

235

3.41

21.00

2.3

1.5

55.31

42.31

nmol/l

1.44

225

Other diseases of hard tissues of teeth

1123

4235

1.38

20.86

1.8

1.7

40.72

41.11

nmol/l

0.22

1078

4158

Haemorrhoids and perianal venous thrombosis

471

2949

1.61

20.81

1.8

1.7

42.25

42.74

nmol/l

0.20

454

2853

Diseases of the eye and adnexa

1986

7873

1.27

20.48

1.8

1.7

40.59

39.79

nmol/l

0.68

1934

7725

Cervicalgia

320

1831

1.77

20.21

2.0

1.7

41.62

41.73

nmol/l

0.03

305

1778

Nerve, nerve root and plexus disorders

2004

9792

1.26

19.95

1.9

1.7

39.24

41.48

nmol/l

3.96

1929

9584

Benign neoplasm: Colon

761

5084

1.44

19.86

1.9

1.7

42.34

43.70

nmol/l

0.88

730

4911

Dentofacial anomalies [including malocclusion]

1302

7950

1.33

19.79

1.8

1.7

41.32

40.29

nmol/l

0.66

1270

7791

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

601

4040

1.51

19.70

1.9

1.8

28.41

43.13

nmol/l

68.01

578

3929

Glucagon-like peptide-1 (GLP-1) analogues

601

4040

1.51

19.70

1.9

1.8

28.41

43.13

nmol/l

68.01

578

3929

Endometriosis

129

293

2.59

19.69

1.2

60.67

57.47

nmol/l

0.32

129

288

Phobic anxiety disorders

339

1994

1.73

19.54

2.0

1.6

36.10

40.41

nmol/l

2.39

329

1962

Other disorders of patella

346

2048

1.72

19.47

1.8

1.7

37.91

41.20

nmol/l

2.23

331

2006

Disorders of thyroid, IBD co-morbidities

277

1060

1.86

19.33

1.7

1.4

49.31

48.92

nmol/l

0.06

271

1046

Personality disorders

632

4309

1.49

19.33

1.9

1.7

39.44

40.28

nmol/l

0.34

617

4225

Gastrointestinal diseases

1316

4981

1.33

19.32

1.8

1.7

39.10

40.57

nmol/l

1.34

1284

4897

Infections with a predominantly sexual mode of transmission

829

5518

1.41

19.31

1.8

1.7

41.17

40.53

nmol/l

0.23

798

5434

Disturbances of skin sensation

489

3160

1.57

19.19

1.7

39.89

41.65

nmol/l

0.93

475

3086

Injuries to the head

2161

10746

1.24

19.04

1.8

1.7

40.02

41.23

nmol/l

1.52

2101

10513

Subjective visual disturbances

382

2333

1.66

18.98

1.8

1.7

41.52

42.15

nmol/l

0.17

368

2262

Extrapyramidal and movement disorders

504

3285

1.55

18.93

1.9

1.7

41.79

43.30

nmol/l

0.81

488

3154

Enthesopathies of lower limb, excluding foot

389

2391

1.65

18.89

1.9

1.7

39.45

40.81

nmol/l

0.54

376

2332

Social phobias

244

1321

1.90

18.86

1.9

1.7

35.47

39.49

nmol/l

1.81

235

1306

Diseases of the respiratory system

1162

4332

1.35

18.86

1.8

1.6

40.28

43.23

nmol/l

3.15

1125

4229

Other metabolic disorders

181

881

2.09

18.77

2.0

1.6

43.52

43.25

nmol/l

0.04

176

860

Dermatophytosis

1254

9591

1.32

18.77

1.8

1.7

41.35

40.16

nmol/l

0.89

1225

9355

Symptoms and signs involving the skin and subcutaneous tissue

1127

8314

1.34

18.65

1.7

42.18

42.28

nmol/l

0.04

1087

8110

Menorrhagia

105

206

2.84

18.64

1.3

1.2

63.61

56.79

nmol/l

0.41

105

201

Gestational diabetes (for exclusion)

314

1248

1.76

18.59

1.1

1.2

50.89

57.67

nmol/l

1.53

309

1239

Disorders of lacrimal system

500

3256

1.54

18.59

2.0

1.7

42.44

42.79

nmol/l

0.10

483

3157

Other enthesopathies

460

2952

1.58

18.57

2.0

1.6

39.68

41.64

nmol/l

1.00

449

2879

Diaphragmatic hernia

457

2927

1.58

18.56

1.8

1.7

43.57

42.35

nmol/l

0.39

444

2819

Artificial joint operation, meniscal resection

1675

8610

1.27

18.06

1.9

1.8

39.89

40.63

nmol/l

0.69

1623

8391

Hypertensive diseases (excluding secondary)

1217

5363

1.33

18.02

2.0

1.7

33.88

39.88

nmol/l

14.19

1188

5270

Temporomandibular joint disorders, including avohilmo

640

4361

1.46

17.99

1.8

1.6

44.61

43.75

nmol/l

0.29

623

4273

First line medication for Crohn's disease

2299

10165

1.23

17.86

1.9

1.7

39.69

41.02

nmol/l

1.58

2253

9939

Allergic asthma (mode)

464

2959

1.55

17.54

1.8

1.6

37.98

41.77

nmol/l

2.85

458

2908

Allergic asthma (mode), excluding more controls

464

2959

1.55

17.52

1.8

1.6

37.98

41.84

nmol/l

2.94

458

2909

Specific personality disorders

527

3536

1.51

17.52

1.9

1.7

39.29

40.79

nmol/l

0.67

517

3461

Osteopathies and chondropathies

862

5886

1.37

17.15

1.8

1.7

42.22

40.81

nmol/l

0.93

830

5736

817

5902

1.39

17.14

1.9

1.7

35.45

40.70

nmol/l

10.33

803

5775

Other and unspecified polyneuropathies, also in other diseases

331

2007

1.68

17.08

1.8

42.78

42.55

nmol/l

0.06

322

1918

Polyp of the female genital tract

135

3.24

17.00

1.1

1.2

52.91

58.51

nmol/l

0.47

130

Redundant prepuce, phimosis and paraphimosis

771

5548

1.41

16.92

1.9

1.8

34.79

36.64

nmol/l

1.92

753

5433

Allergic conjunctivitis

864

6194

1.37

16.88

1.8

1.7

40.96

40.80

nmol/l

0.06

850

6072

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

825

5857

1.38

16.88

1.8

1.7

41.30

40.69

nmol/l

0.25

813

5749

Mental and behavioural disorders due to opioids

157

767

2.16

16.81

2.6

1.8

45.39

35.36

nmol/l

4.53

145

756

Cervicobrachial syndrome

331

2018

1.66

16.63

2.0

1.7

39.73

41.81

nmol/l

0.96

321

1962

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

2259

0.43

16.52

1.6

1.8

42.34

44.65

nmol/l

0.50

2159

Diabetes mellitus in pregnancy

291

1074

1.75

16.50

1.2

50.96

56.72

nmol/l

1.11

286

1065

Substance abuse, excluding more controls

1235

8171

1.30

16.44

1.9

1.7

40.35

40.66

nmol/l

0.17

1188

7999

Umbilical hernia

628

4418

1.44

16.40

2.0

1.8

36.78

40.90

nmol/l

4.98

606

4287

Other functional intestinal disorders

603

3892

1.45

16.27

1.8

1.6

43.71

43.01

nmol/l

0.28

581

3787

Certain infectious and parasitic diseases

1936

7860

1.24

16.23

1.8

1.7

41.43

40.82

nmol/l

0.38

1882

7693

Dental pulpitis, including avohilmo

1968

10441

1.23

16.04

1.8

1.7

38.80

40.69

nmol/l

2.37

1908

10233

Other disorders of lacrimal gland

411

2662

1.56

15.97

2.0

1.7

42.32

42.73

nmol/l

0.12

395

2584

ILD medications

2304

10361

1.21

15.67

1.8

1.7

39.68

41.13

nmol/l

1.90

2258

10129

Haemorrhage from respiratory passages

529

3264

1.47

15.59

1.7

41.84

43.48

nmol/l

0.82

506

3159

Tonsillectomy and adenotomy

1295

7077

1.28

15.34

1.7

1.8

39.06

39.38

nmol/l

0.16

1272

6953

Fissure and fistula of anal and rectal regions

453

3031

1.51

15.28

1.8

1.7

40.67

41.08

nmol/l

0.13

435

2951

Diseases of oesophagus, stomach and duodenum

2006

9860

1.22

15.24

1.8

1.7

41.61

40.67

nmol/l

0.88

1945

9648

Metabolic disorders

1785

8852

1.24

15.19

1.9

1.7

38.78

40.77

nmol/l

2.47

1730

8657

Pain in limb

1467

7819

1.26

15.17

1.8

1.6

40.74

41.92

nmol/l

0.91

1431

7657

Polyneuropathies and other disorders of the peripheral nervous system

370

2376

1.58

15.12

1.8

42.26

42.50

nmol/l

0.07

360

2280

Deforming dorsopathies

418

2760

1.53

14.96

2.0

1.7

40.54

41.73

nmol/l

0.47

403

2694

Gonarthrosis [arthrosis of knee](FG)

1323

6053

1.28

14.85

1.9

1.7

40.54

41.84

nmol/l

1.29

1273

5888

Cardiovascular diseases (excluding rheumatic etc)

1493

6858

1.26

14.83

1.9

1.7

36.31

40.81

nmol/l

9.78

1459

6751

Excessive attrition of teeth

1032

7955

1.31

14.82

1.8

1.7

42.04

41.09

nmol/l

0.56

999

7773

1959

8301

1.22

14.80

1.8

1.7

39.61

42.57

nmol/l

6.18

1908

8088

Autoimmune diseases

2358

10016

1.20

14.78

1.8

1.7

42.46

40.16

nmol/l

3.91

2302

9787

Symptoms and signs involving speech and voice

396

2590

1.54

14.78

1.7

45.64

43.74

nmol/l

0.68

387

2494

Endometriosis of pelvic peritoneum

179

3.16

14.72

1.1

1.2

65.27

57.99

nmol/l

0.50

174

Hypertension, essential

1584

7215

1.25

14.67

1.9

1.8

35.57

41.05

nmol/l

14.92

1538

7065

Asthma (only as main-diagnosis), excluding more controls

1354

6122

1.27

14.58

1.9

1.7

38.12

41.69

nmol/l

6.04

1326

5993

Infections with a predominantly sexual mode of transmission

581

4112

1.43

14.50

1.7

41.42

40.52

nmol/l

0.31

556

4045

Fenamates

189

679

1.91

14.42

1.7

1.5

42.47

49.31

nmol/l

2.48

179

666

Dental operations

1152

4580

1.30

14.42

1.9

1.7

40.36

41.51

nmol/l

0.85

1112

4485

Dysphagia

335

2125

1.59

14.37

1.8

1.7

44.32

43.00

nmol/l

0.42

322

2045

Orchitis and epididymitis

276

1682

1.69

14.32

1.9

1.8

39.06

39.10

nmol/l

0.01

268

1627

Chronic laryngitis and laryngotracheitis

192

1052

1.85

14.22

1.8

1.7

40.81

43.15

nmol/l

0.71

180

1018

Triptan medication for migraine, min. 3 purchases

834

4763

1.34

14.20

1.8

1.6

42.48

42.59

nmol/l

0.03

822

4673

Diverticular disease of intestine

1105

5478

1.30

14.03

1.8

1.7

41.07

41.79

nmol/l

0.48

1059

5336

Allergic rhinitis

602

4275

1.41

13.91

1.9

1.7

39.68

40.29

nmol/l

0.22

590

4191

Other external causes of accidental injury

1547

6243

1.25

13.83

1.7

40.96

41.93

nmol/l

0.74

1497

6131

Viral infections characterized by skin and mucous membrane lesions

1565

10894

1.23

13.80

1.9

1.7

41.63

41.15

nmol/l

0.27

1533

10637

Asthma, hospital admission 2, infections

980

7414

1.30

13.78

1.9

1.7

36.22

41.28

nmol/l

11.05

964

7231

Asthma-related infections

980

7414

1.30

13.78

1.9

1.7

36.22

41.28

nmol/l

11.05

964

7231

Accidents

1546

6243

1.25

13.75

1.7

40.99

41.93

nmol/l

0.71

1496

6131

Diseases of oral cavity, salivary glands and jaws

1067

4238

1.30

13.62

1.9

1.7

41.05

41.11

nmol/l

0.02

1028

4161

Asthma (only as main-diagnosis)

1358

6281

1.26

13.45

1.9

1.7

38.15

41.82

nmol/l

6.37

1329

6145

Cardiac arrhythmias

1194

6123

1.28

13.44

2.0

1.7

39.14

41.56

nmol/l

2.80

1159

6020

Disorders of lipoprotein metabolism and other lipidaemias

1524

7662

1.24

13.26

1.9

1.7

37.82

40.62

nmol/l

4.43

1474

7479

Other diseases of blood and blood-forming organs

139

705

2.02

13.20

2.2

1.8

35.32

39.15

nmol/l

1.23

133

676

Symptoms and signs involving the nervous and musculoskeletal systems

862

6586

1.32

13.19

1.9

1.7

41.70

42.72

nmol/l

0.55

844

6389

Candidiasis

377

2506

1.52

13.13

1.7

1.6

43.81

43.62

nmol/l

0.04

365

2434

ILD medications: prednisolone, methylprednisolone, prednisone

2155

10120

1.20

13.04

1.8

1.7

39.75

41.14

nmol/l

1.73

2111

9890

Gingivitis and periodontal diseases

1948

8350

1.21

13.03

1.7

40.37

41.20

nmol/l

0.72

1877

8186

Blepharochalasis

251

1520

1.66

13.01

1.5

1.7

45.26

45.21

nmol/l

0.01

245

1448

Spondylolisthesis/Spondylolysis

260

1592

1.65

12.99

2.1

1.7

38.33

41.29

nmol/l

1.55

246

1548

Malignant neoplasm of digestive organs

254

3224

0.62

12.90

1.6

1.7

45.38

43.73

nmol/l

0.32

237

3102

Other hypertrichosis

27.73

12.85

1.4

1.3

41.59

29.86

nmol/l

—

COPD, early/later onset

318

4091

0.65

12.80

1.8

1.7

42.86

44.78

nmol/l

0.67

300

3920

Diseases of appendix

1459

10753

1.23

12.55

1.8

1.7

39.99

40.68

nmol/l

0.39

1433

10498

Sleep disorders, other/unspecified

364

2.42

12.45

2.2

1.7

43.72

41.29

nmol/l

0.33

356

Appendicitis, broad definition

1451

10742

1.23

12.38

1.8

1.7

39.98

40.66

nmol/l

0.38

1425

10487

Hypothyroidism, strict autoimmune

1036

5338

1.28

12.37

1.7

1.5

44.60

44.11

nmol/l

0.19

1013

5192

Anomalies of dental arch relationship, including avohilmo

370

2235

1.51

12.36

1.9

1.7

40.34

40.48

nmol/l

0.03

363

2186

Fall on same level

2280

10556

1.18

12.27

1.8

1.7

40.64

40.93

nmol/l

0.20

2200

10346

Other shoulder lesions

173

965

1.83

12.24

1.9

1.7

41.49

40.88

nmol/l

0.06

168

939

Infections of the skin and subcutaneous tissue

1261

10109

1.24

12.16

1.9

1.7

38.14

40.14

nmol/l

2.24

1223

9886

COPD, hospital admissions

317

4047

0.66

12.14

1.8

1.7

42.79

44.76

nmol/l

0.69

299

3876

Atherosclerosis, excluding cerebral and coronary sclerosis

244

3090

0.62

12.12

1.6

1.7

45.17

45.43

nmol/l

0.05

229

2951

Disorders of ocular muscles, binocular movement, accommodation and refraction

807

6145

1.31

12.00

1.7

40.66

41.23

nmol/l

0.25

788

5993

Hallux rigidus

155

839

1.87

11.99

1.7

1.6

46.03

44.00

nmol/l

0.46

148

809

Hypertension

1594

7410

1.22

11.94

1.9

1.8

35.17

41.01

nmol/l

17.24

1549

7258

Hypertensive diseases

1594

7414

1.22

11.90

1.9

1.8

35.17

41.01

nmol/l

17.24

1549

7262

Nasal polyp

367

2485

1.50

11.86

1.7

40.18

41.09

nmol/l

0.38

357

2412

Anaemias

453

2057

1.45

11.86

2.0

1.5

44.33

43.64

nmol/l

0.16

444

2039

Asthma, including avohilmo

2264

10815

1.18

11.82

1.9

1.7

38.26

41.51

nmol/l

8.14

2220

10562

Hernia of abdominal wall, postoperative

323

2132

1.53

11.77

1.9

1.7

39.19

41.29

nmol/l

0.87

311

2080

Abnormal findings on examination of blood, without diagnosis

837

5942

1.30

11.76

1.8

1.7

42.02

42.87

nmol/l

0.50

821

5736

Triptan medication for migraine, single purchase ok

1440

8001

1.23

11.57

1.9

1.7

39.10

39.64

nmol/l

0.35

1416

7848

Migraine, single triptan purchase ok & required. ICD-code if available is included

1440

8001

1.23

11.57

1.9

1.7

39.10

39.64

nmol/l

0.35

1416

7848

Other viral diseases

779

5946

1.31

11.55

1.9

1.7

38.68

39.96

nmol/l

0.65

764

5828

Anogenital herpesviral [herpes simplex] infection

205

1224

1.70

11.45

1.9

1.6

45.44

42.38

nmol/l

0.50

195

1202

Mental and behavioural disorders due to sedatives or hypnotics

188

1107

1.75

11.24

2.4

1.9

40.40

36.67

nmol/l

1.23

177

1081

Other disorders of eyelid

429

2868

1.43

11.22

1.7

43.11

45.13

nmol/l

1.04

417

2740

Acute appendicitis

1375

10584

1.22

11.14

1.8

1.7

39.79

40.58

nmol/l

0.44

1352

10332

Other symptoms and signs involving the digestive system and abdomen

152

837

1.83

11.13

2.0

1.6

42.73

43.81

nmol/l

0.20

146

806

Any reimbursement code in KELA

1410

5784

1.23

11.08

1.8

1.6

38.10

41.47

nmol/l

5.04

1375

5700

Lateral epicondylitis

228

1413

1.64

11.00

2.2

1.7

38.60

40.92

nmol/l

0.76

223

1374

Other symptoms and signs involving cognitive functions and awareness

616

4200

1.34

10.87

1.8

1.7

42.12

42.46

nmol/l

0.13

593

4064

Colonic or urogenital fistula

463

3334

1.40

10.72

1.8

40.79

40.83

nmol/l

0.01

445

3236

Solid cancers, helper endpoint

1050

7708

0.80

10.72

1.8

41.75

40.74

nmol/l

0.54

1028

7518

Hernia of abdominal wall

820

6417

1.29

10.69

1.9

1.7

38.18

41.94

nmol/l

4.86

788

6232

Soft tissue disorders related to use, overuse and pressure

394

2759

1.44

10.65

1.9

1.7

40.96

41.58

nmol/l

0.20

381

2682

Benign neoplasm: Sigmoid colon

264

1707

1.56

10.62

1.7

41.70

42.81

nmol/l

0.32

252

1637

Malignant neoplasm

1090

7977

0.80

10.62

1.8

41.47

40.65

nmol/l

0.44

1067

7786

Gonarthrosis,primary

1311

6612

1.23

10.60

1.9

1.7

41.18

42.42

nmol/l

1.23

1259

6432

Disorders of vestibular function (Vertigo)

521

3765

1.37

10.52

1.8

1.7

43.50

43.22

nmol/l

0.09

503

3636

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

849

6592

1.28

10.50

1.9

1.7

41.78

43.17

nmol/l

0.82

824

6401

Complications of medical and surgical care

1062

7874

1.25

10.49

1.9

1.7

42.44

42.78

nmol/l

0.12

1026

7667

Vocal cord dysfunction

205

1118

1.66

10.48

1.7

1.6

43.65

44.16

nmol/l

0.08

198

1091

Stroke, excluding SAH

512

5058

0.73

10.40

1.7

43.22

43.17

nmol/l

0.01

490

4883

COPD, hospital admissions 1, only main diagnosis

205

2810

0.62

10.39

1.9

1.7

45.15

45.04

nmol/l

0.02

194

2675

Diseases of salivary glands

459

3317

1.40

10.37

1.8

1.7

41.54

41.52

nmol/l

0.01

443

3227

Stroke, including SAH

564

5457

0.75

10.37

1.7

43.08

42.89

nmol/l

0.06

540

5280

Spermatocele

188

1133

1.70

10.31

1.8

42.91

41.27

nmol/l

0.51

183

1085

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

647

4947

1.32

10.18

1.9

1.8

37.31

38.90

nmol/l

1.21

634

4830

Peripheral artery disease

302

3535

0.68

10.13

1.6

1.7

44.71

44.80

nmol/l

0.02

285

3382

Conjunctivitis

1253

8612

1.22

10.10

1.8

1.7

40.85

40.40

nmol/l

0.21

1220

8435

Other viral diseases, not elsewhere classified

512

3771

1.36

9.99

1.8

1.7

39.16

40.58

nmol/l

0.56

503

3693

COPD, hospital admission 2, with asthma infections

200

2732

0.62

9.97

1.8

1.7

41.61

44.61

nmol/l

0.93

191

2612

Functional dyspepsia

339

2341

1.46

9.90

1.6

1.7

39.65

41.99

nmol/l

1.32

330

2274

Infections, IBD-co-morbidities

245

1118

1.58

9.86

1.7

1.5

40.51

43.69

nmol/l

1.13

237

1102

1488

7521

1.20

9.85

1.8

1.7

40.25

42.52

nmol/l

2.76

1447

7338

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1488

7521

1.20

9.85

1.8

1.7

40.25

42.52

nmol/l

2.76

1447

7338

Diseases of external ear

540

4041

1.35

9.82

1.9

1.7

43.04

41.92

nmol/l

0.24

504

3926

Any event in cancer register

1220

8714

0.82

9.82

1.8

1.7

41.66

41.45

nmol/l

0.09

1192

8513

Mixed and other personality disorders

192

1180

1.66

9.76

2.1

1.8

37.40

38.50

nmol/l

0.25

184

1155

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

772

6055

1.28

9.75

1.9

1.7

41.55

43.39

nmol/l

1.16

751

5863

Carpal tunnel syndrome

845

5902

1.27

9.74

1.9

1.7

38.69

42.73

nmol/l

5.77

815

5756

Benign paroxysmal vertigo

296

1999

1.49

9.68

1.8

1.7

43.49

43.34

nmol/l

0.03

285

1924

Abnormal serum enzyme levels

587

4345

1.33

9.67

1.7

43.04

43.97

nmol/l

0.46

579

4165

Substance use, excluding alcohol

498

3699

1.36

9.67

2.1

1.8

40.78

37.65

nmol/l

2.06

475

3627

Other chronic obstructive pulmonary disease

318

3771

0.69

9.55

1.8

1.7

42.86

44.49

nmol/l

0.53

300

3621

Other and unspecified disorders of skin and subcutaneous tissue

434

2.09

9.49

1.8

1.7

47.17

41.31

nmol/l

0.92

415

Dermatitis

907

7257

1.25

9.48

1.8

1.7

41.97

42.18

nmol/l

0.08

880

7072

Heart failure, strict

498

4705

0.74

9.47

1.6

1.7

42.92

43.67

nmol/l

0.29

474

4527

Other chronic obstructive pulmonary disease, including avohilmo

453

5067

0.73

9.39

1.8

1.7

42.98

43.73

nmol/l

0.26

430

4886

Influenza and pneumonia

1980

10825

1.17

9.34

1.8

1.7

39.14

41.10

nmol/l

3.02

1933

10592

Sequelae of injuries, of poisoning and of other consequences of external causes

501

3744

1.35

9.32

1.9

1.8

39.65

39.23

nmol/l

0.15

486

3655

Pain associated with micturition

147

849

1.75

9.31

1.9

1.7

40.99

42.05

nmol/l

0.21

137

824

Malignant neoplasm of prostate

402

3319

0.72

9.31

1.7

44.29

43.91

nmol/l

0.12

389

3196

Pure hypercholesterolaemia

1272

6881

1.21

9.29

1.9

1.7

38.23

41.23

nmol/l

4.50

1223

6707

Persons encountering health services in circumstances related to reproduction

1396

7873

1.20

9.28

1.8

37.50

37.21

nmol/l

0.17

1380

7722

Falls/tendency to fall

2151

9300

1.16

9.26

1.8

1.7

41.45

40.85

nmol/l

0.48

2084

9115

Obsessive-compulsive disorder

155

915

1.73

9.19

2.0

1.6

37.07

40.01

nmol/l

0.80

155

905

Other symptoms and signs involving the urinary system

191

1189

1.63

9.19

2.0

1.8

40.70

41.52

nmol/l

0.19

186

1150

Other and unspecified dermatitis

730

5741

1.28

9.16

1.8

1.7

42.25

42.39

nmol/l

0.05

706

5588

Melanocytic naevi

440

3228

1.37

9.14

1.7

43.96

42.28

nmol/l

0.52

434

3141

Viral warts

408

2961

1.39

9.13

1.9

1.7

41.28

40.02

nmol/l

0.40

401

2887

Emotionally unstable personality disorder

235

1538

1.55

9.09

2.0

1.7

43.01

41.45

nmol/l

0.39

229

1512

Diseases of middle ear and mastoid

1168

7899

1.22

9.08

1.7

39.45

40.18

nmol/l

0.41

1143

7734

All-cause Heart Failure

485

4573

0.74

9.06

1.6

1.7

43.28

43.81

nmol/l

0.19

461

4397

Other diseases of lip and oral mucosa

559

4254

1.32

9.06

1.8

1.7

42.08

41.40

nmol/l

0.27

537

4138

Pollen allergy

365

2569

1.42

9.06

1.9

1.7

39.91

39.52

nmol/l

0.09

357

2518

Any event in hilmo or specialist outpatient

3.84

9.04

1.7

1.3

35.88

42.33

nmol/l

0.93

External causes of morbidity and mortality

1190

4902

1.22

9.02

1.8

1.6

40.38

42.09

nmol/l

1.48

1152

4821

Other disorders of ear

1504

8313

1.19

8.97

1.8

1.7

42.28

41.25

nmol/l

0.92

1445

8118

Other and unspecified nerve root and plexus disorders, also in other diseases

362

2585

1.42

8.93

2.0

1.7

38.91

40.59

nmol/l

0.82

351

2522

Adhesive capsulitis of shoulder

213

1370

1.57

8.85

1.8

1.7

43.21

42.50

nmol/l

0.17

205

1326

Injuries to the ankle and foot

1385

10373

1.19

8.84

1.8

1.7

40.64

40.23

nmol/l

0.22

1350

10159

Other and unspecified disorders of vitreous body

391

2788

1.39

8.82

1.8

1.7

43.85

44.78

nmol/l

0.36

372

2660

Congenital malformations, deformations and chromosomal abnormalities

1230

9455

1.20

8.82

1.8

1.7

39.71

40.22

nmol/l

0.29

1203

9255

Finngen Rheumatological endpoints

1909

9349

1.17

8.76

1.9

1.7

39.45

41.18

nmol/l

2.08

1854

9148

Disorders of refraction and accommodation

452

3342

1.36

8.75

1.7

39.45

41.30

nmol/l

0.77

443

3266

Any dementia

117

1436

0.56

8.70

1.4

1.7

54.80

48.48

nmol/l

1.15

111

1350

Implicit viral Sepsis

406

2967

1.38

8.64

2.0

1.7

41.63

42.38

nmol/l

0.25

392

2870

Actinic keratosis

303

1944

1.45

8.62

1.7

49.11

47.98

nmol/l

0.34

290

1837

COPD, hospital admissions 3, with asthma pneumonia sepsis

147

2069

0.60

8.52

1.8

1.7

42.63

45.54

nmol/l

0.63

139

1970

Disorders of synovium and tendon

846

5971

1.25

8.52

1.9

1.6

41.05

41.95

nmol/l

0.49

822

5842

Asthma, hospital admissions , main diagnosis only

1387

10342

1.19

8.51

1.9

1.7

38.06

41.54

nmol/l

6.23

1358

10102

Skin changes due to chronic exposure to nonionizing radiation

311

2002

1.44

8.51

1.7

49.16

47.86

nmol/l

0.40

298

1891

COPD

351

3976

0.72

8.50

1.8

1.7

44.24

44.23

nmol/l

0.00

330

3824

Hypothyroidism, drug reimbursement

202

903

1.59

8.49

1.7

1.5

42.10

46.87

nmol/l

1.78

192

889

Presence of other devices

235

1551

1.52

8.49

1.6

1.7

43.71

46.42

nmol/l

1.27

223

1489

Dyspnoea

1425

8906

1.19

8.48

1.9

1.7

39.09

42.48

nmol/l

6.90

1387

8674

COPD related to multimorbidity

268

3281

0.69

8.48

1.9

1.7

41.80

45.62

nmol/l

1.64

251

3129

Caries of enamel

1690

10461

1.17

8.44

1.8

1.7

40.42

40.20

nmol/l

0.11

1626

10255

Other benign neoplasms of skin

440

3271

1.35

8.40

1.8

1.7

42.39

42.77

nmol/l

0.12

415

3162

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

1667

0.53

8.39

2.0

1.8

47.00

44.24

nmol/l

0.24

1589

Complications of procedures, not elsewhere classified

1302

9065

1.19

8.38

1.8

1.7

41.62

41.87

nmol/l

0.13

1253

8849

Persons with potential health hazards related to communicable diseases

752

5958

1.26

8.34

1.7

40.95

40.57

nmol/l

0.11

743

5839

Heart failure,strict

486

4515

0.75

8.27

1.7

42.47

43.48

nmol/l

0.43

463

4352

Other follicular disorders

154

937

1.68

8.21

1.8

37.28

39.52

nmol/l

0.64

147

915

Malignant neoplasm of prostate, including Hilmo

450

3552

0.75

8.13

1.6

1.8

44.70

43.54

nmol/l

0.50

435

3425

Emergency coronary revascularization (for ACS)

1434

7395

1.18

8.07

1.9

1.8

38.84

40.46

nmol/l

2.11

1391

7197

Percutaneous Coronary Intervention

1373

7116

1.19

8.05

1.9

1.8

38.43

40.40

nmol/l

2.82

1333

6928

Inflammatory bowel disease treatment related agents

2177

10667

1.15

7.87

1.8

1.7

40.03

41.02

nmol/l

1.02

2135

10425

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

479

3631

1.32

7.85

1.8

1.6

42.49

41.97

nmol/l

0.13

458

3577

Acute appendicitis, no complications

1122

9360

1.20

7.82

1.8

1.7

40.19

nmol/l

0.00

1105

9151

Benign neoplasm: Rectum, anus and anal canal

257

1769

1.47

7.79

1.9

1.8

41.44

43.33

nmol/l

0.69

249

1697

Malignant neoplasm, wide definition for exclusion

1215

8451

0.84

7.77

1.8

41.60

40.48

nmol/l

0.70

1188

8258

Other disorders of bone

364

2667

1.38

7.77

1.8

38.77

39.49

nmol/l

0.26

351

2602

Urticaria and erythema

503

3862

1.31

7.72

1.8

1.7

42.47

42.07

nmol/l

0.08

487

3768

Coronary revascularization (ANGIO or CABG)

1371

7124

1.18

7.71

1.9

1.8

38.30

40.38

nmol/l

3.14

1331

6936

Conjunctivitis (acute, non atopic)

458

3462

1.33

7.70

1.7

40.54

40.86

nmol/l

0.08

440

3386

Viral hepatitis

200

1319

1.55

7.68

2.2

1.8

48.57

36.27

nmol/l

7.95

188

1289

Ischaemic Stroke, excluding all haemorrhages

473

4599

0.76

7.66

1.7

43.30

43.62

nmol/l

0.10

451

4433

COPD/asthma/ILD related infections

1740

7523

1.16

7.58

1.8

1.7

39.62

42.53

nmol/l

5.30

1697

7340

COPD/asthma related infections

1740

7523

1.16

7.58

1.8

1.7

39.62

42.53

nmol/l

5.30

1697

7340

Other symptoms and signs involving the nervous and musculoskeletal systems

591

4645

1.28

7.57

2.0

1.7

40.00

42.38

nmol/l

1.46

582

4506

Hypothyroidism, strict autoimmune, 3 medication purchases required

1035

5801

1.21

7.55

1.7

1.6

44.83

44.54

nmol/l

0.10

1012

5627

Hydrocele

260

1811

1.46

7.52

1.6

1.7

41.78

40.50

nmol/l

0.42

251

1744

Ischemic heart diseases

1436

7367

1.18

7.46

1.9

1.8

38.13

40.36

nmol/l

3.74

1401

7178

Chromosomal abnormalities, not elsewhere classified

246

2.32

7.45

2.3

1.7

34.13

36.63

nmol/l

0.45

240

Ovarian dysfunction: androgen excess

+∞

7.43

1.6

0.0

31.57

—

nmol/l

—

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

230

1575

1.50

7.42

2.2

1.8

41.82

36.20

nmol/l

2.75

222

1548

Diseases of inner ear

648

4994

1.26

7.35

1.8

1.7

43.27

42.71

nmol/l

0.22

626

4828

Seborrhoeic dermatitis

177

1145

1.57

7.34

2.0

1.8

39.77

40.50

nmol/l

0.17

171

1105

Other heart diseases

1025

5572

1.21

7.31

1.9

1.7

38.04

40.11

nmol/l

2.20

997

5478

Herpesviral [herpes simplex] infections

330

2402

1.38

7.31

1.9

1.7

40.44

42.83

nmol/l

0.62

325

2341

Other medical care

344

4187

0.73

7.30

1.8

1.7

42.74

43.74

nmol/l

0.37

332

4035

Other heart diseases, wide

1775

9440

1.15

7.29

1.9

1.7

39.44

39.97

nmol/l

0.41

1723

9257

Other disorders of skin and subcutaneous tissue, not elsewhere classified

192

1264

1.53

7.29

1.9

1.7

43.59

42.19

nmol/l

0.29

179

1211

Benign neoplasm: Rectum

236

1626

1.47

7.17

1.9

1.8

40.65

43.04

nmol/l

0.94

229

1558

Other viral hepatitis

185

1220

1.55

7.17

2.2

1.9

48.28

36.09

nmol/l

8.05

173

1195

Heartburn

170

1095

1.57

7.15

1.7

1.8

38.31

41.31

nmol/l

0.92

162

1059

Excessive earwax

814

6518

1.22

7.09

1.8

1.7

40.61

41.96

nmol/l

0.75

779

6336

Benign lipomatous neoplasm

412

3118

1.33

7.09

1.8

40.72

41.54

nmol/l

0.23

404

3016

Thyrotoxicosis, other and/or unspecified

191

1268

1.52

6.95

1.7

51.70

43.32

nmol/l

2.16

186

1229

Organic, including symptomatic, mental disorders

331

3190

0.73

6.92

1.7

49.97

44.16

nmol/l

2.72

315

3044

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

170

1106

1.56

6.92

2.0

1.7

36.84

38.12

nmol/l

0.36

165

1083

Fever of other and unknown origin

915

6771

1.21

6.90

1.9

1.7

41.07

41.67

nmol/l

0.30

897

6595

Mycoses

395

2987

1.33

6.86

1.8

1.7

45.05

41.48

nmol/l

1.38

385

2896

Other spirochaetal diseases

410

3116

1.32

6.86

1.7

45.20

41.23

nmol/l

2.63

395

3011

Erosion of teeth , including avohilmo

456

3521

1.31

6.84

1.9

1.7

43.97

40.50

nmol/l

1.53

439

3443

Other predominantly sexually transmitted diseases, not elsewhere classified

385

2905

1.34

6.83

1.8

1.7

37.78

40.33

nmol/l

1.21

373

2858

Hypertrophic disorders of skin

482

1.86

6.83

1.9

1.6

43.26

40.77

nmol/l

0.35

469

Cerebrovascular diseases

769

6584

0.82

6.81

1.7

42.42

42.26

nmol/l

0.07

734

6390

Other sexually transmitted chlamydial diseases

258

1834

1.43

6.75

1.7

1.6

42.61

39.33

nmol/l

0.74

248

1811

Vasomotor rhinitis (mode)

101

579

1.77

6.74

1.9

1.7

40.59

40.21

nmol/l

0.07

561

Constipation

1270

7511

1.17

6.73

1.9

1.7

43.59

42.33

nmol/l

0.93

1217

7318

Later onset COPD

1348

0.58

6.71

1.6

50.77

51.32

nmol/l

0.06

1255

Dementia

177

1826

0.66

6.66

1.6

1.7

54.59

47.62

nmol/l

2.21

167

1718

Contact with and exposure to communicable diseases

594

4732

1.26

6.66

1.7

41.22

40.93

nmol/l

0.07

588

4641

Sequelae of external causes of morbidity and mortality

345

2570

1.35

6.65

1.9

1.7

42.89

41.74

nmol/l

0.38

333

2480

Benign neoplasm: Ascending colon

166

1082

1.55

6.65

2.0

1.8

42.49

43.41

nmol/l

0.23

159

1033

Thyrotoxicosis

224

1550

1.45

6.64

1.7

50.41

43.75

nmol/l

1.82

219

1502

Hypertrophic scar

444

1.88

6.62

1.9

1.6

41.51

41.12

nmol/l

0.05

431

Ganglion

278

2003

1.40

6.60

1.9

1.6

41.86

41.53

nmol/l

0.08

272

1957

Other disorders of veins

409

3105

1.32

6.59

1.7

43.64

42.89

nmol/l

0.24

391

3002

Urolithiasis

542

4298

1.27

6.58

1.7

41.01

42.23

nmol/l

0.58

526

4139

Anogenital herpesviral [herpes simplex] infection

113

674

1.71

6.57

1.8

1.7

42.87

41.78

nmol/l

0.15

107

658

Dislocation, sprain and strain of joints and ligaments at neck level

282

2043

1.40

6.55

2.0

1.8

40.94

39.68

nmol/l

0.35

277

1995

Symptoms and signs involving cognition, perception, emotional state and behaviour

1635

9728

1.15

6.53

1.8

1.7

42.25

41.31

nmol/l

0.74

1576

9509

Poisoning by drugs, medicaments and biological substances

476

3721

1.29

6.53

2.0

1.7

40.83

39.64

nmol/l

0.46

454

3645

Myocardial infarction

538

4762

0.79

6.52

1.7

40.81

42.66

nmol/l

1.26

512

4614

Oedema, not elsewhere classified

392

2942

1.32

6.50

1.8

1.7

42.35

43.19

nmol/l

0.28

380

2836

Disorders of conjunctiva

1361

9434

1.16

6.47

1.8

1.7

41.71

40.64

nmol/l

0.68

1325

9235

Heart failure and coronary heart disease

349

3283

0.75

6.45

1.6

1.7

42.58

44.42

nmol/l

0.85

335

3150

Any dementia, excluding more controls

115

1293

0.61

6.43

1.4

1.6

53.69

48.29

nmol/l

0.98

109

1215

Chronic viral hepatitis

165

1092

1.55

6.38

2.3

1.8

49.84

35.84

nmol/l

8.94

153

1071

332

2263

1.35

6.37

1.7

48.62

47.09

nmol/l

0.51

317

2145

Other diseases of anus and rectum

367

2772

1.33

6.34

1.8

1.7

41.01

42.26

nmol/l

0.50

352

2685

Abrasion of teeth

415

3197

1.31

6.32

1.7

44.73

41.56

nmol/l

1.67

407

3103

Myocardial infarction, strict

505

4536

0.79

6.28

1.7

41.62

43.00

nmol/l

0.75

485

4392

Other spirochaetal diseases

399

3063

1.31

6.26

1.8

1.7

45.38

41.35

nmol/l

2.62

384

2958

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

571

4586

1.25

6.25

1.7

40.05

39.68

nmol/l

0.12

560

4486

Injuries to the abdomen, lower back, lumbar spine and pelvis

619

4956

1.24

6.25

1.7

42.84

40.78

nmol/l

1.22

602

4824

Calculus of kidney and ureter

507

4017

1.27

6.23

1.7

1.8

40.16

42.00

nmol/l

1.04

492

3871

Other disorders of the musculoskeletal system and connective tissue

204

1409

1.46

6.20

2.0

1.8

39.75

41.45

nmol/l

0.54

199

1358

Nontoxic goitre/thyroid nodule

168

1114

1.51

6.18

1.7

42.23

45.80

nmol/l

1.06

163

1072

Dementia, including avohilmo

201

1990

0.69

6.15

1.5

1.7

53.32

47.14

nmol/l

2.11

191

1878

Disorders of vitreous body and globe

523

3993

1.26

6.15

1.8

1.7

44.90

43.76

nmol/l

0.53

500

3836

Lyme disease

393

3022

1.31

6.10

1.8

1.7

45.27

41.37

nmol/l

2.44

379

2919

Undetermined asthma, excluding more controls

169

1127

1.51

6.10

2.1

1.7

36.33

43.09

nmol/l

4.03

163

1091

Disorders of vitreous body

505

3866

1.27

6.09

1.8

1.7

44.89

43.73

nmol/l

0.53

482

3711

Acute bronchitis

604

4800

1.24

6.02

1.7

37.17

41.27

nmol/l

4.56

588

4668

Persons encountering health services in other circumstances

644

5231

1.23

6.01

1.8

1.7

40.68

41.73

nmol/l

0.44

631

5080

Heart failure and bmi 25plus

321

2879

0.75

5.97

1.7

1.8

39.94

39.60

nmol/l

0.10

302

2766

Spirochaetal infections, other/unspecified

395

3050

1.30

5.96

1.8

1.7

45.12

41.33

nmol/l

2.34

381

2946

Other disorders of prostate

375

1.91

5.93

2.0

1.8

42.77

42.46

nmol/l

0.04

359

Chronic lower respiratory diseases

2252

10726

1.12

5.92

1.8

1.7

38.54

41.32

nmol/l

6.06

2196

10488

Undetermined asthma

169

1135

1.50

5.91

2.1

1.7

36.33

43.05

nmol/l

4.01

163

1100

Disorders of tooth development and eruption

301

1807

1.36

5.89

1.8

1.7

41.54

39.64

nmol/l

0.61

294

1777

Sensorineural hearing loss

1036

5983

1.18

5.87

1.7

42.98

42.11

nmol/l

0.60

986

5823

Other and unspecified follicular disorders

516

1.77

5.85

2.0

1.8

38.29

39.11

nmol/l

0.12

500

Viral infections characterized by skin and mucous membrane lesions

726

6022

1.21

5.77

1.9

1.7

40.65

40.70

nmol/l

0.02

716

5881

Benign neoplasm: Colon, unspecified

299

2232

1.35

5.75

1.8

1.7

42.54

44.30

nmol/l

0.64

284

2132

Other predominantly sexually transmitted diseases, not elsewhere classified

290

2157

1.36

5.75

1.8

1.7

39.84

40.51

nmol/l

0.16

279

2119

Other sexually transmitted chlamydial diseases

172

1173

1.49

5.73

1.7

41.48

38.90

nmol/l

0.53

164

1156

Viral and other specified intestinal infections

608

4789

1.23

5.73

1.8

1.7

39.91

38.98

nmol/l

0.23

601

4705

Otitis externa

346

2642

1.32

5.72

1.8

1.7

44.27

40.89

nmol/l

0.62

327

2574

Care involving use of rehabilitation procedures

1035

8149

1.17

5.67

1.8

1.7

39.45

41.49

nmol/l

1.77

1018

7947

Benign neoplasm of other and ill-defined parts of digestive system

182

1252

1.46

5.66

1.7

1.8

42.07

43.17

nmol/l

0.16

177

1199

Recurrent dislocation and subluxation of joint

151

1004

1.53

5.66

2.1

1.7

35.66

37.60

nmol/l

0.67

146

986

Testicular hyperfunction

20.24

5.65

2.9

1.3

22.78

37.73

nmol/l

—

Disorders of continuity of bone

152

1013

1.52

5.60

1.9

1.8

40.59

39.37

nmol/l

0.26

146

984

Visual field defects

111

689

1.63

5.57

2.3

1.8

45.39

42.08

nmol/l

0.53

106

663

Zoster [herpes zoster]

551

4391

1.24

5.57

1.8

1.7

44.07

43.09

nmol/l

0.40

535

4234

Other disorders of skin and subcutaneous tissue

892

6726

1.18

5.43

1.8

1.7

43.14

42.70

nmol/l

0.19

868

6526

Congenital malformations, deformations and chromosomal abnormalities

1099

9042

1.16

5.41

1.8

1.7

39.75

40.16

nmol/l

0.20

1078

8858

Other diseases of liver

275

2050

1.35

5.41

1.9

1.8

37.73

40.00

nmol/l

0.69

265

1985

Other diseases of blood and blood-forming organs, wide

295

2221

1.34

5.40

2.1

1.8

39.62

41.61

nmol/l

0.66

282

2150

Sacrococcygeal disorders, not elsewhere classified

180

2.26

5.39

2.5

1.6

38.77

41.12

nmol/l

0.28

173

Injury, poisoning and certain other consequences of external causes

919

3895

1.19

5.39

1.8

1.6

41.17

42.57

nmol/l

0.88

887

3834

Disorders of sclera, cornea, iris and ciliary body

922

7868

1.18

5.38

1.9

1.7

41.89

40.41

nmol/l

0.85

900

7667

Conductive and sensorineural hearing loss

1128

6570

1.16

5.36

1.7

43.05

41.76

nmol/l

1.09

1076

6401

Provisional assignment of new diseases of uncertain etiology

808

6812

1.19

5.33

1.6

1.7

40.55

41.94

nmol/l

0.92

797

6619

Injury of muscle and tendon at hip and thigh level

179

1247

1.46

5.32

1.9

1.8

38.14

40.05

nmol/l

0.55

169

1206

Ovarian dysfunction: estrogen excess

+∞

5.29

1.2

0.0

39.40

—

nmol/l

—

Codes for special purposes

808

6818

1.19

5.28

1.6

1.7

40.55

41.96

nmol/l

0.93

797

6625

Keratitis

606

4996

1.22

5.24

1.9

1.7

41.14

40.18

nmol/l

0.43

591

4864

COPD (mode)

251

2651

0.74

5.20

1.8

1.7

42.49

44.76

nmol/l

0.78

236

2556

Dizziness and giddiness

1028

7019

1.16

5.15

1.8

1.7

43.05

42.72

nmol/l

0.14

987

6840

Hypoparathyroidism

127

2.47

5.15

2.4

1.5

41.45

41.91

nmol/l

0.03

121

Other arrhythmias

1009

6548

1.17

5.13

1.9

1.7

42.28

41.66

nmol/l

0.34

973

6400

Asthma-related pneumonia

442

3523

1.26

5.12

1.8

1.7

36.66

42.24

nmol/l

6.47

435

3415

Injuries to the neck

418

3322

1.27

5.12

1.9

1.7

41.86

40.51

nmol/l

0.49

409

3240

Diseases of pulp and periapical tissues, including avohilmo

1901

8802

1.12

5.10

1.7

40.42

41.53

nmol/l

1.13

1833

8643

Superficial injury of lower leg

370

2898

1.29

5.08

1.9

1.7

38.99

40.83

nmol/l

0.74

359

2833

Other inflammation of eyelid

158

1083

1.47

5.07

1.6

1.7

41.50

42.00

nmol/l

0.08

150

1048

Major coronary heart disease event

1393

7394

1.14

5.03

1.9

1.8

38.30

40.35

nmol/l

3.13

1353

7200

Algoneurodystrophy

267

1.99

5.03

2.1

1.7

42.31

40.17

nmol/l

0.27

261

Asthma-related pneumonia or sepsis

442

3533

1.25

5.01

1.8

1.7

36.66

42.19

nmol/l

6.38

435

3425

Asthma, hospital admissions 3, pneumonia

442

3533

1.25

5.01

1.8

1.7

36.66

42.19

nmol/l

6.38

435

3425

Heart failure, not strict

861

6846

0.85

4.99

1.8

1.7

41.50

41.67

nmol/l

0.07

826

6656

Other viral diseases

574

4720

1.22

4.98

1.9

1.7

38.32

40.05

nmol/l

0.74

562

4625

Appendectomy

1143

9533

1.15

4.97

1.8

1.7

39.72

40.33

nmol/l

0.36

1124

9319

Mental and behavioural disorders due to use of other stimulants, including caffeine

105

669

1.62

4.96

2.4

1.9

42.47

34.71

nmol/l

2.26

663

Hard cardiovascular diseases

1432

7530

1.14

4.96

1.9

1.8

38.36

40.07

nmol/l

2.32

1394

7344

Hypermetropia

103

648

1.61

4.93

1.8

1.7

40.69

39.71

nmol/l

0.10

103

628

Other bacterial intestinal infections

299

2287

1.32

4.93

1.8

1.7

40.67

41.84

nmol/l

0.35

290

2211

Asthma (diagnoses ohter than nonallergic)

1385

10143

1.14

4.91

1.9

1.7

37.92

42.08

nmol/l

9.20

1357

9894

Inguinal hernia

1466

8677

1.13

4.91

1.7

1.8

42.16

38.66

nmol/l

6.70

1427

8478

Chronic gastritis

251

1874

1.35

4.88

2.0

1.7

44.30

44.45

nmol/l

0.03

238

1794

Covid-19 confirmed case

505

4119

1.23

4.87

1.6

1.7

40.75

42.51

nmol/l

0.92

496

3983

Superficial injury of abdomen, lower back and pelvis

256

1922

1.34

4.86

1.6

1.8

40.72

40.23

nmol/l

0.11

246

1870

Poisoning by medicine

415

3321

1.26

4.82

2.0

1.7

40.91

39.71

nmol/l

0.43

397

3254

Any prescribed medicine buy

4.19

4.78

1.9

1.7

37.60

35.76

nmol/l

0.13

Implicit viral Sepsis

271

2057

1.33

4.75

1.9

1.7

42.56

42.10

nmol/l

0.11

264

1988

Retinal detachments and breaks

432

3476

1.25

4.74

1.6

1.7

45.21

43.40

nmol/l

0.80

415

3337

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

860

6593

1.17

4.74

1.8

1.7

43.73

42.50

nmol/l

0.61

834

6392

Urticaria

398

3174

1.26

4.73

1.9

1.7

42.61

42.36

nmol/l

0.04

384

3099

Early onset COPD

219

2944

0.74

4.71

1.9

1.7

39.36

42.29

nmol/l

1.10

208

2838

Olecranon bursitis

138

940

1.49

4.70

1.9

1.7

37.31

41.16

nmol/l

1.36

132

907

Otitis externa, unspecified

175

1244

1.42

4.68

2.0

1.8

42.39

40.25

nmol/l

0.27

168

1211

Sulfonylureas

222

2372

0.74

4.60

1.9

1.6

40.56

48.87

nmol/l

6.51

207

2256

Viral Sepsis

271

2067

1.32

4.60

1.9

1.7

42.56

42.10

nmol/l

0.11

264

1998

Fracture at wrist and hand level

774

6597

1.18

4.59

1.9

1.8

39.90

38.25

nmol/l

1.30

758

6458

Primary hyperparathyroidism

436

1.71

4.58

1.7

48.76

42.47

nmol/l

0.52

411

Diastasis of muscle

2.98

4.58

1.9

1.4

36.60

39.57

nmol/l

0.24

malignant neoplasm of male genital organs

498

3695

0.81

4.58

1.8

41.47

42.95

nmol/l

0.78

485

3564

Major coronary heart disease event excluding revascularizations

707

5553

0.84

4.51

1.7

40.89

41.85

nmol/l

0.55

681

5391

Myocardial infarction, unclassifiable

115

1531

0.67

4.49

1.6

1.7

43.28

45.82

nmol/l

0.63

109

1456

Congenital malformations of genital organs

598

1.59

4.45

1.9

1.5

39.82

44.54

nmol/l

1.03

587

Candidiasis

157

1105

1.43

4.44

1.8

1.7

48.31

42.37

nmol/l

1.37

150

1069

Non-ischemic cardiomyopathy

229

2447

0.75

4.44

1.6

1.8

42.72

43.86

nmol/l

0.28

218

2341

Early syphilis

241

2.01

4.40

1.7

1.9

40.41

36.35

nmol/l

0.52

235

Radiculopathy

175

1258

1.40

4.38

1.9

1.7

38.42

42.70

nmol/l

1.97

167

1216

Adverse effects, not elsewhere classified

255

1946

1.32

4.34

1.7

38.08

42.03

nmol/l

1.85

249

1894

Malignant neoplasm of stomach

390

0.33

4.28

1.4

1.7

61.00

43.71

nmol/l

0.56

368

All pneumoniae

1800

10870

1.11

4.21

1.8

1.7

39.26

40.80

nmol/l

1.89

1753

10633

Coxarthrosis

663

3703

1.19

4.18

1.8

1.7

41.33

43.19

nmol/l

1.45

645

3597

Other acute lower respiratory infections

890

7370

1.15

4.17

1.8

1.7

37.66

40.67

nmol/l

3.42

869

7187

Early syphilis

267

1.92

4.16

1.8

41.65

36.25

nmol/l

0.70

259

Atopic dermatitis

1005

7211

1.15

4.15

1.7

40.38

40.33

nmol/l

0.02

981

7079

Other gastritis (incl. Duodenitis)

280

2179

1.29

4.14

1.8

1.7

42.39

42.68

nmol/l

0.07

273

2102

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

314

2485

1.27

4.10

1.9

1.8

40.37

39.19

nmol/l

0.37

297

2438

Spirochaetal infections, other/unspecified

107

712

1.52

4.08

1.8

46.13

40.33

nmol/l

1.56

102

681

Other and unspecified effects of external causes

451

3713

1.22

4.07

1.8

1.7

36.76

40.87

nmol/l

3.37

442

3629

Acute alcohol intoxication, ICD10

312

3917

0.79

4.07

1.8

39.16

39.46

nmol/l

0.09

304

3820

Labour and delivery complicated by fetal stress [distress]

184

876

1.38

4.05

1.2

62.83

54.35

nmol/l

1.33

184

869

Noninfective enteritis and colitis

774

6669

1.16

4.05

1.8

1.7

40.73

40.28

nmol/l

0.19

755

6505

Peripheral artery operations in Hilmo

1167

0.62

4.05

2.0

1.8

42.71

43.68

nmol/l

0.16

1111

Cutaneous abscess, furuncle and carbuncle

497

4138

1.21

4.02

1.9

1.7

39.52

39.85

nmol/l

0.10

481

4039

Other viral diseases, not elsewhere classified

318

2520

1.27

4.00

1.9

1.7

38.41

39.58

nmol/l

0.29

311

2461

Trigger finger

163

1181

1.39

3.95

1.9

1.6

42.13

42.49

nmol/l

0.08

158

1144

Assault

366

2972

1.25

3.89

1.9

1.8

37.58

36.65

nmol/l

0.36

351

2916

Examination and encounter for administrative purposes

490

1.62

3.88

2.0

1.6

42.88

39.63

nmol/l

0.55

478

Mixed disorders of conduct and emotions, excluding more controls

279

1.83

3.86

1.7

1.5

36.16

38.93

nmol/l

0.28

279

Pituitary-dependent Cushing's disease

4.95

3.85

2.1

1.5

29.82

37.88

nmol/l

0.54

Nausea and vomiting

304

2364

1.27

3.83

1.6

44.71

42.80

nmol/l

0.44

299

2298

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

369

2960

1.24

3.82

1.7

1.6

42.43

44.12

nmol/l

0.42

363

2899

Primary gonarthrosis, bilateral

507

3629

1.20

3.82

1.9

1.7

42.22

44.80

nmol/l

1.88

487

3494

Superficial injury of wrist and hand

364

2955

1.24

3.82

1.7

38.66

39.51

nmol/l

0.31

355

2895

Lesion of ulnar nerve

243

1882

1.30

3.80

2.0

1.7

37.80

40.58

nmol/l

1.09

234

1831

Specific development disorders of scholastic skills

101

668

1.52

3.80

2.0

1.7

34.67

37.56

nmol/l

0.52

101

659

Poisoning by narcotics and psychodysleptics [hallucinogens]

312

1.80

3.80

2.0

1.8

40.88

36.16

nmol/l

0.57

305

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

493

1.61

3.79

2.4

1.6

37.97

40.11

nmol/l

0.41

481

Polyarthrosis

118

753

1.46

3.78

1.8

1.6

43.71

44.87

nmol/l

0.18

113

722

Open wound of lower leg

240

1857

1.30

3.78

1.7

1.8

42.00

39.95

nmol/l

0.63

229

1807

Diabetic nephropathy, excluding more controls

149

1684

0.72

3.77

1.6

1.8

48.02

35.31

nmol/l

2.86

143

1636

Heterophoria

109

742

1.48

3.76

1.5

1.7

40.81

40.27

nmol/l

0.09

104

724

Other otitis externa (chronic)

606

1.54

3.73

1.9

1.7

50.96

40.29

nmol/l

0.67

589

Pneumonias (Asthma/COPD co-morbidities)

1780

10867

1.10

3.73

1.8

1.7

39.33

40.78

nmol/l

1.71

1734

10629

Artificial joint re-operation

364

1.69

3.69

2.5

1.8

41.36

44.59

nmol/l

0.55

343

Peritonsillar abscess

396

3259

1.22

3.66

1.6

1.7

38.09

40.38

nmol/l

1.20

390

3195

Thoracic aortic aneurysm

245

1912

1.29

3.65

1.7

1.8

42.80

42.29

nmol/l

0.13

231

1829

Asthma, unspecified (mode), excluding more controls

771

5009

1.16

3.61

1.9

1.7

38.01

42.58

nmol/l

6.19

751

4892

Acute alcohol intoxication

379

4598

0.82

3.60

1.7

40.51

40.05

nmol/l

0.15

370

4475

Localized swelling, mass and lump of skin and subcutaneous tissue

414

3426

1.21

3.59

1.7

43.85

41.48

nmol/l

0.88

394

3326

Myocardial infarction, with ST-elevation

137

1889

0.72

3.58

1.6

1.8

41.65

43.32

nmol/l

0.39

128

1806

Benign neoplasm: Pancreas

171

2.02

3.57

1.6

1.7

50.71

42.22

nmol/l

0.32

160

Striking against or struck by other objects

756

6580

1.15

3.57

1.9

1.8

38.68

38.52

nmol/l

0.07

730

6435

Disorders of eyelid, lacrimal system and orbit

1152

7807

1.12

3.53

1.8

1.7

43.05

42.75

nmol/l

0.14

1118

7598

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

158

2.04

3.51

1.6

52.50

42.93

nmol/l

0.71

149

Caries of dentine

406

3273

1.21

3.50

2.0

1.7

41.05

40.22

nmol/l

0.28

391

3213

Presbyopia

100

681

1.49

3.49

1.8

1.9

37.04

38.83

nmol/l

0.49

655

Cellulitis

386

3186

1.22

3.48

2.0

1.7

39.09

40.04

nmol/l

0.32

371

3102

Cramp and spasm

514

1.56

3.44

2.0

1.8

43.79

38.97

nmol/l

0.94

496

Localized hypertrichosis

10.24

3.42

1.3

1.1

42.33

37.57

nmol/l

—

Special screening examination for neoplasms

490

1.57

3.42

1.7

48.88

42.19

nmol/l

0.99

477

Unspecific neurodegenerative disorder

165

1509

0.75

3.41

1.6

55.50

49.05

nmol/l

1.95

157

1414

Coxarthrosis, primary, with hip surgery

450

3528

1.20

3.40

1.8

1.7

42.19

44.88

nmol/l

1.93

439

3374

Dermatitis and eczema

1947

11069

1.09

3.39

1.8

1.7

41.50

40.77

nmol/l

0.59

1893

10828

Other CVD

183

1386

1.33

3.37

1.8

1.7

45.41

44.12

nmol/l

0.30

174

1324

Carbimazole or st.post thyroidectomy, condition for graves disease

185

1404

1.32

3.37

1.6

1.7

44.14

43.45

nmol/l

0.13

177

1360

Dental caries, including avohilmo

1231

5641

1.12

3.36

1.8

1.7

40.75

41.95

nmol/l

0.96

1183

5535

Other skin changes

191

1458

1.32

3.35

1.7

44.87

43.63

nmol/l

0.28

186

1401

Asthma, unspecified (mode)

772

5082

1.15

3.32

1.9

1.7

38.04

42.76

nmol/l

6.59

752

4961

Abnormal findings on diagnostic imaging of central nervous system

455

1.58

3.30

1.9

1.7

42.23

39.72

nmol/l

0.33

437

Enlarged lymph nodes

234

1841

1.28

3.28

1.8

1.7

44.27

41.49

nmol/l

0.62

229

1786

Fibroblastic disorders

269

2151

1.26

3.27

1.7

42.59

44.23

nmol/l

0.59

263

2076

Unspecified haematuria

619

4427

1.16

3.27

1.7

43.70

42.84

nmol/l

0.38

602

4277

Cholecystectomy

737

5556

1.15

3.23

1.7

40.85

44.71

nmol/l

3.68

713

5378

Assault by bodily force

208

1623

1.30

3.20

2.0

1.9

36.84

36.81

nmol/l

0.01

200

1588

Acquired clawhand, clubhand, clawfoot and clubfoot

3.09

3.20

1.5

1.8

37.62

38.07

nmol/l

0.02

Complications of internal orthopaedic prosthetic devices, implants and grafts

204

1582

1.30

3.19

2.1

1.7

42.95

43.83

nmol/l

0.25

195

1509

Superficial injury of thorax

246

1957

1.27

3.17

1.8

40.21

40.08

nmol/l

0.03

236

1906

Childhood asthma (age<16)

316

2031

1.24

3.17

1.7

1.6

36.13

40.02

nmol/l

1.43

310

2012

Dental caries

453

3682

1.19

3.16

2.0

1.7

41.10

39.99

nmol/l

0.44

438

3619

Status post-ami

233

2239

0.79

3.15

1.7

42.32

45.64

nmol/l

1.48

214

2129

Childhood asthma (age<16), excluding more controls

316

2032

1.23

3.15

1.7

1.6

36.13

40.06

nmol/l

1.45

310

2011

Missing teeth due to accident, extraction or parodontitis

753

6229

1.14

3.14

1.8

1.7

42.31

42.71

nmol/l

0.14

700

6058

Peripheral arterial reconstruction

1312

0.69

3.14

1.6

1.7

43.44

45.97

nmol/l

0.68

1241

Schizophrenia or delusion

488

5712

0.85

3.14

1.8

39.05

38.28

nmol/l

0.24

475

5599

Schizophrenia, schizotypal and delusional disorders

488

5711

0.85

3.13

1.8

39.05

38.30

nmol/l

0.23

475

5597

Car occupant injured in other and unspecified transport accidents

329

2707

1.22

3.12

1.9

1.7

40.30

39.92

nmol/l

0.09

320

2644

Helminthiases

360

1.63

3.10

1.6

40.26

41.34

nmol/l

0.15

351

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1625

8948

1.10

3.10

1.8

35.87

41.53

nmol/l

15.53

1565

8760

Other strabismus

317

2590

1.23

3.09

1.7

42.12

40.58

nmol/l

0.51

308

2528

Sequelae with surgical and medical care as external cause

231

1829

1.27

3.09

2.0

1.7

42.62

42.17

nmol/l

0.11

221

1761

Malignant neoplasm of stomach, including Hilmo

454

0.48

3.08

1.7

1.8

53.45

43.66

nmol/l

0.50

430

Colorectal cancer

158

2035

0.76

3.08

1.5

1.8

40.09

44.78

nmol/l

2.29

148

1946

Other neurological diseases

951

6659

1.12

3.07

1.8

1.7

41.57

42.61

nmol/l

0.65

923

6457

Unspecified dementia

336

0.43

3.07

1.4

1.6

63.44

48.96

nmol/l

0.61

317

Colorectal adenocarcinoma

126

1709

0.73

3.07

1.5

1.8

42.00

44.47

nmol/l

0.70

118

1626

Glucosamine medication

334

2190

1.22

3.07

1.9

1.7

44.58

45.67

nmol/l

0.38

313

2089

Hypotension

152

1141

1.34

3.03

1.8

1.7

45.29

44.31

nmol/l

0.21

144

1089

Subacute thyroiditis

168

1.93

3.01

1.9

1.5

48.19

43.06

nmol/l

0.39

162

Mental and behabioural disorders of puerperum, not classified elsewhere, excluding more controls

3.61

3.01

1.2

1.1

57.64

49.18

nmol/l

0.34

Autoimmune diseases related-to ILD

1436

11206

1.10

3.00

1.7

41.56

40.74

nmol/l

0.54

1400

10950

Diseases of pulp and periapical tissues and dental caries

1091

5010

1.12

3.00

1.8

1.7

40.90

42.06

nmol/l

0.80

1050

4920

Phlebitis and thrombophlebitis (not including DVT)

275

2231

1.24

2.98

1.8

40.35

41.53

nmol/l

0.39

264

2159

Open wound of wrist and hand

1022

8976

1.12

2.98

1.8

39.18

39.24

nmol/l

0.03

992

8781

Strabismus

376

3139

1.20

2.98

1.7

42.27

40.98

nmol/l

0.43

366

3060

Gluteal tendinitis

169

1.91

2.96

1.3

1.7

44.26

43.59

nmol/l

0.04

160

Hidradenitis suppurativa

397

1.59

2.95

1.7

35.37

39.99

nmol/l

1.05

390

Fall on same level involving ice and snow

811

7195

1.13

2.94

1.8

1.7

40.62

40.97

nmol/l

0.16

789

7011

Gonarthrosis, primary, with knee surgery

565

3887

1.16

2.93

1.9

1.7

39.95

45.17

nmol/l

8.80

538

3746

Oxycodone

447

3438

1.18

2.90

2.0

1.6

40.88

44.11

nmol/l

2.14

425

3330

Other and unspecified erythematous conditions

229

1.77

2.90

1.8

1.7

41.43

39.85

nmol/l

0.14

219

Disorders of optic nerve and visual pathways

117

851

1.39

2.89

1.8

40.99

41.11

nmol/l

0.02

112

825

Other congenital malformations

172

1326

1.31

2.87

1.7

40.95

40.25

nmol/l

0.10

167

1297

Other noninfective gastroenteritis and colitis

315

2601

1.22

2.87

1.8

1.7

42.06

40.53

nmol/l

0.45

302

2530

Other systemic involvement of connective tissue (FG)

189

1457

1.28

2.83

1.7

1.6

42.09

45.68

nmol/l

0.67

181

1403

Disorders of iron metabolism

195

1.85

2.82

2.0

1.8

34.86

39.12

nmol/l

0.84

189

Other bursopathies

164

1261

1.31

2.81

2.0

1.7

40.97

41.83

nmol/l

0.15

158

1219

Hypersomnia

145

1.98

2.80

2.4

1.7

42.11

38.94

nmol/l

0.23

140

Sudden idiopathic hearing loss

122

899

1.37

2.80

2.0

1.8

42.45

41.70

nmol/l

0.14

115

863

Mental and behavioural disorders due to psychoactive substance use

1273

10756

1.10

2.78

1.9

1.7

40.33

39.78

nmol/l

0.36

1225

10520

Complications of surgical and medical care, not elsewhere classified

1577

9921

1.09

2.77

1.8

1.7

42.05

41.53

nmol/l

0.28

1521

9696

Caries of dentine, including avohilmo

1317

6122

1.10

2.75

1.8

1.7

40.58

41.96

nmol/l

1.26

1265

6008

Mental retardation, wide definition

519

0.55

2.72

1.8

36.10

37.96

nmol/l

0.14

504

Spontaneous rupture of synovium and tendon

675

1.42

2.71

1.8

1.7

38.41

42.20

nmol/l

0.87

652

Syncope and collapse

627

4707

1.14

2.71

1.7

1.6

43.14

42.85

nmol/l

0.10

604

4568

Gout

378

2809

1.19

2.70

1.8

1.6

37.20

44.47

nmol/l

8.06

361

2713

Undefined dementia

337

0.46

2.68

1.4

1.6

61.82

49.96

nmol/l

0.51

317

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

694

6115

1.13

2.67

1.8

1.7

38.65

39.76

nmol/l

0.50

676

6003

Other benign neoplasms of connective and other soft tissue

122

907

1.36

2.66

1.6

1.8

42.42

40.77

nmol/l

0.23

122

875

Atopic dermatitis, strict definition with reimbursement

491

4099

1.16

2.65

1.7

1.6

39.69

41.42

nmol/l

0.76

479

4023

Meningitis, viral

3.48

2.65

1.3

1.7

45.70

41.82

nmol/l

—

COPD-related respiratory insufficiency

925

0.67

2.63

1.8

1.7

36.60

44.95

nmol/l

2.28

883

Condition for Implicit Sepsis (Organ dysfunction codes)

1524

9665

1.09

2.63

1.8

1.7

41.81

40.74

nmol/l

0.93

1474

9446

Other specified/unspecified spondylopathies

127

1.99

2.62

1.8

1.6

43.96

41.87

nmol/l

0.20

121

Injuries to the thorax

772

6884

1.12

2.61

1.8

41.82

40.58

nmol/l

0.66

732

6703

Coronary artery bypass grafting

242

2210

0.81

2.60

1.5

1.7

45.07

46.37

nmol/l

0.33

230

2098

Other maltreatment syndromes

636

1.43

2.56

1.7

1.9

36.85

36.28

nmol/l

0.11

624

Peroneal tendinitis

129

1.98

2.53

2.5

1.8

38.44

38.63

nmol/l

0.02

124

Failure and rejection of transplanted organs and tissues

188

1.81

2.52

1.7

1.8

44.85

37.95

nmol/l

0.59

178

Bell's palsy

157

1221

1.29

2.51

1.7

42.33

41.89

nmol/l

0.07

150

1185

Benign neoplasm: Descending colon

561

1.44

2.50

1.8

42.49

42.12

nmol/l

0.05

533

Otalgia

569

1.43

2.49

1.9

1.6

45.70

41.25

nmol/l

0.75

554

Chondropathies

251

2064

1.22

2.48

1.8

38.56

39.57

nmol/l

0.30

239

2012

Fracture of lumbar spine and pelvis

223

1807

1.24

2.47

1.7

1.8

46.56

41.68

nmol/l

2.15

216

1744

Lactose intolerance, other/unspecified

241

1.68

2.47

1.6

38.20

40.17

nmol/l

0.30

234

Panniculitis affecting regions of neck and back

295

1.61

2.47

2.2

1.7

38.40

39.14

nmol/l

0.09

285

Malignant neoplasm of rectum

875

0.67

2.46

1.4

1.8

41.57

43.27

nmol/l

0.31

834

Left bundle-branch block

529

1.45

2.46

1.7

1.8

45.51

42.96

nmol/l

0.26

516

Open wound of ankle and foot

190

1519

1.26

2.46

1.8

41.71

38.81

nmol/l

0.73

184

1475

Other and unspecified mental retardation

189

0.36

2.45

1.1

1.8

33.43

35.27

nmol/l

—

181

Fitting and adjustment of other devices

348

2660

1.18

2.44

1.7

42.51

45.73

nmol/l

1.93

324

2539

Ill-defined and unknown causes of mortality

693

0.63

2.44

1.8

1.7

49.55

42.50

nmol/l

0.76

664

Mental retardation

501

0.57

2.44

1.8

36.10

37.36

nmol/l

0.09

488

Other erythematous conditions

250

1.66

2.42

1.8

1.7

41.20

40.22

nmol/l

0.08

238

Benign neoplasm: Skin of eyelid, including canthus

136

1045

1.31

2.39

1.7

1.8

41.83

42.96

nmol/l

0.23

123

1001

Misadventures to patients during surgical and medical care

157

1231

1.28

2.37

2.2

1.7

42.41

42.56

nmol/l

0.02

150

1182

Impacted maxillary molar

110

823

1.35

2.37

1.5

45.69

40.86

nmol/l

0.49

110

817

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

160

2020

0.79

2.36

1.6

1.8

51.49

40.90

nmol/l

4.09

153

1943

Other bacterial intestinal infections

205

1659

1.24

2.36

1.8

42.54

42.25

nmol/l

0.05

198

1602

Epilepsy

413

3552

1.16

2.35

1.8

1.6

46.93

43.22

nmol/l

1.34

402

3461

Budesonide

207

1679

1.24

2.35

1.6

1.7

39.92

40.25

nmol/l

0.07

201

1630

Infection of intervertebral disc (pyogenic)

126

1.95

2.35

2.2

1.7

46.92

40.48

nmol/l

0.80

121

Benign neoplasm of male genital organs

317

1.58

2.33

1.8

37.97

39.17

nmol/l

0.13

305

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

340

1.55

2.33

2.1

1.7

38.67

37.06

nmol/l

0.22

330

Immunodeficiencies

404

1.50

2.33

2.0

1.7

42.72

40.44

nmol/l

0.23

389

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

765

4325

1.12

2.33

1.8

1.7

40.83

41.63

nmol/l

0.39

748

4246

Diseases of arteries, arterioles and capillaries

755

6212

0.90

2.33

1.8

1.7

42.94

42.51

nmol/l

0.20

724

6024

Mandibular retrognathia AND surgery (BSSO)

269

1.62

2.32

1.6

1.7

35.84

39.06

nmol/l

0.43

264

Oral corticosteroids

1836

10143

1.08

2.32

1.8

1.7

39.98

41.15

nmol/l

1.15

1797

9907

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

118

895

1.33

2.30

1.9

1.8

42.28

42.07

nmol/l

0.03

112

861

Noninfectious colitis NAS

176

1406

1.26

2.29

1.8

40.39

39.51

nmol/l

0.16

168

1367

Collagenous colitis

673

1.38

2.27

1.8

1.7

42.60

40.66

nmol/l

0.32

649

Separation of retinal layers (serosa)

642

1.39

2.26

1.8

1.9

36.91

37.94

nmol/l

0.24

619

Coxarthrosis, primary

615

4621

1.13

2.26

1.8

1.7

41.47

44.26

nmol/l

2.74

597

4441

Other and unspecified coagulation defects

440

1.47

2.25

1.8

1.7

41.80

40.49

nmol/l

0.16

428

Lactose intolerance

271

1.61

2.25

1.7

1.6

37.47

39.45

nmol/l

0.32

264

Intracranial injury

959

8256

1.10

2.25

1.8

1.7

40.22

40.83

nmol/l

0.34

937

8054

Diabetic retinopathy, excluding more controls

300

1993

0.84

2.25

1.8

43.61

34.57

nmol/l

7.18

288

1941

Pedal cyclist injured in collision with motor vehicle

384

1.51

2.24

1.5

1.7

44.04

37.97

nmol/l

1.01

373

Other and unspecified urticaria

233

1925

1.22

2.22

1.9

1.7

43.98

41.87

nmol/l

0.30

224

1873

Other congenital malformations of circulatory system

241

1.64

2.22

2.3

1.7

43.77

38.32

nmol/l

0.46

229

Substance abuse

1235

10698

1.09

2.20

1.9

1.8

40.35

39.75

nmol/l

0.39

1188

10461

Hypertrophy of bone

3.16

2.20

1.4

1.6

34.33

37.30

nmol/l

—

Malignant neoplasm of oesophagus, including Hilmo

413

0.55

2.19

1.9

1.8

46.43

41.38

nmol/l

0.24

393

Mental and behavioural disorders due to cannabinoids

100

751

1.36

2.19

2.1

1.9

40.41

34.66

nmol/l

1.53

743

Viral meningitis

444

1.46

2.18

2.2

1.7

38.03

39.03

nmol/l

0.13

434

Embedded and impacted teeth

547

3993

1.14

2.17

1.5

1.7

40.93

40.15

nmol/l

0.21

539

3928

Other peripheral vertigo

577

1.39

2.17

1.6

1.8

47.53

42.30

nmol/l

0.85

549

Other systemic involvement of connective tissue

199

1623

1.23

2.15

1.7

41.87

45.06

nmol/l

0.61

191

1568

Primary coxarthrosis, bilateral

246

2050

1.20

2.15

1.9

1.7

39.33

44.41

nmol/l

3.91

240

1956

Malignant neoplasm of rectum, including Hilmo

1151

0.73

2.14

1.4

1.8

40.76

43.43

nmol/l

0.73

1098

Other diseases of urinary system

1309

7963

0.92

2.13

1.7

45.83

43.11

nmol/l

3.09

1273

7752

Amblyopia ex anopsia

380

1.49

2.13

1.9

1.6

41.98

40.60

nmol/l

0.14

369

Impacted teeth

404

3123

1.16

2.12

1.4

1.6

40.51

40.27

nmol/l

0.05

398

3072

Chronic apical periodontitis

1957

10440

1.07

2.11

1.8

1.7

40.72

41.05

nmol/l

0.20

1876

10242

Papulosquamous disorders

539

4779

1.13

2.11

1.7

1.8

43.64

40.90

nmol/l

1.19

521

4630

Other specified disorders of external ear

431

1.46

2.10

1.7

1.8

41.44

40.01

nmol/l

0.18

415

Suggestive for eosinophilic asthma

129

1006

1.29

2.09

2.0

1.8

40.92

41.85

nmol/l

0.19

123

969

Other and unspecified iron deficiency

305

2595

1.18

2.09

1.8

1.7

45.28

44.55

nmol/l

0.14

295

2497

Other infective otitis externa

565

1.39

2.09

1.9

1.7

45.44

40.26

nmol/l

0.88

547

Bacterial intestinal infections, IBD co-morbidities

203

1668

1.22

2.07

1.8

41.99

42.24

nmol/l

0.05

196

1607

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

479

4222

1.14

2.07

1.8

1.7

42.49

41.64

nmol/l

0.24

458

4138

Mild mental retardation

327

0.51

2.06

2.1

1.7

38.06

37.85

nmol/l

0.01

318

Disorder of lipoprotein metabolism, unspecified

159

1275

1.25

2.05

1.8

1.7

39.44

44.19

nmol/l

1.79

151

1220

Open bite

508

1.41

2.05

2.0

1.6

45.82

40.43

nmol/l

0.47

498

Injury of muscle and tendon at lower leg level

295

2515

1.18

2.05

1.7

1.8

38.46

39.50

nmol/l

0.44

290

2446

Other hearing loss

232

1891

1.20

2.04

1.8

1.7

43.76

44.33

nmol/l

0.15

221

1820

N06DA Anticholinesterases

119

1208

0.77

2.04

1.6

57.58

49.53

nmol/l

1.84

113

1131

Use of anticholinesterases

119

1208

0.77

2.04

1.6

57.58

49.53

nmol/l

1.84

113

1131

Other specified/unspecified arthritis

322

2762

1.17

2.03

1.7

1.6

41.35

42.31

nmol/l

0.32

313

2687

Alcohol dependence

449

5095

0.88

2.03

1.9

1.8

41.55

39.67

nmol/l

1.01

437

4959

Helminthiases

149

1.78

1.97

1.4

1.8

38.69

40.52

nmol/l

0.21

144

Stomatitis and related lesions

255

2154

1.19

1.96

2.0

1.7

42.58

40.73

nmol/l

0.49

248

2095

Atopic dermatitis, strict definition

458

3959

1.14

1.95

1.7

1.6

39.18

41.31

nmol/l

1.00

448

3888

Perichondritis of external ear

120

1.86

1.95

1.7

1.6

43.73

42.41

nmol/l

0.07

115

Dengue fever [classical dengue]

3.43

1.94

3.0

1.2

39.00

39.23

nmol/l

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1691

10796

1.07

1.94

1.8

1.7

39.41

40.76

nmol/l

1.45

1645

10559

Benign neoplasm: Stomach

547

1.38

1.93

1.6

1.7

39.63

43.46

nmol/l

0.96

521

Bilateral sagittal split ramus osteotomy operation

364

1.47

1.93

1.8

1.7

36.25

39.52

nmol/l

0.55

357

Diabetic nephropathy

150

1833

0.80

1.93

1.6

1.8

47.88

36.82

nmol/l

2.31

144

1766

Early onset COPD, excluding more controls

219

2610

0.83

1.91

1.9

1.7

39.36

43.43

nmol/l

1.81

208

2524

Later onset COPD, excluding more controls

961

0.76

1.89

1.7

1.5

49.63

51.89

nmol/l

0.35

899

Open wound of hip and thigh

544

1.38

1.88

2.1

1.8

35.73

37.48

nmol/l

0.29

530

Polymyalgia rheumatica

636

1.34

1.87

1.5

1.7

37.67

45.60

nmol/l

3.40

605

Maternal care for known or suspected malpresentation of fetus

126

717

1.28

1.86

1.2

62.18

56.10

nmol/l

0.89

126

712

Wide developmental disorders

526

1.38

1.86

1.7

32.08

37.11

nmol/l

1.26

520

Adenocarcinoma and papillary adenocarcinoma of stomach

198

0.45

1.85

1.3

1.9

58.67

43.37

nmol/l

—

188

Other superficial mycoses

177

1456

1.22

1.85

1.8

43.70

39.05

nmol/l

1.00

170

1419

Injury of unspecified body region

760

1.31

1.85

1.7

1.8

42.49

40.54

nmol/l

0.27

734

Cardiodefibrillation

458

4051

1.13

1.84

1.7

44.75

43.56

nmol/l

0.54

447

3884

Acanthosis nigricans

2.69

1.84

1.6

1.7

36.22

39.66

nmol/l

—

Conotruncal defects

165

0.42

1.82

1.7

39.43

36.28

nmol/l

—

159

Venous thromboembolism

618

5384

1.11

1.82

1.9

1.7

40.14

43.12

nmol/l

2.96

605

5199

Abscess of anal and rectal regions

176

1451

1.22

1.82

1.8

38.11

38.33

nmol/l

0.04

169

1410

Fracture of skull and facial bones

440

3899

1.13

1.81

1.8

39.61

38.14

nmol/l

0.64

425

3808

All influenza

421

3718

1.14

1.81

1.8

39.76

39.96

nmol/l

0.07

411

3619

Other disorders of Eustachian tube

239

1.57

1.80

2.4

1.6

37.22

42.12

nmol/l

0.32

229

Conduction disorders

352

2486

1.15

1.80

1.8

1.7

44.72

43.04

nmol/l

0.54

332

2393

Diseases of liver

500

4464

1.12

1.80

1.8

41.85

41.06

nmol/l

0.25

482

4321

Myeloproliferative diseases

633

1.34

1.79

2.1

1.8

40.05

42.07

nmol/l

0.38

603

Pedestrian injured in collision with pedal cycle

354

1.46

1.79

2.0

1.8

44.86

38.37

nmol/l

1.24

341

Suicide or other Intentional self-harm

429

3799

1.13

1.78

1.9

1.7

40.77

39.87

nmol/l

0.29

408

3720

Herpesviral keratitis and keratoconjunctivitis

387

1.44

1.78

2.1

1.7

37.87

39.51

nmol/l

0.19

371

Diabetic retinopathy, strict definition

189

2001

0.83

1.78

1.8

51.29

34.99

nmol/l

5.96

180

1936

Erythema nodosum

169

1.67

1.78

1.7

1.5

50.39

42.86

nmol/l

0.29

163

Unspecified jaundice

437

0.61

1.78

1.5

1.8

48.50

40.79

nmol/l

0.79

414

Septicaemia

422

4457

0.88

1.78

1.9

1.7

43.06

42.85

nmol/l

0.05

407

4308

Abnormal findings on diagnostic imaging of lung

550

4733

1.12

1.77

1.7

43.09

43.40

nmol/l

0.11

535

4558

Autoimmune hepatitis

2.27

1.76

2.2

1.4

58.58

38.66

nmol/l

0.84

Other and unspecified acne

194

1.63

1.75

2.3

1.6

46.71

38.13

nmol/l

0.82

189

Lesion of lateral popliteal nerve

576

1.35

1.75

1.8

44.47

40.28

nmol/l

0.69

557

Pedestrian injured in collision with heavy transport vehicle or bus

0.00

1.74

0.0

1.5

—

37.70

—

Viral and other specified intestinal infections

440

3816

1.13

1.74

1.8

1.7

41.28

38.09

nmol/l

0.78

435

3745

Adult-onset Still disease

0.00

1.74

0.0

1.5

—

39.63

—

Suppurative and unspecified otitis media

716

5784

1.10

1.73

1.6

1.7

38.46

39.50

nmol/l

0.54

701

5677

Fracture of rib(s), sternum and thoracic spine

463

4129

1.13

1.72

1.8

42.75

40.92

nmol/l

0.73

435

4001

Atrial fibrillation and flutter

612

3584

1.11

1.72

1.9

1.7

38.86

40.37

nmol/l

0.95

592

3513

Other specified disorders of muscle

316

1.47

1.71

1.8

34.48

38.00

nmol/l

0.66

310

Lesion of plantar nerve

242

1.54

1.70

1.6

40.27

41.89

nmol/l

0.19

234

Melanocytic naevi of scalp and neck

243

1.54

1.70

2.3

1.7

46.84

39.63

nmol/l

0.69

232

Nonsuppurative otitis media

420

3222

1.13

1.70

1.8

1.6

38.53

40.69

nmol/l

0.80

410

3163

Mixed disorders of conduct and emotions

350

1.45

1.70

1.7

1.6

36.16

38.41

nmol/l

0.22

345

Other ill-defined and unspecified causes of mortality

600

0.68

1.70

1.9

1.7

46.95

42.16

nmol/l

0.57

574

Bacterial Sepsis

502

4782

0.89

1.70

1.9

1.7

42.40

42.84

nmol/l

0.15

480

4627

Malignant neoplasm of oesophagus

267

0.52

1.69

2.0

1.8

40.07

41.89

nmol/l

0.14

253

Disorders of gallbladder, biliary tract and pancreas

1279

8639

0.93

1.69

1.7

41.35

42.22

nmol/l

0.63

1231

8426

Dengue fever [classical dengue]

2.97

1.69

3.0

1.2

39.00

41.56

nmol/l

—

Diabetic retinopathy

356

2528

0.87

1.68

1.7

1.8

43.98

35.27

nmol/l

8.19

337

2451

Vestibular neuronitis

102

798

1.29

1.68

2.0

1.8

43.57

39.77

nmol/l

0.81

766

Degeneration of the brain due to alcohol

278

0.53

1.67

1.1

1.8

61.90

40.36

nmol/l

1.09

263

All chronic kidney diseases

629

5662

0.91

1.67

1.7

43.03

42.49

nmol/l

0.18

607

5483

Cholecystitis

138

1120

1.24

1.65

1.8

41.20

43.13

nmol/l

0.41

133

1075

Yaws

2.49

1.65

1.2

1.6

51.80

36.43

nmol/l

—

Acute suppurative otitis media

552

4650

1.11

1.65

1.6

1.7

37.30

38.65

nmol/l

0.70

537

4567

Corneal ulcer

300

2611

1.15

1.65

2.0

1.8

40.27

39.32

nmol/l

0.29

291

2542

Other disorders of white blood cells

470

1.37

1.64

2.2

1.7

35.67

39.95

nmol/l

0.74

452

Benign neoplasm of bone and articular cartilage

117

935

1.26

1.63

1.7

1.8

40.31

38.96

nmol/l

0.24

111

909

Degeneration of nervous system due to alcohol

275

0.54

1.62

1.1

1.8

61.90

40.12

nmol/l

1.11

261

Orthopaedic devices associated with adverse incidents

1.89

1.62

1.9

1.7

45.36

43.64

nmol/l

0.16

Impacted cerumen

101

794

1.28

1.61

2.0

1.7

39.10

41.73

nmol/l

0.52

764

Benign neoplasm: Connective and other soft tissue of head, face and neck

152

1.67

1.59

1.5

1.7

47.20

40.63

nmol/l

0.27

145

Other disorders of binocular movement

207

1.57

1.58

1.9

1.6

37.03

39.77

nmol/l

0.27

201

Valvular heart disease excluding rheumatic fever

544

4344

0.90

1.58

1.8

1.7

45.78

41.96

nmol/l

3.15

521

4223

Paroxysmal tachycardia

328

2408

1.14

1.58

2.0

1.6

42.52

43.42

nmol/l

0.27

316

2352

Abnormalities of gait and mobility

115

921

1.25

1.57

1.7

45.02

43.52

nmol/l

0.27

110

879

Diseases of the myoneural junction and muscle

153

1264

1.22

1.57

1.8

38.46

41.07

nmol/l

0.61

147

1220

Acute pancreatitis

296

2584

1.15

1.57

1.8

38.88

40.89

nmol/l

0.91

288

2503

Renal tubulo-interstitial diseases

1040

8324

0.93

1.57

1.7

42.31

43.25

nmol/l

0.50

1006

8106

Other disorders of conjunctiva

138

1128

1.23

1.57

1.8

49.23

42.74

nmol/l

1.91

132

1085

Autism

424

1.39

1.57

1.8

1.7

32.43

36.44

nmol/l

0.75

418

Autism spe

416

1.39

1.56

1.8

32.30

36.46

nmol/l

0.77

410

Diabetes, insulin treatment (Kela reimbursement)

1683

9592

1.06

1.56

1.8

35.99

41.19

nmol/l

13.78

1620

9390

Autoimmune polyglandular failure

3.57

1.56

4.0

1.3

52.80

33.13

nmol/l

—

Use of bromocriptine

3.54

1.55

2.6

1.7

38.00

44.53

nmol/l

—

Other congenital malformations of skin

373

1.41

1.55

1.6

1.7

41.65

40.12

nmol/l

0.14

360

Bacterial infection, other or unspecified

585

5581

0.91

1.55

1.8

1.7

43.23

42.58

nmol/l

0.26

562

5409

Other specific arthropathies

3.50

1.55

2.0

1.2

28.40

37.33

nmol/l

—

Type 2 diabetes, wide definition

1208

7224

1.07

1.54

1.8

1.7

34.88

42.42

nmol/l

20.33

1151

7052

Pneumonia due to Haemophilus influenzae

0.00

1.54

0.0

1.7

—

37.73

—

Lipomatosis, not elsewhere classified

2.70

1.54

1.4

1.9

30.14

41.70

nmol/l

—

Pedal cyclist injured in transport accident

383

3406

1.13

1.54

1.9

1.8

42.30

39.14

nmol/l

1.85

374

3326

Oral lichen planus

130

1.71

1.54

1.6

1.8

58.95

42.02

nmol/l

0.89

125

Other CVD (FINNGEN)

138

874

1.23

1.53

1.8

1.6

43.56

46.32

nmol/l

0.74

130

841

Retrobulbar neuritis in diseases classified elsewhere

2.68

1.53

1.1

1.6

70.29

33.56

nmol/l

—

AV-block

184

1357

1.19

1.53

1.7

44.96

44.91

nmol/l

0.01

169

1293

Aortic aneurysm

323

2788

1.14

1.53

1.7

43.58

44.01

nmol/l

0.12

305

2663

Systemic connective tissue disorders

271

2355

1.15

1.52

1.7

42.80

44.51

nmol/l

0.36

260

2273

Non-rheumatic valve diseases

541

4307

0.90

1.52

1.8

1.7

45.91

41.97

nmol/l

3.30

518

4186

Fracture of lower leg, including ankle

825

7544

1.08

1.52

1.8

1.7

38.81

40.08

nmol/l

0.93

808

7368

Coxarthrosis [arthrosis of hip](FG)

667

4289

1.10

1.51

1.8

1.7

41.34

43.58

nmol/l

1.99

649

4153

Human immunodeficiency virus [HIV] disease resulting in other conditions

429

1.39

1.51

1.8

1.9

49.19

36.58

nmol/l

2.26

422

Hyperlipidaemia, other/unspecified

492

4087

1.11

1.50

1.8

1.7

40.69

43.90

nmol/l

2.26

465

3955

Conductive hearing loss, unspecified

101

803

1.27

1.49

1.6

1.8

44.52

39.71

nmol/l

1.04

778

Bacterial pneumoniae

483

4715

0.90

1.49

1.8

1.7

40.04

42.06

nmol/l

1.07

476

4562

Other osteochondropathies

126

1029

1.23

1.49

1.7

1.8

38.17

38.86

nmol/l

0.12

120

999

Persons encountering health services for specific procedures and health care

1883

10707

1.06

1.47

1.8

1.7

40.31

40.90

nmol/l

0.45

1835

10468

Malignant neoplasm of colon, including Hilmo

126

1535

0.82

1.47

1.6

1.8

40.77

44.50

nmol/l

1.31

120

1460

Evidence of alcohol involvement determined by blood alcohol level

227

0.52

1.46

2.3

1.7

35.83

38.50

nmol/l

0.28

219

Cauda equina syndrome

125

1.71

1.46

1.6

1.7

38.90

39.07

nmol/l

0.01

120

Other specified and unspecified disorders of eyelid

125

1.71

1.46

2.0

1.7

37.43

41.66

nmol/l

0.41

119

Open wound of forearm

161

1350

1.20

1.45

1.8

41.16

38.52

nmol/l

0.71

152

1309

Urethritis and urethral syndrome

196

1.55

1.44

1.8

1.7

45.70

40.30

nmol/l

0.70

190

Exposure to excessive natural cold

137

0.43

1.42

2.3

1.9

43.50

38.03

nmol/l

—

132

Inflammatory bowel disease

549

5005

1.10

1.41

1.8

39.89

39.59

nmol/l

0.10

538

4881

Sequelae of cerebrovascular disease

302

2952

0.88

1.41

1.7

45.47

44.39

nmol/l

0.29

281

2827

Benign neoplasm: Skin of other and unspecified parts of face

747

1.26

1.41

1.9

1.7

41.19

42.83

nmol/l

0.23

721

Other disorders of urethra and urinary system

566

4478

0.91

1.40

1.6

47.81

46.34

nmol/l

0.52

549

4326

5-aminosalicylic acid

387

3467

1.12

1.40

1.8

38.96

39.28

nmol/l

0.10

381

3385

Injuries to unspecified part of trunk, limb or body region

133

1099

1.22

1.40

1.8

42.09

40.16

nmol/l

0.36

128

1062

Sequelae of injuries of head

102

821

1.25

1.40

2.0

1.8

41.66

37.80

nmol/l

0.73

800

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

2.10

1.39

1.8

57.00

50.02

nmol/l

0.34

Brain meningioma, including Hilmo

230

1.49

1.39

1.7

1.8

47.79

44.48

nmol/l

0.34

218

Other bacterial diseases

1436

10217

0.94

1.39

1.9

1.7

40.86

40.17

nmol/l

0.45

1395

9980

Other arthritis (FG)

382

3422

1.12

1.38

1.7

41.74

42.27

nmol/l

0.17

372

3322

Acute pancreatitis (for exclusion)

296

2614

1.14

1.37

1.7

1.8

38.88

40.73

nmol/l

0.81

288

2526

Gonococcal infection

409

1.36

1.8

1.9

33.98

37.32

nmol/l

0.78

400

307

1.42

1.36

2.2

1.8

35.21

37.83

nmol/l

0.35

301

DVT of lower extremities and pulmonary embolism

450

4055

1.11

1.34

1.9

1.7

39.74

42.93

nmol/l

2.53

442

3900

Personal history of malignant neoplasm

224

1.48

1.33

1.8

1.6

41.67

43.74

nmol/l

0.14

217

Bacterial pneumonia, not elsewhere classified

444

4314

0.90

1.32

1.8

1.7

40.18

42.12

nmol/l

0.93

437

4174

Polypectomy (DHB20)

118

972

1.22

1.32

1.9

1.8

39.46

39.65

nmol/l

0.04

118

938

Acute and transient psychotic disorders

148

1752

0.84

1.31

1.9

40.27

37.57

nmol/l

0.49

143

1710

Chronic hepatitis, not elsewhere classified

284

1.42

1.30

1.5

1.7

52.81

38.43

nmol/l

1.24

272

Diseases of the digestive system

571

5211

1.09

1.30

1.7

42.44

42.69

nmol/l

0.09

549

5042

Iron deficiency anaemia

386

3421

1.11

1.30

1.9

1.6

44.76

44.41

nmol/l

0.08

372

3294

Insulin, combination of fast acting with intermediate-acting or long-acting

902

8819

0.93

1.29

1.7

1.8

42.64

40.84

nmol/l

1.08

873

8583

Mental retardation, excluding more controls

413

0.68

1.29

1.8

1.7

36.10

37.74

nmol/l

0.12

406

Calcific aortic valvular stenosis, including rheumatic fever

198

2216

0.86

1.28

1.6

1.7

45.29

45.61

nmol/l

0.07

186

2108

Chronic periodontitis, including avohilmo

1569

9980

1.05

1.26

1.8

40.67

40.57

nmol/l

0.06

1503

9768

Malignant neoplasm of eye and adnexa, including Hilmo

119

0.42

1.25

1.2

1.9

46.00

42.04

nmol/l

—

113

Palmar fascial fibromatosis [Dupuytren]

175

1500

1.17

1.25

1.7

45.15

44.41

nmol/l

0.18

170

1442

Presence of cardiac and vascular implants and grafts

508

4128

0.91

1.25

1.6

1.8

44.49

43.42

nmol/l

0.42

465

4004

Primary open-angle glaucoma

212

1782

1.15

1.24

1.6

1.7

48.29

45.36

nmol/l

1.03

206

1692

Immunodeficiency with predominantly antibody defects

237

1.45

1.24

2.3

1.7

43.15

38.96

nmol/l

0.48

232

Other and unspecified myopathies

110

906

1.22

1.24

1.8

38.17

40.54

nmol/l

0.44

104

874

Familial benign pemphigus (Hailey-Hailey disease)

2.73

1.23

1.0

1.7

81.00

44.32

nmol/l

—

Myositis ossificans

2.71

1.23

1.6

1.4

43.80

41.21

nmol/l

—

Calcific aortic valvular stenosis, diagnosis (helper)

198

2210

0.87

1.23

1.6

1.7

45.29

45.65

nmol/l

0.08

186

2102

Operations 2 for CAVS

198

2210

0.87

1.23

1.6

1.7

45.29

45.65

nmol/l

0.08

186

2102

Carrier of infectious disease

221

1.46

1.22

1.7

36.44

39.33

nmol/l

0.42

214

Glaucoma secondary to other eye disorders

325

0.64

1.22

1.7

48.00

39.36

nmol/l

0.75

311

Alcohol abuse, main dg

255

2881

0.88

1.22

1.7

1.8

39.16

39.21

nmol/l

0.01

250

2805

Sequelae of inflammatory diseases of the central nervous system

2.19

1.21

1.8

39.63

34.55

nmol/l

—

Gonococcal infection

366

1.35

1.21

1.9

34.18

37.40

nmol/l

0.66

359

Toxic effect of other and unspecified substances

206

1.48

1.20

1.6

1.8

35.00

36.26

nmol/l

0.13

199

Other septicaemia

367

3906

0.90

1.20

1.9

1.7

43.65

43.17

nmol/l

0.10

355

3766

Fatigue fracture of vertebra

2.35

1.19

1.2

55.33

39.12

nmol/l

—

Anomalies of pupillary function

173

1.52

1.19

1.2

1.8

54.85

38.12

nmol/l

1.18

167

Autoimmune diseases excluding thyroid diseases

1914

9975

1.05

1.19

1.7

42.92

40.12

nmol/l

4.28

1872

9746

Neovascular glaucoma

322

0.65

1.18

1.7

48.00

40.87

nmol/l

0.57

307

Circumscribed brain atrophy

127

0.47

1.17

1.7

1.8

38.50

43.13

nmol/l

—

119

Alopecia areata

190

1.49

1.17

1.5

1.6

47.21

40.79

nmol/l

0.62

184

Calcific aortic valvular stenosis, operated

199

2211

0.87

1.17

1.6

1.7

45.29

45.68

nmol/l

0.09

187

2103

Calcific aortic valvular stenosis

199

2211

0.87

1.17

1.6

1.7

45.29

45.68

nmol/l

0.09

187

2103

Other disorders of glucose regulation and pancreatic internal secretion

116

967

1.21

1.17

1.8

51.49

39.21

nmol/l

3.50

110

939

Gastric ulcer

166

1426

1.17

1.9

1.7

46.29

43.66

nmol/l

0.59

161

1368

Explicit Sepsis

444

4539

0.91

1.17

1.9

1.7

43.84

43.43

nmol/l

0.09

429

4387

Thiazolidinediones

135

1141

1.19

1.17

2.1

1.7

34.66

45.55

nmol/l

7.83

123

1095

Psoriasis

412

3748

1.10

1.16

1.7

1.8

42.90

40.52

nmol/l

0.76

397

3638

Flatulence and related conditions

1.75

1.16

1.6

1.5

40.20

37.90

nmol/l

0.17

Other leukaemias of specified cell type

2.58

1.16

3.2

1.4

59.40

37.75

nmol/l

—

In situ neoplasms

246

2173

1.13

1.16

1.5

1.6

47.83

48.18

nmol/l

0.07

236

2086

Monosomies and deletions from the autosomes, not elsewhere classified

2.57

1.16

1.4

1.6

32.60

31.55

nmol/l

—

Fracture of femur

170

1787

0.86

1.16

1.6

1.7

47.26

42.49

nmol/l

1.45

164

1720

Bacterial infection, other or unspecified

669

6087

0.93

1.15

1.8

1.7

42.55

42.34

nmol/l

0.08

641

5909

Fracture of foot, except ankle

389

3534

1.10

1.14

1.7

42.78

39.25

nmol/l

1.71

383

3453

Other and unspecified epidermal thickening

233

1.43

1.14

1.3

1.8

44.06

40.13

nmol/l

0.38

221

Dermatitis due to ingested food

321

1.35

1.14

1.3

1.5

39.44

37.85

nmol/l

0.17

316

Renal failure

472

4549

0.92

1.13

1.7

42.90

43.03

nmol/l

0.04

453

4375

Arteriovenous malformation of peripheral vessels

2.01

1.13

1.6

36.30

34.66

nmol/l

—

Disorders of orbit

310

1.36

1.12

2.0

1.7

41.14

40.13

nmol/l

0.07

299

Unspecified fall

712

6540

1.07

1.12

1.7

41.90

40.71

nmol/l

0.60

686

6368

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

406

1.32

1.12

1.6

1.8

43.17

37.89

nmol/l

0.52

394

Malignant neoplasm of colon

1107

0.82

1.11

1.6

1.8

39.14

43.92

nmol/l

1.41

1057

Acidosis

207

0.57

1.11

2.3

1.7

34.58

42.06

nmol/l

0.72

200

Traumatic spondylopathy

2.46

1.10

1.2

1.3

47.80

42.05

nmol/l

—

Need for immunization against single bacterial diseases

2.45

1.10

1.6

1.4

36.80

39.67

nmol/l

—

Diagnoses used for exclusion with ILD

312

2808

1.11

1.10

1.9

1.8

41.05

41.14

nmol/l

0.02

301

2714

Dislocation, sprain and strain of joints and ligaments of head

460

1.29

1.10

1.5

1.7

42.78

39.07

nmol/l

0.68

449

Hypoglycaemia, other or unspecified

792

1.22

1.09

1.9

1.8

53.32

38.56

nmol/l

3.58

766

Cytomegalovirus infection, IBD co-morbidity

244

1.41

1.09

1.4

1.8

37.00

39.42

nmol/l

0.19

233

Pediculosis, acariasis and other infestations

273

2443

1.12

1.08

1.8

1.7

39.63

39.66

nmol/l

0.01

265

2383

Coagulation defects, purpura and other haemorrhagic conditions

226

1999

1.13

1.08

1.7

1.8

43.15

41.80

nmol/l

0.35

221

1935

Degeneration of macula and posterior pole

360

2597

1.10

1.07

1.8

1.7

47.35

46.06

nmol/l

0.31

349

2470

Brain meningioma

219

1.42

1.07

1.8

46.94

44.90

nmol/l

0.18

207

Toxic effect of ethanol

646

0.77

1.07

1.6

1.8

41.26

38.51

nmol/l

0.32

631

Other complications of labour and delivery, not elsewhere classified

712

1.21

1.05

1.1

1.2

63.24

53.92

nmol/l

1.10

707

Accidental poisoning by and exposure to alcohol

288

0.65

1.05

1.6

1.7

35.21

39.62

nmol/l

0.48

276

Assault by hanging, strangulation and suffocation

2.14

1.05

2.4

1.7

36.14

33.37

nmol/l

—

Atrial fibrillation and flutter with reimbursement

427

2484

1.10

1.05

1.7

39.92

42.50

nmol/l

1.54

408

2428

Disorder of external ear, unspecified

315

1.34

1.04

2.2

1.7

40.76

39.27

nmol/l

0.09

304

Retained (old) intraocular foreign body

0.00

1.03

0.0

1.9

—

40.54

—

Insulin medication

902

8043

0.94

1.03

1.7

42.64

41.78

nmol/l

0.39

873

7858

Use of disulfiram, acamprosate or naltrexone

209

1850

1.14

1.03

1.9

37.44

37.36

nmol/l

0.02

199

1803

Pneumonia, organism unspecified

1517

10154

1.05

1.02

1.8

1.7

39.42

40.65

nmol/l

1.18

1470

9929

Benign neoplasm: Spinal meninges

1.91

1.02

1.9

2.0

46.80

41.92

nmol/l

—

Non-Hodgkin lymphoma, all

310

0.67

1.01

2.0

1.7

54.62

43.82

nmol/l

0.68

291

Brain glioblastoma and astrocytoma

225

0.61

1.01

1.4

1.9

43.36

37.66

nmol/l

0.60

218

Herpesviral [herpes simplex] infections

121

1030

1.18

1.00

1.9

1.7

38.10

41.58

nmol/l

0.71

121

997

Other surgical follow-up care

326

1.33

1.00

1.7

43.00

39.26

nmol/l

0.46

316

Other diseases of pleura

447

4251

0.92

0.99

1.8

1.7

44.67

43.74

nmol/l

0.38

431

4079

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

405

1.29

0.99

1.6

1.8

41.90

38.32

nmol/l

0.45

392

Follicular cysts of skin and subcutaneous tissue

265

2382

1.12

0.99

1.7

1.8

42.21

39.72

nmol/l

0.88

260

2314

Type 1 diabetes, strict definition, subgroup 2

0.00

0.99

0.0

1.3

—

31.14

—

Dyshidrosis [pompholyx]

148

1.50

0.99

2.5

1.6

32.05

40.15

nmol/l

1.38

141

Traumatic cerebral oedema

0.00

0.99

0.0

1.6

—

33.07

—

Chlamydial lymphogranuloma (venereum)

2.46

0.99

1.7

1.8

34.00

37.18

nmol/l

—

Myeloproliferative diseases (CML excluded)

566

1.24

0.98

1.9

1.8

41.52

42.08

nmol/l

0.08

537

Tic and related disorders

132

1.54

0.98

1.3

1.6

35.40

38.21

nmol/l

0.24

132

Mental and behavioural disorders due to alcohol, excluding acute intoxication

863

9094

0.94

0.98

1.9

1.8

41.13

39.83

nmol/l

0.92

833

8869

Bacterial pneumonia (organism specified)

509

4977

0.93

0.98

1.8

1.7

40.38

42.09

nmol/l

0.86

502

4803

Cytomegaloviral disease

267

1.36

0.97

1.4

1.7

35.86

38.84

nmol/l

0.26

256

Periodontitis

1562

9995

1.05

0.97

1.8

40.68

40.57

nmol/l

0.06

1496

9783

Malignant neoplasm of rectosigmoid junction, including Hilmo

199

0.60

0.97

2.2

1.7

38.25

43.61

nmol/l

0.48

188

Non-small cell lung cancer, adenocarcinoma

377

0.71

0.97

1.4

1.7

46.37

46.03

nmol/l

0.02

355

Inflammatory disease of uterus

504

1.25

0.97

1.1

1.2

50.83

55.14

nmol/l

0.46

498

Thyrotoxicosis with toxic multinodular goitre

190

1.43

0.97

1.4

1.7

47.44

44.20

nmol/l

0.21

180

Psoriasis vulgaris

283

2558

1.11

0.97

1.7

1.8

43.85

39.92

nmol/l

1.04

270

2481

therapeutic use

182

1.44

0.96

1.8

1.7

43.60

42.63

nmol/l

0.09

172

Chronic periodontitis, complicated

701

7397

0.94

0.96

1.7

1.8

41.43

41.41

nmol/l

0.01

657

7200

Other and unspecified vaccines and biological substances

1.79

0.95

1.2

1.4

26.56

35.02

nmol/l

—

Polyglandular dysfunction

2.31

0.95

3.5

1.3

52.67

33.07

nmol/l

—

Effects of other deprivation

2.30

0.95

2.7

1.8

41.67

36.22

nmol/l

—

Malignant neoplasm, without specification of site, including Hilmo

270

0.66

0.95

1.7

1.8

37.72

43.81

nmol/l

0.81

257

Other blood glucose lowering drugs, excl. Insulins

162

1419

1.14

0.93

1.9

1.7

34.92

45.49

nmol/l

9.95

156

1361

Nonspecific lymphadenitis

634

1.22

0.93

1.6

1.8

43.27

38.95

nmol/l

0.64

621

Other or unspecified ileus, impaction or obstruction

187

1653

1.13

0.93

2.0

1.7

43.31

42.66

nmol/l

0.15

181

1590

Effects of foreign body entering through natural orifice

515

4791

1.08

0.93

1.8

39.67

38.69

nmol/l

0.49

500

4672

Scabies

232

2080

1.12

0.93

1.8

1.7

38.25

39.35

nmol/l

0.28

225

2033

Malignant neoplasm of larynx, including Hilmo

171

0.58

0.92

1.5

1.8

40.70

43.53

nmol/l

—

162

Ulcerative colitis

412

3802

1.09

0.91

1.7

1.8

39.15

39.14

nmol/l

0.00

403

3709

Lesion of radial nerve

402

1.28

0.91

2.8

1.8

40.00

39.34

nmol/l

0.05

388

Suppurative and necrotic conditions of lower respiratory tract

653

0.79

0.91

1.6

1.8

44.65

39.41

nmol/l

0.74

626

Other/unspecified cytomegaloviral diseases

219

1.39

0.91

1.5

1.7

37.73

38.73

nmol/l

0.06

209

Carcinoma in situ of prostate

1.65

0.90

2.1

1.8

44.50

43.74

nmol/l

0.06

Retention of urine

429

3253

1.08

0.90

1.9

1.7

45.54

44.32

nmol/l

0.42

405

3121

Other specified and unspecified disorders of eye and adnexa

306

1.32

0.89

1.5

1.8

45.25

39.65

nmol/l

0.75

293

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

102

867

1.18

0.89

1.9

1.8

40.49

40.32

nmol/l

0.03

839

Anoxic brain damage

130

0.53

0.89

1.9

1.7

46.71

40.66

nmol/l

—

123

Valvular operations

158

1793

0.88

1.7

43.99

42.34

nmol/l

0.41

153

1726

Contact with machinery

246

2225

1.11

0.87

1.6

1.8

42.80

38.96

nmol/l

1.78

240

2149

Hypertensive heart and/or renal disease

253

2088

0.90

0.87

1.6

1.7

40.24

46.87

nmol/l

4.94

242

2003

Anisometropia and aniseikonia

229

1.36

0.87

1.5

1.7

44.29

39.91

nmol/l

0.53

218

Insulin, fast-acting (human)

221

2455

0.90

0.87

1.8

52.93

37.81

nmol/l

11.83

216

2401

Myocardial infarction, without ST-elevation

392

3865

0.92

0.86

1.6

1.7

42.34

44.63

nmol/l

1.24

373

3707

Alcohol use disorder, ICD-based

795

8396

0.94

0.86

1.9

1.8

41.08

39.73

nmol/l

0.89

765

8187

Paralytic ileus and intestinal obstruction

255

2308

1.11

0.86

2.0

1.7

43.43

42.64

nmol/l

0.22

246

2228

Pulmonary heart disease, diseases of pulmonary circulation

310

2834

1.10

0.86

1.9

1.7

39.97

43.07

nmol/l

1.86

305

2718

Defect, injury or illness of lumbar spine

1.98

0.85

1.0

1.3

32.83

33.58

nmol/l

—

Nutritional anaemias

442

3953

1.08

0.85

1.9

1.7

45.85

44.56

nmol/l

0.37

427

3800

Shoulder region

137

1.48

0.85

1.3

1.7

44.40

40.11

nmol/l

0.39

132

Other specified congenital malformation syndromes affecting multiple systems

196

1.39

0.85

2.0

1.6

40.85

37.12

nmol/l

0.22

191

Varicose veins

452

3673

0.93

0.84

1.6

1.7

44.75

44.38

nmol/l

0.13

439

3535

Other and unspecified mononeuropathies of lower limb

179

1.41

0.84

2.1

1.6

44.36

41.45

nmol/l

0.20

171

Other necrotizing vasculopathies (FG)

362

1.28

0.84

1.5

1.7

51.29

42.71

nmol/l

1.18

345

Osteonecrosis due to drugs

111

0.53

0.84

2.3

1.9

43.83

42.49

nmol/l

—

104

L01XE Protein kinase inhibitors

366

0.73

0.84

2.1

1.7

44.26

41.69

nmol/l

0.20

346

Other demyelinating diseases of the central nervous system

377

0.74

0.84

1.2

1.7

38.00

39.65

nmol/l

0.18

367

Congenital malformations of the respiratory system

154

1.44

0.84

2.6

1.7

40.32

36.77

nmol/l

0.36

149

Rheumatoid arthritis, including avohilmo

271

2975

0.91

0.83

1.6

1.7

44.94

42.92

nmol/l

0.59

265

2877

Hallux valgus (acquired)

194

1244

1.12

0.83

1.8

1.6

44.21

45.11

nmol/l

0.19

188

1199

Disseminated intravascular coagulation [defibrination syndrome]

1.92

0.83

2.0

1.7

47.17

40.91

nmol/l

—

Diseases caused by chlamydiae

1.75

0.83

1.4

1.5

37.75

41.30

nmol/l

—

Malignant neoplasm of oral cavity, including Hilmo

455

0.76

0.83

1.9

1.8

42.49

40.73

nmol/l

0.20

432

Malignant neoplasm of skin

461

3394

0.93

0.82

1.5

1.7

46.24

43.95

nmol/l

1.30

443

3268

751

1.18

0.82

1.6

51.73

49.29

nmol/l

0.40

701

Dialysis

521

0.78

0.82

1.4

1.8

42.49

38.10

nmol/l

0.72

504

Gout, FINNGEN

378

3487

1.08

0.82

1.8

1.7

37.20

44.19

nmol/l

7.74

361

3337

Pedal cyclist injured in noncollision transport accidents

185

1654

1.12

0.81

2.0

1.8

41.57

38.70

nmol/l

0.95

180

1608

Melanocytic naevi of upper limb, including shoulder

189

1.39

0.81

1.6

1.7

33.96

40.63

nmol/l

1.19

180

Sub-endpoint used in defining T1D endpoints

439

4637

0.93

0.81

1.7

1.8

50.04

38.62

nmol/l

10.28

432

4517

L02BX Other hormone antagonists and related agents

543

0.79

0.81

2.0

1.7

44.40

46.87

nmol/l

0.34

507

Malignant neoplasm of oral cavity

340

0.73

0.81

1.6

1.8

41.04

40.33

nmol/l

0.06

325

Macular cyst

164

1.41

0.80

1.6

1.7

41.91

42.02

nmol/l

0.01

155

Superficial injury of ankle and foot

186

1666

1.12

0.80

1.7

1.8

39.40

38.51

nmol/l

0.19

180

1630

Contact with lifting and transmission devices, not elsewhere classified

313

1.30

0.80

2.1

1.8

38.35

37.37

nmol/l

0.13

300

Congenital malformations of the respiratory system

139

1.45

0.80

2.6

1.7

40.85

36.68

nmol/l

0.39

134

Periapical abscess

682

7214

0.94

0.80

1.9

1.8

39.80

40.00

nmol/l

0.07

657

7041

Cholelithiasis, broad definition with cholecystitis

921

6511

0.95

0.79

1.7

41.04

44.10

nmol/l

3.43

885

6324

Non-small cell lung cancer, adenocarcinoma, helper endpoint

362

0.74

0.79

1.4

1.7

46.37

45.78

nmol/l

0.04

342

Oral lichen planus and hypothyroidism or thyroxine medication

1.68

0.79

1.4

1.8

73.63

43.50

nmol/l

—

Corneal scars and opacities

234

1.33

0.78

1.5

1.8

42.26

39.26

nmol/l

0.46

224

Unspecified visual impairment (binocular)

125

0.55

0.78

2.1

1.7

93.29

41.37

nmol/l

—

119

Speech disturbances, not elsewhere classified

713

1.18

0.77

1.6

1.8

43.51

41.83

nmol/l

0.19

682

Other congenital musculoskeletal deformities

1.80

0.77

1.2

1.7

50.67

36.94

nmol/l

—

Other diseases caused by chlamydiae

1.71

0.76

1.9

1.5

35.78

40.42

nmol/l

—

Biological medicines for asthma

236

1.33

0.75

2.2

1.8

37.71

39.25

nmol/l

0.14

230

Postprocedural disorders of digestive system, not elsewhere classified

227

1.33

0.75

1.5

1.8

43.13

40.29

nmol/l

0.27

213

Toxic effect of carbon monoxide

219

1.34

0.74

2.6

1.8

36.83

38.45

nmol/l

0.22

210

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

133

0.60

0.74

1.3

1.8

40.25

42.32

nmol/l

—

125

Enteropathic arthropathies

219

1.33

0.74

1.6

33.00

36.76

nmol/l

0.74

214

Other abnormal findings of blood chemistry

415

1.24

0.73

1.9

1.7

40.12

40.95

nmol/l

0.08

398

Normal-pressure hydrocephalus

219

0.68

0.73

2.1

1.7

44.13

47.64

nmol/l

0.18

203

Sulfasalazine

382

3556

1.08

0.73

1.7

43.96

41.21

nmol/l

1.04

377

3463

Assault by other and unspecified firearm discharge

1.80

0.73

1.4

2.2

34.14

35.34

nmol/l

—

Chalazion

143

1270

1.13

0.73

1.7

1.8

43.16

40.75

nmol/l

0.55

135

1232

Secondary right heart disease

242

0.70

0.73

1.9

1.7

58.47

42.15

nmol/l

1.20

225

Open wound of thorax

264

0.71

0.73

1.9

1.7

31.95

37.96

nmol/l

0.51

255

Primary_lymphoid and hematopoietic malignant neoplasms

258

2364

1.09

0.72

1.8

42.95

42.91

nmol/l

0.01

251

2262

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

356

0.76

0.72

1.5

1.8

56.14

43.76

nmol/l

1.43

334

Noninfective disorders of pinna

1.98

0.72

3.0

1.8

24.80

41.08

nmol/l

—

Gout, unspecified

264

2424

1.09

0.71

1.9

1.7

35.95

43.79

nmol/l

8.10

251

2310

Adhesive middle ear disease

177

1.37

0.71

1.7

31.38

39.16

nmol/l

1.86

170

Other and unspecified paralytic syndromes

143

1.41

0.71

1.6

1.9

33.45

36.58

nmol/l

0.29

136

Exclusion endpoint for clefts

238

1.31

0.71

1.8

1.6

43.26

37.77

nmol/l

0.40

232

Monoarthritis, not elsewhere classified

399

1.23

0.71

1.7

44.20

40.48

nmol/l

0.43

385

Other and unspecified disorders of pigmentation

1.57

0.70

1.4

1.7

45.00

37.60

nmol/l

—

Pectus carinatum

1.93

0.70

2.2

1.6

33.80

28.74

nmol/l

—

Rheumatic valve diseases

143

0.63

0.70

1.2

1.9

42.89

40.93

nmol/l

—

135

Cardiomyopathy

207

2274

0.91

0.70

1.6

1.7

39.67

41.79

nmol/l

0.74

202

2192

DVT of lower extremities

197

1787

1.10

0.69

1.8

40.14

42.02

nmol/l

0.57

191

1724

Other specified and unspecified disorders of iris and ciliary body

1.70

0.69

2.0

1.3

44.86

33.52

nmol/l

—

Transient ischemic attack

537

4097

1.06

0.69

1.8

1.7

41.76

43.86

nmol/l

1.42

519

3942

Necrosis of pulp, including avohilmo

999

9557

1.04

0.67

1.8

1.7

39.08

40.16

nmol/l

0.60

970

9353

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

232

1.31

0.67

1.6

1.7

38.27

37.06

nmol/l

0.14

224

Behavioural disorders

373

0.77

0.67

2.3

1.8

43.03

36.74

nmol/l

0.56

366

Complications following infusion, transfusion and therapeutic injection

119

1.44

0.67

1.9

1.8

45.71

38.45

nmol/l

0.37

114

Unspecified mental disorder

716

6816

1.05

0.67

1.9

1.8

38.03

39.22

nmol/l

0.61

696

6677

Non-allergic asthma

751

1.16

0.67

1.6

1.7

39.13

40.60

nmol/l

0.29

728

Purpura and other haemorrhagic conditions

154

1383

1.12

0.67

1.6

1.8

44.48

41.12

nmol/l

0.90

149

1332

Other coagulation defects

605

1.18

0.65

1.9

1.7

41.15

41.06

nmol/l

0.01

584

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1376

9124

0.96

0.65

1.7

42.32

41.31

nmol/l

0.80

1329

8900

Alcohol induced polyneuropathy

130

0.61

0.65

1.3

1.7

36.75

41.70

nmol/l

—

123

1.76

0.64

1.2

1.4

22.00

34.03

nmol/l

—

Alopecia universalis

1.76

0.64

1.0

1.4

37.40

39.62

nmol/l

—

Other injuries of upper limb, level unspecified

153

0.65

0.64

2.2

1.7

44.00

39.62

nmol/l

—

145

Psoriatic arthropathies, strict definition

0.00

0.63

0.0

1.2

—

42.42

—

1236

10500

1.04

0.63

1.8

40.67

39.87

nmol/l

0.58

1196

10257

Other fall from one level to another

371

3473

1.07

0.63

1.7

1.8

41.79

40.12

nmol/l

0.58

365

3384

Erythema intertrigo

190

1.32

0.63

1.9

1.7

37.56

37.97

nmol/l

0.04

179

Superficial injury of ankle and foot, unspecified

1.62

0.63

1.6

2.0

32.00

35.79

nmol/l

—

Autoimmune diseases excluding thyroid diseases, strict definition

1820

9668

1.03

0.63

1.7

43.08

40.19

nmol/l

4.30

1782

9447

Pleural plaque

710

1.16

0.63

1.6

1.7

47.49

48.59

nmol/l

0.19

662

Malignant neoplasm of renal pelvis, including Hilmo

103

0.58

0.63

1.5

1.8

44.00

42.58

nmol/l

—

Upper arm

1.71

0.62

1.2

1.9

38.00

37.57

nmol/l

—

Benign neoplasm: Skin of lower limb, including hip

208

1.31

0.62

1.6

1.8

44.33

40.79

nmol/l

0.39

198

Discharge of firework

0.00

0.62

0.0

1.7

—

32.95

—

Accidental poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours

1.70

0.62

2.2

1.7

42.20

39.40

nmol/l

—

Gout due to impairment of renal function

1.48

0.62

1.4

1.8

39.00

44.66

nmol/l

0.49

Lordosis

1.70

0.62

1.2

1.1

26.00

39.13

nmol/l

—

Tuberculosis of other organs, strict

103

0.58

0.62

1.3

1.6

34.83

43.55

nmol/l

—

Mucosal proctocolitis

228

2099

1.09

0.62

1.8

38.34

38.49

nmol/l

0.03

223

2046

Ventral hernia

238

2194

1.09

0.62

1.9

1.7

40.67

42.36

nmol/l

0.48

225

2112

Pemphigus vulgaris

0.00

0.61

0.0

1.5

—

44.15

—

Adenocarcinoma of small intestine

0.00

0.61

0.0

1.3

—

45.50

—

Papillary adenocarcinoma of thyroid gland

316

1.24

0.61

1.9

1.7

41.31

41.00

nmol/l

0.03

305

Other noninfective disorders of lymphatic vessels and lymph nodes

267

0.75

0.61

2.5

1.8

38.05

39.69

nmol/l

0.12

261

Cholelithiasis

862

6197

0.96

0.61

1.7

40.88

44.17

nmol/l

3.73

827

6014

Type of accident

434

4092

1.06

0.61

1.7

41.44

40.07

nmol/l

0.48

420

3991

Papilloedema, unspecified

218

1.29

0.60

1.6

1.7

36.29

41.99

nmol/l

0.85

209

Malignant neoplasm of accessory sinuses

0.00

0.60

0.0

1.4

—

40.59

—

Loose body in joint

272

1.26

0.60

1.8

1.7

37.53

38.78

nmol/l

0.14

263

Fall on and from stairs and steps

309

2883

1.07

0.60

1.8

1.7

41.34

40.67

nmol/l

0.20

299

2800

Other sideroblastic anaemias

0.00

0.59

0.0

1.4

—

39.48

—

Other retinal disorders

722

5880

0.96

0.58

1.8

1.7

45.97

41.84

nmol/l

3.32

703

5690

Enduring personality changes

1.51

0.58

2.3

1.8

39.88

36.65

nmol/l

—

Erysipelas

832

7666

0.96

0.58

1.9

1.8

40.07

40.71

nmol/l

0.34

803

7461

Other bacterial diseases

1684

10373

1.03

0.58

1.9

1.7

39.48

40.40

nmol/l

0.74

1633

10149

Injury of eye and orbit

303

2833

1.07

0.57

1.8

38.45

38.21

nmol/l

0.07

294

2768

Third [oculomotor] nerve palsy

141

1.36

0.57

2.0

1.7

34.95

41.43

nmol/l

0.84

134

Malignant neoplasm of parotid gland, including Hilmo

0.56

0.57

2.0

1.8

43.60

40.71

nmol/l

—

ILD medications: pirfenidone

0.56

1.8

36.20

46.84

nmol/l

—

Whooping cough

1.56

0.56

1.3

1.5

33.70

34.05

nmol/l

—

Open wound of head

904

9047

0.96

0.56

1.8

40.08

39.50

nmol/l

0.33

872

8840

Diffuse large B-cell lymphoma, helper endpoint

357

1.21

0.55

1.8

49.95

42.25

nmol/l

1.04

338

Diffuse large B-cell lymphoma, including Hilmo

357

1.21

0.55

1.8

49.95

42.25

nmol/l

1.04

338

Diffuse large B-cell lymphoma

357

1.21

0.55

1.8

49.95

42.25

nmol/l

1.04

338

Infective bursitis

385

1.20

0.55

2.2

1.8

38.89

38.08

nmol/l

0.06

375

Other diseases of the digestive system

370

3485

1.06

0.55

1.7

42.28

42.80

nmol/l

0.15

353

3354

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases

1.50

0.55

1.0

1.9

52.11

40.27

nmol/l

—

Benign neoplasm: Floor of mouth

1.61

0.55

1.7

2.0

37.33

40.58

nmol/l

—

Toxic effect of alcohol

317

0.78

0.55

1.7

1.8

35.64

36.74

nmol/l

0.10

306

Need for immunization against other single viral diseases

276

1.24

0.55

1.6

1.8

49.47

36.48

nmol/l

1.23

269

Implicit bacterial Sepsis

487

4426

0.95

0.54

1.8

1.7

42.26

43.20

nmol/l

0.37

461

4273

Bus occupant injured in other and unspecified transport accidents

1.49

0.54

2.0

1.7

27.89

36.54

nmol/l

—

Explicit fungal Sepsis

1.51

0.54

2.4

1.6

55.36

44.48

nmol/l

0.48

Exposure to ignition of highly flammable material

0.61

0.54

2.8

1.9

35.50

36.20

nmol/l

—

Other diseases of gallbladder

258

1.24

0.54

1.9

1.7

37.00

41.50

nmol/l

0.67

247

Pacemaker

278

2488

1.07

0.54

1.6

1.7

46.67

45.25

nmol/l

0.44

263

2370

Implicit Sepsis

1250

8846

1.03

0.53

1.8

1.7

41.65

41.30

nmol/l

0.19

1203

8636

Pyothorax

491

0.83

0.53

1.7

1.8

45.12

38.58

nmol/l

0.76

468

Drug-induced cataract

232

1.26

0.53

1.7

1.8

36.34

39.76

nmol/l

0.45

225

Abnormal spermatozoa

193

1782

1.09

0.52

2.0

1.7

39.99

43.85

nmol/l

1.51

174

1702

Respiratory tuberculosis, confirmed

132

0.68

0.52

1.3

1.8

55.11

43.32

nmol/l

—

125

Tuberculosis of other organs

0.60

0.52

1.3

1.7

34.83

42.24

nmol/l

—

Other specified/unspecified systemic involvement of connective tissue

296

1.22

0.51

2.0

1.6

52.44

42.48

nmol/l

0.81

287

Malignant neoplasm of corpus uteri, including Hilmo

1.50

0.51

1.0

1.2

43.00

69.55

nmol/l

—

Ischaemic heart disease, wide definition

1151

6899

1.03

0.51

1.8

38.88

40.96

nmol/l

2.68

1117

6715

Implicit bacterial Sepsis

431

4024

0.95

0.51

1.8

1.7

43.04

43.32

nmol/l

0.09

411

3878

Carcinoma in situ of skin of scalp and neck

135

1.34

0.51

1.4

1.7

58.33

46.78

nmol/l

0.80

125

Use of donepezil

674

0.87

0.51

1.7

1.5

56.95

50.17

nmol/l

0.99

634

Effects of air pressure and water pressure

101

1.42

0.51

2.1

1.9

37.07

34.23

nmol/l

0.33

101

Clear cell adenocarcinoma of kidney

445

0.83

0.51

1.5

1.8

40.38

41.61

nmol/l

0.12

423

Disorders of lens

835

5412

0.96

0.51

1.7

45.20

42.04

nmol/l

2.44

796

5261

Familial hypercholesterolemia

148

1352

1.10

0.51

1.9

1.7

37.02

44.93

nmol/l

5.21

134

1288

Use of galantamine

225

0.75

0.50

1.6

1.7

57.29

50.80

nmol/l

0.34

208

Leisure time condition

240

2238

1.07

0.50

1.6

1.8

43.84

40.11

nmol/l

1.03

234

2177

Superficial injury of head

314

2954

1.06

0.50

1.8

1.7

38.63

39.53

nmol/l

0.33

305

2883

Chronic tubulo-interstitial nephritis

201

0.74

0.49

1.5

1.7

46.87

41.50

nmol/l

0.33

192

Respiratory conditions due to other external agents

106

0.66

0.49

1.6

1.9

33.14

43.88

nmol/l

—

Outcome of delivery

487

0.87

0.48

1.2

59.10

50.30

nmol/l

0.68

480

Combinations of oral blood glucose lowering drugs

413

3925

1.05

0.48

1.8

1.7

32.36

44.69

nmol/l

32.37

396

3796

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

400

3336

0.95

0.48

1.6

1.5

47.06

49.35

nmol/l

0.70

379

3233

Gout, idiopatic and unspecified

319

3010

1.06

0.48

1.9

1.7

36.13

43.63

nmol/l

8.82

304

2874

Senile cataract

680

4336

0.96

0.48

1.7

45.78

43.36

nmol/l

1.35

643

4201

Malignant neoplasm, without specification of site

177

0.73

0.47

1.5

1.8

32.69

45.12

nmol/l

2.73

169

Other disorders of pigmentation

272

1.22

0.47

1.8

1.7

40.18

41.11

nmol/l

0.09

257

Other misadventures during surgical and medical care

191

1.26

0.47

2.3

1.7

44.08

40.31

nmol/l

0.30

180

Mental and behavioural disorders due to alcohol

1007

9985

0.97

0.46

1.9

1.8

40.66

39.81

nmol/l

0.57

974

9757

Drug-induced hypoglycaemia without coma

176

0.73

0.46

1.5

1.8

34.92

40.45

nmol/l

0.68

168

Retinal vascular occlusion

768

1.12

0.46

1.4

1.7

43.91

44.29

nmol/l

0.05

729

Mantle cell lymphoma

0.61

0.46

2.4

2.0

36.80

43.24

nmol/l

—

Acute renal failure

214

2293

0.93

0.46

1.7

1.8

41.07

42.69

nmol/l

0.46

202

2200

Injury of muscle and tendon at ankle and foot level

310

1.20

0.46

2.4

1.8

36.57

36.70

nmol/l

0.01

298

Hereditary retinal dystrophy

153

0.71

0.46

1.5

1.8

34.36

36.54

nmol/l

0.21

148

Respiratory tuberculosis, clinically confirmed

0.61

0.46

1.6

1.7

53.80

43.31

nmol/l

—

Rheumatoid arthritis

232

2223

0.93

0.46

1.6

44.69

44.20

nmol/l

0.10

227

2148

Fracture of shoulder and upper arm

455

4338

1.05

0.45

1.7

1.8

42.56

39.75

nmol/l

1.59

445

4232

Cardiomyopathy, Hypertrophic obstructive

165

1.28

0.45

1.3

1.7

43.10

39.40

nmol/l

0.30

158

Left hemicolectomy

164

0.73

0.45

1.8

1.7

43.00

40.89

nmol/l

0.17

155

Benign neoplasm: Skin of scalp and neck

210

1.24

0.45

2.1

1.8

47.96

41.59

nmol/l

0.32

200

Endometriosis ASRM stages 1,2

524

1.15

0.45

1.1

1.2

66.07

55.18

nmol/l

1.00

518

Retinal vascular disorders

779

1.12

0.45

1.4

1.7

43.79

44.25

nmol/l

0.06

740

Allergic contact dermatitis due to drugs in contact with skin

141

0.71

0.45

2.0

1.7

41.20

41.11

nmol/l

—

133

Disorders in reading

247

1.22

0.45

2.1

1.8

31.37

35.96

nmol/l

0.60

242

Injuries to the elbow and forearm

999

8513

1.03

0.44

1.8

1.7

40.56

40.67

nmol/l

0.04

973

8319

Other juvenile arthritis

404

1.17

0.44

1.7

1.6

46.19

40.82

nmol/l

0.32

398

Malignant melanoma of skin

947

0.90

0.44

1.5

1.8

44.75

43.46

nmol/l

0.20

904

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

283

2671

1.06

0.44

1.7

1.8

38.21

38.93

nmol/l

0.20

277

2602

Exposure to other specified electric current

377

1.18

0.44

2.4

1.8

32.25

37.82

nmol/l

1.08

368

Other bursitis of hip

1.37

0.44

1.5

45.92

43.39

nmol/l

0.16

283

1.20

0.44

1.5

1.6

41.32

41.13

nmol/l

0.01

272

Respiratory tuberculosis, bacteriologically and histologically confirmed

140

0.71

0.43

1.3

1.8

52.10

42.96

nmol/l

—

133

Malignant neoplasm of base of tongue

0.63

0.43

1.5

1.9

36.33

40.07

nmol/l

—

Exposure to vibration

0.00

0.43

0.0

1.9

—

35.07

—

Malignant neoplasm of corpus uteri

1.61

0.43

1.0

1.2

41.80

68.29

nmol/l

—

Diabetic neuropathy

135

1235

1.09

0.43

1.8

1.7

44.23

37.14

nmol/l

2.50

128

1182

Amoebiasis

1.39

0.43

1.9

1.8

47.50

40.25

nmol/l

0.22

Classical phenylketonuria

0.00

0.43

0.0

1.5

—

45.00

—

Congenital ptosis

1.59

0.42

1.0

1.4

36.60

35.91

nmol/l

—

LSIL lesion of the cervix uteri, vagina or vulva

480

1.15

0.42

1.1

1.2

52.04

55.69

nmol/l

0.34

475

Exposure to other and unspecified man-made environmental factors

203

1.24

0.42

1.5

1.8

34.68

37.19

nmol/l

0.34

198

Other infective (teno)synovitis

1.58

0.42

2.0

1.6

32.60

37.16

nmol/l

—

Osteolysis

0.00

0.42

0.0

1.6

—

40.20

—

Moyamoya

0.00

0.42

0.0

1.5

—

43.87

—

Duodenal ulcer - Chronic without haemorrhage or perforation, drug-induced

0.00

0.42

0.0

1.7

—

43.00

—

Cystic fibrosis with intestinal manifestations

0.00

0.42

0.0

1.3

—

34.20

—

Chronic drug-induced interstitial lung disorders

0.00

0.42

0.0

1.4

—

47.75

—

Other and unspecified thalassaemias

0.00

0.42

0.0

1.4

—

30.33

—

Malignant neoplasm of eye, brain and central nervous system

520

0.86

0.42

1.8

39.56

39.11

nmol/l

0.06

502

Ankylosis of teeth

1.52

0.41

1.6

1.4

32.60

36.30

nmol/l

—

Malignant neoplasm of pyriform sinus

0.00

0.41

0.0

1.4

—

43.33

—

Asthma/COPD (KELA code 203)

1521

10676

0.98

0.41

1.8

1.7

38.40

41.35

nmol/l

5.29

1486

10439

Lichenoid drug reaction

0.00

0.41

0.0

2.0

—

39.75

—

Cystic fibrosis, other manifestations/unspecified

0.00

0.41

0.0

1.2

—

42.65

—

Haemophilus septicemia

0.00

0.41

0.0

1.5

—

32.82

—

Small kidney of unknown cause

0.00

0.41

0.0

1.8

—

37.59

—

Other specified/unspecified disorders of middle ear and mastoid

0.00

0.41

0.0

1.3

—

32.53

—

Crushing injury of wrist and hand

241

1.21

0.41

1.5

1.8

45.03

36.48

nmol/l

1.22

231

Charcot foot

194

0.77

0.41

1.5

1.7

32.60

40.98

nmol/l

1.35

185

Other congenital malformations of the digestive system

414

1.16

0.41

1.6

1.8

41.81

38.91

nmol/l

0.33

401

Pityriasis lichenoides et varioliformis acuta

0.00

0.40

0.0

1.8

—

42.94

—

Other nonautoimmune haemolytic anaemias

0.00

0.40

0.0

1.6

—

39.22

—

Other retinal disorders in diseases classified elsewhere

0.00

0.40

0.0

1.6

—

44.78

—

Mucocutaneous lymph node syndrome [Kawasaki]

0.00

0.40

0.0

1.6

—

32.56

—

Retinal haemorrhage

141

1.28

0.40

1.8

1.7

48.78

40.52

nmol/l

0.62

135

IBD patients in KELA-register

410

3922

1.05

0.40

1.7

1.8

39.14

38.93

nmol/l

0.06

401

3833

Other malignant neoplasms of skin (=non-melanoma skin cancer)

393

2822

0.95

0.40

1.6

1.7

47.24

44.92

nmol/l

1.12

375

2705

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

311

2955

1.05

0.40

1.6

1.8

38.86

38.97

nmol/l

0.03

305

2882

Amoebiasis

1.32

0.40

1.8

29.88

40.08

nmol/l

—

Failure of sterile precautions during surgical operation

1.45

0.40

2.4

1.4

46.60

37.57

nmol/l

—

Severe visual impairment, monocular

1.32

0.40

1.4

1.6

39.63

40.48

nmol/l

—

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases

1.40

0.39

1.0

1.9

52.11

39.39

nmol/l

—

Internuclear ophthalmoplegia

1.44

0.39

1.0

1.9

54.60

41.49

nmol/l

—

Ulcerative colitis (strict definition, all Crohn cases excluded)

247

2333

1.06

0.39

1.7

1.8

38.10

38.86

nmol/l

0.20

241

2271

Hypertensive Heart Disease

228

1896

0.94

0.39

1.6

1.7

39.93

47.61

nmol/l

5.75

217

1818

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

196

1.23

0.39

2.0

1.8

37.96

39.51

nmol/l

0.16

187

Coronary atherosclerosis

934

5736

1.03

0.39

1.8

1.7

39.74

41.47

nmol/l

1.62

904

5573

Epiphora

106

1.33

0.39

2.0

1.6

42.29

42.05

nmol/l

0.01

100

Intentional self-harm by jumping or lying before moving object

1.42

0.39

2.8

1.7

32.20

36.64

nmol/l

—

Other superficial injuries of ankle and foot

1.39

0.39

1.1

1.6

40.91

41.33

nmol/l

0.03

Trichomoniasis

0.00

0.39

0.0

1.3

—

38.47

—

Benign neoplasm of thyroid gland

160

1.25

0.38

1.6

40.55

43.42

nmol/l

0.22

153

Panniculitis, unspecified

1.37

0.38

2.8

1.6

43.44

39.39

nmol/l

—

Infective dermatitis

130

1203

1.08

0.37

1.7

1.8

39.66

41.38

nmol/l

0.41

125

1162

Heart failure and antihypertensive medication

311

2136

0.95

0.37

1.8

1.7

39.01

44.39

nmol/l

3.71

298

2094

Pericarditis

412

1.15

0.36

1.6

1.7

38.07

39.34

nmol/l

0.20

398

Other disorders of fluid, electrolyte and acid-base balance

268

2687

0.95

0.36

1.9

1.7

48.96

43.64

nmol/l

2.10

258

2589

Other infiltrative disorders of skin and subcutaneous tissue

1.48

0.36

1.8

1.6

28.00

38.27

nmol/l

—

Other mosquito-borne viral fevers

0.64

0.36

1.2

1.8

47.80

38.39

nmol/l

—

Lesion of medial popliteal nerve

1.45

0.36

1.7

1.9

42.33

38.81

nmol/l

—

Lung transplantation

123

0.72

0.36

3.4

1.8

44.11

38.89

nmol/l

—

118

Injuries to the hip and thigh

573

5011

1.04

0.36

1.9

1.7

41.46

41.64

nmol/l

0.06

553

4855

Other/unspecified disorders of vestibular function

263

1.18

0.36

2.1

1.7

45.39

40.97

nmol/l

0.47

248

GI-bleeding

368

3523

1.05

0.36

1.7

42.56

42.75

nmol/l

0.05

351

3392

Basal cell carcinoma

365

2639

0.96

0.35

1.5

1.7

47.63

45.20

nmol/l

1.14

347

2529

Mature T/NK-cell lymphomas, hilmo

123

0.73

0.35

1.2

1.7

40.44

43.27

nmol/l

—

116

Condition for Implicit Sepsis (Organ dysfunction codes)

1334

9202

1.02

0.35

1.8

1.7

41.82

40.90

nmol/l

0.67

1286

8990

Malignant neoplasm of larynx

134

0.74

0.35

1.5

1.8

40.70

43.79

nmol/l

—

125

Cerebrovascular diseases (FINNGEN)

458

3366

0.96

0.35

1.8

1.7

39.83

41.17

nmol/l

0.61

446

3295

Iridocyclitis

288

2745

1.05

0.35

1.9

1.7

43.35

40.36

nmol/l

0.78

283

2666

Pneumocystosis

156

0.76

0.35

1.8

48.00

41.16

nmol/l

0.29

149

Migraine, unspecified, drug-induced

1.37

0.34

1.8

1.6

33.50

36.20

nmol/l

—

Ulcerative colitis (strict definition, require KELA)

289

2756

1.05

0.34

1.7

1.8

37.92

38.78

nmol/l

0.26

283

2685

Acute bronchiolitis

595

1.11

0.34

1.6

1.5

38.53

38.19

nmol/l

0.03

584

Use of memantine

780

0.91

0.34

1.4

1.5

62.84

50.24

nmol/l

2.98

731

Use of other anti-dementia drugs

780

0.91

0.34

1.4

1.5

62.84

50.24

nmol/l

2.98

731

Benign neoplasm: Other and unspecified parts of small intestine

1.35

0.34

1.5

1.6

39.64

43.13

nmol/l

0.16

Presence of other functional implants

571

3828

1.03

0.34

1.6

1.7

44.75

43.84

nmol/l

0.39

548

3706

Other and unspecified nonorganic psychotic disorders

349

3637

0.96

0.33

1.8

38.54

37.34

nmol/l

0.33

342

3566

Malignant neoplasm of other and ill-defined sites, including Hilmo

0.66

0.33

3.0

1.8

39.67

42.55

nmol/l

—

Late syphilis

165

0.78

0.32

1.5

1.8

36.62

39.86

nmol/l

0.29

159

Malignant neoplasm of oropharynx, including Hilmo

252

0.83

0.32

1.4

1.9

48.33

40.11

nmol/l

0.54

240

Lagophthalmos

1.33

0.32

1.1

1.9

43.55

42.66

nmol/l

0.04

Other melanin hyperpigmentation

1.31

0.32

1.8

38.08

42.35

nmol/l

0.34

Angina pectoris

744

4820

1.03

0.32

1.8

1.7

39.44

42.70

nmol/l

3.64

721

4670

Abnormal findings on antenatal screening of mother

512

1.11

0.32

1.3

1.2

73.02

55.35

nmol/l

0.65

507

SLE (Finngen)

183

1.21

0.32

1.8

1.6

34.55

42.32

nmol/l

1.30

178

Other and unspecified injuries of abdomen, lower back and pelvis

165

1.22

0.31

2.2

1.8

45.85

39.10

nmol/l

0.50

160

STROKE

779

5438

0.97

0.31

1.8

1.7

40.41

40.99

nmol/l

0.30

755

5301

Glomerular disorders in diseases classified elsewhere

142

1511

0.94

0.30

1.7

1.8

46.90

40.50

nmol/l

0.96

137

1454

Extreme obesity with alveolar hypoventilation

334

1.14

0.30

2.1

1.8

31.24

40.50

nmol/l

2.70

322

Burn and corrosion of shoulder and upper limb, except wrist and hand

282

0.85

0.30

1.2

1.7

33.29

38.37

nmol/l

0.53

272

Inflammatory bowel disease, strict (require KELA)

410

3957

1.04

0.30

1.7

1.8

39.14

39.02

nmol/l

0.03

401

3866

Vitamin B12 deficiency anemia due to intrinsic factor deficiency

1.30

0.30

1.7

1.8

56.00

47.09

nmol/l

0.53

Morphin

1.29

0.30

1.9

1.4

46.92

45.50

nmol/l

0.07

Pustulosis palmaris et plantaris

259

1.16

0.30

1.6

1.7

48.90

40.12

nmol/l

0.58

250

Malignant cancer of tonsil and base of tongue, including Hilmo

324

0.86

0.29

1.4

1.9

47.29

40.08

nmol/l

0.60

308

Other specified and unspecified retinal disorders

269

1.16

0.29

1.7

1.8

37.13

38.99

nmol/l

0.27

259

Mixed connective tissue disease

316

1.14

0.29

2.1

1.7

48.89

42.64

nmol/l

0.43

302

Graves ophthalmopathy, strict

107

0.75

0.29

2.8

1.6

53.50

43.51

nmol/l

—

102

Scar conditions and fibrosis of skin

288

1.15

0.29

1.4

1.6

43.30

40.54

nmol/l

0.19

277

Gastroduodenal ulcer

247

2354

1.05

0.29

1.8

1.7

46.07

43.83

nmol/l

0.67

240

2260

Personal history of allergy to drugs, medicaments and biological substances

103

1.27

0.28

1.3

1.7

52.46

37.54

nmol/l

0.61

103

Dissection of aorta

280

0.85

0.28

1.7

42.29

41.38

nmol/l

0.10

269

Benign neoplasm: Brain, supratentorial

149

1.21

0.28

2.1

1.8

36.33

38.63

nmol/l

0.19

143

Rheumatic fever incl heart disease

205

0.83

0.28

1.6

1.8

45.71

39.68

nmol/l

0.30

193

Malignant neoplasm of base of tongue, including Hilmo

117

0.76

0.28

1.6

1.8

44.56

40.03

nmol/l

—

110

ILD-related respiratory insufficiency

214

1.17

0.28

1.5

1.7

42.92

43.20

nmol/l

0.03

199

Spinal enthesopathy

103

1.26

0.28

1.2

1.7

44.77

43.45

nmol/l

0.08

Other/unspecified rheumatoid arthritis

637

0.91

0.27

2.0

1.7

44.71

42.97

nmol/l

0.23

607

Malignant neoplasm of rectosigmoid junction

120

0.75

0.27

2.4

1.9

38.67

41.93

nmol/l

—

114

Colitis due to radiation

1.24

0.27

2.0

1.6

45.25

43.33

nmol/l

—

Familial hypercholesterolemia, with ischemic heart disease

749

1.08

0.27

1.7

1.8

36.78

45.93

nmol/l

3.63

712

Benign neoplasm: Prostate

1.22

0.27

1.8

1.7

38.00

48.28

nmol/l

—

Type 1 diabetes

432

4452

0.97

0.27

1.7

1.8

50.08

40.01

nmol/l

8.06

425

4353

Habit and impulse disorders

319

1.14

0.27

1.9

1.7

37.17

38.07

nmol/l

0.08

313

Other conjunctival vascular disorders and cysts

159

1.20

0.27

1.6

1.8

54.42

40.08

nmol/l

0.78

153

Unstable angina pectoris

390

3180

0.97

0.26

1.7

42.33

44.88

nmol/l

1.25

376

3049

Pediculosis and phthiriasis

1.25

0.26

2.1

1.8

41.33

38.86

nmol/l

—

Congenital malformations of the nervous system

225

1.16

0.26

1.7

44.58

38.50

nmol/l

0.42

220

Bleeding

1205

8726

0.98

0.26

1.7

1.8

41.75

40.58

nmol/l

0.93

1162

8504

Other bullous disorders

216

1.16

0.25

1.7

52.48

41.17

nmol/l

1.07

209

Unspecified acute lower respiratory infection

252

2421

1.04

0.25

1.8

38.28

39.52

nmol/l

0.39

247

2362

Contusion of ankle

502

1.10

0.25

1.7

38.22

38.32

nmol/l

0.01

489

Malignant neoplasm of mesothelium and soft tissue

298

0.87

0.25

2.5

1.7

37.12

42.51

nmol/l

0.67

283

Hypersensitivity pneumonitis due to organic dust

142

1.20

0.25

1.6

1.7

40.47

41.87

nmol/l

0.10

134

Nephrotic syndrome

350

0.88

0.24

1.6

1.8

53.94

38.61

nmol/l

0.49

337

Malignant cancer of tonsil and base of tongue

265

0.86

0.24

1.3

1.9

47.61

40.18

nmol/l

0.52

254

Other and unspecified disorders of psychological development

134

0.80

0.24

2.3

1.6

30.82

36.15

nmol/l

0.29

129

Adrenomedullary hyperfunction

1.37

0.24

2.8

1.4

34.60

47.11

nmol/l

—

Superficial injuries involving multiple body regions

307

0.88

0.24

1.6

40.96

38.42

nmol/l

0.17

296

Ankylosing hyperostosis [Forestier]

115

1.22

0.23

2.2

1.6

32.86

41.35

nmol/l

1.46

110

Hereditary factor VIII deficiency

1.33

0.23

2.4

1.6

26.80

33.63

nmol/l

—

Other respiratory disorders and diseases

165

1730

0.95

0.23

2.0

1.7

44.20

43.15

nmol/l

0.23

160

1652

Other diseases of the respiratory system

165

1730

0.95

0.23

2.0

1.7

44.20

43.15

nmol/l

0.23

160

1652

Other fibroblastic disorders

1.33

0.23

1.0

1.4

42.80

39.82

nmol/l

—

Ankylosing spondylitis, strict definition

785

1.07

0.23

1.6

1.9

34.33

36.65

nmol/l

0.65

767

Insulin, intermediate and long-acting

848

8402

0.98

0.23

1.7

1.8

43.11

40.75

nmol/l

1.53

822

8171

Superficial injury of neck

295

0.88

0.22

2.2

1.8

40.54

39.48

nmol/l

0.08

288

Malignant neoplasm of tonsil, including Hilmo

221

0.86

0.22

1.4

1.8

48.58

39.95

nmol/l

0.51

212

Infliximab

314

1.12

0.22

2.1

1.8

33.71

36.46

nmol/l

0.40

307

Peutz-Jeghers syndrome

0.00

0.22

0.0

2.8

—

33.00

—

Artificial opening status

477

1.09

0.22

1.7

1.8

35.71

40.80

nmol/l

1.85

463

Drowning and submersion in swimming-pool or bath

0.00

0.22

0.0

2.0

—

35.20

—

Keratosis follicularis et parafollicularis in cutem penetrans [Kyrle]

0.00

0.22

0.0

1.6

—

44.90

—

Night blindness

0.00

0.22

0.0

1.4

—

33.18

—

Crushing injuries involving multiple body regions

0.00

0.22

0.0

1.4

—

35.83

—

Induced delusional disorder

0.00

0.22

0.0

2.5

—

36.45

—

Congenital syphilis

0.00

0.22

0.0

1.0

—

43.00

—

Disorders of other digestive organs in diseases classified elsewhere

0.00

0.22

0.0

1.2

—

39.83

—

Mucinosis of skin

0.00

0.22

0.0

1.6

—

44.91

—

Anaemia due to enzyme disorders

0.00

0.22

0.0

1.3

—

31.40

—

Pemphigus foliaceus

0.00

0.22

0.0

1.5

—

45.45

—

Benign neoplasm: Trachea

0.00

0.22

0.0

1.1

—

40.10

—

Congenital malformation syndromes due to known exogenous causes, not elsewhere classified

0.00

0.21

0.0

1.3

—

31.95

—

Amputation of ankle

0.00

0.21

0.0

1.6

—

42.50

—

Iliac crest spur

0.00

0.21

0.0

1.2

—

44.42

—

Traumatic amputation of hip and thigh

0.00

0.21

0.0

1.5

—

39.30

—

Pedestrian injured in collision with other nonmotor vehicle

0.00

0.21

0.0

1.2

—

47.36

—

Congenital heart conduction disorder

0.00

0.21

0.0

1.4

—

28.10

—

Acquired coagulation factor deficiency

0.00

0.21

0.0

1.6

—

45.18

—

Pityriasis alba

0.00

0.21

0.0

1.6

—

36.83

—

Trisomy 21 (Down syndrome) due to meiotic nondisjunction

0.00

0.21

0.0

2.3

—

36.00

—

Melanoma in situ of ear and external auricular canal

0.00

0.21

0.0

1.8

—

36.08

—

Ophthalmic devices associated with adverse incidents

0.00

0.21

0.0

1.2

—

50.00

—

Complications of anaesthesia during the puerperium

0.00

0.21

0.0

1.1

—

37.20

—

Lumbosacral spina bifida and hydrocephalus

0.00

0.21

0.0

1.4

—

30.33

—

Other hypersecretion of intestinal hormones

0.00

0.21

0.0

1.1

—

44.31

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

469

4573

1.03

0.21

1.7

1.8

41.17

40.14

nmol/l

0.36

453

4461

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1417

9912

0.99

0.21

1.9

1.7

42.97

41.32

nmol/l

1.32

1373

9678

Other and unspecified vasculitis limited to skin

188

0.85

0.21

2.3

1.8

33.81

38.56

nmol/l

0.46

176

Unspecified nephritic syndrome

239

1.13

0.21

1.9

1.8

36.67

40.06

nmol/l

0.43

228

104

0.76

0.21

2.6

1.6

36.75

38.53

nmol/l

—

Other and unspecified atrophic disorders of skin

0.00

0.21

0.0

1.6

—

36.88

—

Hirsprung

0.00

0.21

0.0

1.2

—

31.81

—

Keratoconus

402

1.10

0.21

2.4

1.8

33.93

36.76

nmol/l

0.40

391

Need for immunization against other single infectious diseases

0.00

0.21

0.0

1.6

—

43.00

—

Dislocations, sprains and strains involving multiple body regions

0.00

0.21

0.0

1.5

—

39.46

—

Other injuries involving multiple body regions, not elsewhere classified

0.00

0.21

0.0

1.7

—

33.54

—

Malignant neoplasm of brain

439

0.91

0.21

1.5

1.9

39.35

38.09

nmol/l

0.17

425

Leprosy [Hansen's disease]

0.00

0.20

0.0

2.1

—

43.93

—

Occupant of railway train or railway vehicle injured in transport accident

0.00

0.20

0.0

1.4

—

41.71

—

Amyloidosis, other/unspecified

117

1.20

0.20

1.2

1.8

43.57

44.21

nmol/l

0.03

110

Nocardiosis

0.00

0.20

0.0

1.7

—

37.29

—

Defect, injury or illness of chest

0.00

0.20

0.0

1.3

—

37.50

—

Other and unspecified hereditary haemolytic anaemias

0.00

0.20

0.0

2.1

—

41.64

—

Benign neoplasm: Urethra

0.00

0.20

0.0

1.4

—

43.79

—

Other combined immunodeficiencies

0.00

0.20

0.0

2.0

—

37.86

—

Transepidermal elimination disorders

0.00

0.20

0.0

1.6

—

45.14

—

Polyp of middle ear

0.00

0.20

0.0

1.6

—

41.36

—

155

0.83

0.20

1.5

1.6

28.69

40.32

nmol/l

1.40

149

Ototoxic hearing loss

0.00

0.20

0.0

1.2

—

35.50

—

Contusion of other and unspecified parts of foot

654

1.07

0.20

1.8

1.7

40.05

38.43

nmol/l

0.18

639

Radiodermatitis

0.00

0.20

0.0

1.7

—

48.29

—

Abnormal findings on diagnostic imaging of breast

0.00

0.20

0.0

1.4

—

40.57

—

Foreign body on external eye

368

3582

1.03

0.20

1.8

38.48

38.08

nmol/l

0.16

356

3495

Type 1 diabetes, wide definition, subgroup 1

383

3727

1.03

0.19

1.7

1.8

51.37

39.62

nmol/l

9.05

377

3645

Monoplegia

133

0.82

0.19

1.5

1.7

34.55

39.73

nmol/l

0.38

128

Torticollis

207

0.87

0.19

1.7

39.11

37.14

nmol/l

0.16

200

Congenital lens malformations

1.16

0.19

1.0

1.4

36.17

34.21

nmol/l

—

Laparoscopic left hemicolectomy

154

0.84

0.19

1.5

1.9

39.00

41.03

nmol/l

0.16

147

Acute nephritic syndrome

238

0.88

0.18

1.7

1.8

33.14

40.41

nmol/l

1.22

230

Hypertrophic cardiomyopathy

444

1.08

0.18

1.5

1.8

37.54

38.89

nmol/l

0.18

428

Sixth [abducent] nerve palsy

261

1.11

0.18

2.0

1.7

42.00

40.65

nmol/l

0.07

247

Migraine with aura, drug-induced

1.19

0.18

3.4

1.8

24.29

36.58

nmol/l

—

Alcohol abuse counselling and surveillance

310

0.90

0.18

1.9

40.43

37.77

nmol/l

0.24

301

Hydrocephalus

466

0.92

0.18

1.9

1.7

40.95

42.82

nmol/l

0.21

444

Focal epilepsy

252

2595

0.97

0.17

1.8

1.7

48.57

40.53

nmol/l

2.84

246

2518

Acquired haemolytic anaemia

184

0.87

0.17

1.7

54.56

41.61

nmol/l

0.91

177

Necrotizing fasciitis

0.74

0.17

1.0

1.5

55.80

39.73

nmol/l

—

Erysipelas

1175

8850

1.01

0.17

1.9

1.8

39.73

40.07

nmol/l

0.19

1133

8639

Cerebral atherosclerosis

0.74

0.17

2.2

1.7

37.60

45.45

nmol/l

—

Occlusion and stenosis of arteries, not leading to stroke

0.74

0.17

1.6

1.4

42.20

45.61

nmol/l

—

Other lack of coordination

148

1.15

0.17

1.4

1.6

41.71

40.90

nmol/l

0.06

140

Disorders of globe

167

1.14

0.17

2.2

1.8

44.74

40.44

nmol/l

0.31

158

Endometriosis ASRM stages 3,4

543

1.07

0.17

1.2

63.95

57.95

nmol/l

0.52

537

Malignant neoplasm of brain, including Hilmo

567

0.93

0.16

1.7

1.8

39.72

39.01

nmol/l

0.09

546

Injury of muscle and tendon at wrist and hand level

246

2390

1.03

0.16

2.0

1.8

39.55

38.99

nmol/l

0.13

237

2329

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

251

2366

1.03

0.16

1.7

1.8

39.67

39.59

nmol/l

0.02

246

2301

Alcohol use disorder, Swedish definition

1108

10024

1.01

0.16

1.8

41.22

39.74

nmol/l

1.29

1071

9787

Secondary thrombocytopenia

120

1.17

0.16

2.1

1.8

43.71

41.54

nmol/l

0.14

114

Insulin, fast-acting

585

5741

1.02

0.16

1.7

1.8

47.27

39.91

nmol/l

6.63

574

5578

Acute tubulo-interstitial nephritis

592

5199

0.98

0.16

1.7

1.6

43.49

45.60

nmol/l

0.95

575

5025

Vasculitis limited to skin, not elsewhere classified

204

0.88

0.16

2.2

1.8

34.28

38.33

nmol/l

0.43

192

Diseases of arteries, arterioles and capillaries (FINNGEN)

382

2704

0.98

0.16

1.8

1.7

40.05

41.74

nmol/l

0.86

371

2645

Spondylopathies in diseases classified elsewhere

1.11

0.16

2.8

1.6

31.13

43.77

nmol/l

—

Carcinoma in situ, bladder

287

0.90

0.16

1.2

1.7

42.00

44.84

nmol/l

0.29

268

Congenital malformations of cardiac chambers and connections

0.75

0.16

1.8

1.3

44.83

31.93

nmol/l

—

Pulmonary eosinophilia, not elsewhere classified

0.79

0.15

3.2

1.6

49.00

42.14

nmol/l

—

Postzoster neuralgia

1.21

0.15

2.6

1.7

42.50

43.66

nmol/l

—

Erythema multiforme

197

1.12

0.15

2.3

1.7

38.18

39.38

nmol/l

0.10

186

Aplastic and other anaemias

408

3882

0.98

0.15

1.7

47.91

44.30

nmol/l

1.40

391

3729

Burn and corrosion of hip and lower limb, except ankle and foot

303

1.09

0.15

1.7

1.8

43.82

38.21

nmol/l

0.43

293

Ulcer of lower limb, not elsewhere classified

133

1381

0.96

0.15

1.8

1.7

44.40

42.68

nmol/l

0.39

126

1318

Mixed conductive and sensorineural hearing loss

882

0.95

0.15

1.7

44.87

42.52

nmol/l

0.40

851

Peripheral retinal degeneration

226

1.11

0.15

2.0

1.7

56.88

40.39

nmol/l

1.09

218

Exposure to other and unspecified animate mechanical forces

342

1.08

0.15

1.9

1.7

38.78

39.71

nmol/l

0.10

333

Congenital malformations of great arteries

203

1.11

0.15

1.4

1.7

36.48

39.17

nmol/l

0.24

198

L04AC Interleukin inhibitors

869

1.05

0.15

1.7

1.9

36.42

38.01

nmol/l

0.43

844

Emphysema

605

0.94

0.15

1.4

1.7

51.73

43.25

nmol/l

0.80

579

Basal cell carcinoma, including avohilmo

402

2827

0.98

0.15

1.5

1.7

47.31

44.82

nmol/l

1.29

380

2710

Communicating hydrocephalus

150

0.86

0.14

2.1

1.7

33.92

40.77

nmol/l

0.75

143

Renal tubulo-interstitial disorders in diseases classified elsewhere

1.19

0.14

1.2

1.7

38.73

38.88

nmol/l

0.01

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

451

3118

0.98

0.14

1.5

1.7

47.51

44.50

nmol/l

1.88

430

2997

Glaucoma

485

4096

1.02

0.14

1.6

1.7

45.89

43.84

nmol/l

0.78

477

3924

Other condition

207

2012

1.03

0.14

1.8

38.53

39.73

nmol/l

0.38

200

1957

Schizoid personality disorder

285

0.91

0.14

2.1

1.7

41.15

38.26

nmol/l

0.18

277

Complications of genitourinary prosthetic devices, implants and grafts

131

1.15

0.14

1.7

1.6

48.53

41.73

nmol/l

0.29

123

L04AX Other immunosuppressants

746

7351

1.01

0.14

1.7

41.45

41.01

nmol/l

0.19

730

7156

Other ulcerative colitis

798

0.95

0.14

1.9

1.8

37.59

38.17

nmol/l

0.07

776

Liquid cancers, helper endpoint

412

3663

0.98

0.14

1.8

1.7

42.07

42.72

nmol/l

0.23

395

3540

Graves ophthalmopathy

118

0.85

0.14

2.7

1.6

53.60

43.96

nmol/l

—

113

Injuries involving multiple body regions

460

0.93

0.14

1.8

1.7

41.05

37.51

nmol/l

0.40

446

Other and unspecified anaemias

380

3548

1.02

0.14

1.7

48.00

44.49

nmol/l

1.25

364

3403

Inflammatory disorders of male genital organs, not elsewhere classified

237

1.10

0.14

1.8

1.7

44.88

37.89

nmol/l

0.77

228

Protozoal diseases

266

1.09

0.14

1.6

1.7

46.24

40.47

nmol/l

0.52

256

Dipeptidyl peptidase 4 (DPP-4) inhibitors

640

5200

0.98

0.13

1.8

1.7

34.16

44.74

nmol/l

32.41

608

5052

Glaucoma-related operations

276

1.09

0.13

1.7

42.30

43.32

nmol/l

0.11

259

Viral encephalitis, not elsewhere classified/unspecified

199

1.11

0.13

1.5

1.8

45.86

38.41

nmol/l

0.65

188

Prolonged pregnancy

771

1.04

0.13

1.2

73.35

55.12

nmol/l

1.36

766

Other cataract

458

3405

1.02

0.13

1.7

47.82

42.87

nmol/l

2.50

444

3286

Hypocalcemia

180

0.89

0.13

2.1

1.8

39.56

39.84

nmol/l

0.02

171

Adult respiratory distress syndrome

106

0.85

0.13

2.3

1.8

25.78

41.64

nmol/l

—

100

Other anaemias

383

3572

1.02

0.13

1.7

48.19

44.52

nmol/l

1.34

367

3427

Convulsions, not elsewhere classified

388

3760

1.02

0.13

1.9

1.7

44.55

40.32

nmol/l

1.86

379

3672

Abscess of lung

190

0.89

0.13

1.4

1.7

44.76

38.74

nmol/l

0.81

183

severe traumatic brain injury, does not include concussion

265

2590

1.02

0.13

1.7

1.8

43.39

41.31

nmol/l

0.72

258

2490

Perforation of tympanic membrane

104

1001

1.04

0.13

1.8

40.39

40.22

nmol/l

0.02

971

Disorders resulting from impaired renal tubular function

386

0.93

0.13

1.6

1.8

40.92

38.41

nmol/l

0.26

371

Chronic pancreatitis

187

1820

1.03

0.13

1.6

1.8

43.97

40.41

nmol/l

1.09

181

1758

Oesophageal obstruction

277

1.08

0.13

1.3

1.7

46.87

41.23

nmol/l

0.73

264

Paranoid personality disorder

200

0.90

0.12

1.7

1.6

35.83

39.42

nmol/l

0.30

192

Fracture of forearm

610

5508

1.01

0.12

1.7

41.53

40.37

nmol/l

0.49

595

5381

Iridocyclitis in diseases classified elsewhere

179

0.89

0.12

2.0

1.7

35.37

40.72

nmol/l

0.65

172

Gout, strict definition

218

2128

1.03

0.12

2.0

1.7

35.16

43.63

nmol/l

8.13

206

2027

Implicit Sepsis

1083

8081

1.01

0.12

1.8

1.7

41.52

41.58

nmol/l

0.03

1043

7877

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

133

1.13

0.12

2.5

1.4

44.47

39.86

nmol/l

0.23

128

Polyarthropathies

982

6345

1.01

0.12

1.8

1.7

40.49

41.91

nmol/l

0.93

953

6211

Kela-code for severe mental illness

635

6268

1.01

0.12

1.9

1.8

37.90

39.04

nmol/l

0.53

616

6137

Other infestations

157

0.89

0.11

1.9

1.7

47.93

40.03

nmol/l

0.38

149

Cholangitis (primary sclerosing, PSC), with reimbursement 202

221

1.09

0.11

2.0

1.8

60.83

36.59

nmol/l

2.24

212

Other and unspecified hydrocephalus

136

0.88

0.11

1.5

1.8

39.08

41.21

nmol/l

0.11

130

Other necrotizing vasculopathies

465

1.05

0.11

1.5

1.7

51.07

41.42

nmol/l

1.56

443

Adenocarcinoma and Papillary adenocarcinoma of kidney

146

0.89

0.10

1.5

1.9

40.77

40.94

nmol/l

0.01

139

Malignant neoplasm of tongue, including Hilmo

280

0.93

0.10

1.5

1.8

42.50

39.68

nmol/l

0.28

267

Late syphilis

187

0.91

0.10

1.5

1.8

38.12

39.03

nmol/l

0.06

180

Chronic kidney disease

297

2962

0.98

0.10

1.6

1.7

43.16

43.58

nmol/l

0.11

285

2834

Pneumonia due to Streptococcus pneumoniae

514

0.95

0.10

2.0

1.8

37.65

38.64

nmol/l

0.16

494

Malignant neoplasm of other and unspecified parts of tongue

135

1.11

0.09

1.5

1.8

43.13

40.04

nmol/l

0.23

129

Abnormal reflex

1.09

0.09

1.0

1.6

39.10

39.20

nmol/l

—

Nystagmus and other irregular eye movements

135

1.11

0.09

2.1

1.8

50.40

35.39

nmol/l

1.22

128

Frostbite involving multiple body regions and unspecified frostbite

1.07

0.09

2.4

1.7

28.40

38.23

nmol/l

—

Hypo-osmolality and hyponatraemia

140

1357

1.03

0.09

1.8

1.7

53.75

43.11

nmol/l

3.22

133

1308

Radial styloid tenosynovitis [de Quervain]

369

1.06

0.09

1.8

1.6

43.95

42.52

nmol/l

0.15

364

Congenital cataract

1.07

0.09

1.0

1.4

41.40

35.85

nmol/l

—

Disorders of lacrimal system and orbit in diseases classified elsewhere

114

0.88

0.09

2.7

1.7

53.60

43.98

nmol/l

—

108

Second line medication for Crohn's disease

780

7722

1.01

0.09

1.7

41.43

40.95

nmol/l

0.21

763

7521

Ventricular septal defect, a heart condition

206

0.92

0.09

2.1

1.6

46.95

39.08

nmol/l

0.47

200

Hodgkin lymphoma, hilmo

350

1.06

0.09

1.6

1.8

42.41

38.32

nmol/l

0.62

335

Acute hepatitis A

1.14

0.09

1.8

44.00

36.51

nmol/l

—

Other abnormal immunological findings in serum

155

1.10

0.09

1.8

48.71

39.85

nmol/l

0.46

149

Insulin, fast-acting or short human

585

5783

1.01

0.09

1.7

1.8

47.27

39.75

nmol/l

6.88

574

5616

Chronic nephritic syndrome

439

1.05

0.09

1.7

1.8

38.84

39.09

nmol/l

0.02

420

Other renal tubulo-interstitial diseases

134

0.89

0.08

1.7

24.92

42.96

nmol/l

4.64

127

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

512

0.96

0.08

1.5

1.8

55.02

42.89

nmol/l

2.06

487

Diseases of spleen

175

1.09

0.08

1.7

42.05

40.42

nmol/l

0.09

168

Other diseases of peritoneum

216

0.93

0.08

1.6

1.8

41.45

41.41

nmol/l

0.00

207

Nondiabetic hypoglycaemic coma

0.80

0.08

1.4

1.7

51.40

33.97

nmol/l

—

Other and unspecified haemorrhagic conditions

117

1.11

0.08

1.1

1.8

44.77

40.04

nmol/l

0.40

112

Aphakia

123

0.89

0.08

1.5

1.8

53.55

38.36

nmol/l

0.91

118

Complications of other internal prosthetic devices, implants and grafts

236

0.93

0.08

1.8

1.7

46.73

40.35

nmol/l

0.66

225

Use of rivastigmine

488

1.04

0.08

1.6

1.5

56.49

50.16

nmol/l

0.67

458

Cystitis

849

5086

0.99

0.07

1.5

1.6

47.72

45.88

nmol/l

1.05

828

4926

Portal vein thrombosis

147

1.09

0.07

1.6

1.8

43.69

40.04

nmol/l

0.21

142

Malignant neoplasm of oropharynx

194

0.93

0.07

1.2

1.9

52.39

40.98

nmol/l

0.71

185

SLE, strict definition

177

1.07

0.06

1.9

1.7

34.58

41.85

nmol/l

1.00

172

SLE, ICD10

177

1.07

0.06

1.9

1.7

34.58

41.85

nmol/l

1.00

172

Viral pneumonia (known virus, not influenza)

234

0.94

0.06

1.9

1.7

41.55

38.31

nmol/l

0.26

221

Burns and corrosions

230

2332

0.99

0.06

1.7

1.8

38.24

38.78

nmol/l

0.12

222

2273

Follow-up examination after treatment for conditions other than malignant neoplasms

491

3279

0.99

0.06

1.6

44.90

42.00

nmol/l

1.50

473

3222

Burns and corrosions of multiple body regions

148

1.09

0.06

2.1

1.7

39.56

39.18

nmol/l

0.02

143

Chronic Coagulation defects

172

0.93

0.06

2.8

1.5

39.69

40.70

nmol/l

0.07

166

Persistent delusional disorders

890

0.98

0.05

1.9

37.22

37.26

nmol/l

0.00

864

Pustular psoriasis

306

1.05

0.05

1.6

1.7

48.09

39.79

nmol/l

0.58

295

Juvenile arthritis (FINNGEN)

474

1.03

0.05

1.8

1.7

44.53

39.95

nmol/l

0.28

467

Malignant neoplasm of other connective and soft tissue

188

1.07

0.05

2.1

1.8

36.75

40.34

nmol/l

0.31

179

Lung diseases due to external agents

122

1242

0.98

0.05

1.8

41.49

42.75

nmol/l

0.25

114

1190

All kidney diseases

1495

10169

1.00

0.05

1.7

40.73

41.79

nmol/l

0.84

1454

9932

Chronic myeloproliferative disease

1.11

0.05

1.6

1.8

43.30

45.95

nmol/l

—

Contusion of toe(s) with damage to nail

139

1.08

0.05

2.6

1.7

38.13

38.51

nmol/l

0.02

134

Other retinal artery occlusion

149

1.08

0.05

1.2

1.7

38.94

41.92

nmol/l

0.22

142

Poor fetal growth

667

0.97

0.05

1.2

55.85

56.05

nmol/l

0.01

659

Acute appendicitis, with complications

253

2557

0.99

0.05

1.9

1.8

38.04

40.40

nmol/l

0.79

247

2484

Colorectal neuroendocrine tumor and carcinoma

110

1.09

0.05

1.2

1.7

27.67

38.80

nmol/l

2.39

105

Contraceptive management

763

5319

1.01

0.05

1.8

38.08

37.74

nmol/l

0.16

749

5216

Other abnormalities of plasma proteins

120

1.09

0.05

1.7

1.9

46.15

40.20

nmol/l

0.70

113

Focal epilepsy, strict definition

234

2364

0.99

0.04

1.7

1.8

47.51

40.44

nmol/l

2.43

228

2290

Contusion of toe(s) without damage to nail

268

1.05

0.04

1.5

1.6

41.46

39.57

nmol/l

0.16

261

Discitis, unspecified

130

1.08

0.04

2.1

1.6

46.64

40.69

nmol/l

0.56

124

Right hemicolectomy

377

1.04

0.04

1.5

1.8

37.74

41.64

nmol/l

0.56

356

Vitamin B12 deficiency anaemia

595

1.03

0.04

1.7

55.90

44.79

nmol/l

2.09

567

Carcinoma in situ of other and unspecified sites

302

0.96

0.04

1.3

1.8

41.76

44.51

nmol/l

0.31

281

ILD medications: immunosuppressive drugs

979

9131

1.00

0.04

1.7

41.80

40.66

nmol/l

0.66

961

8911

Focal epilepsy, mode (most common among epilepsy diagnosis)

225

2226

1.01

0.04

1.8

48.88

40.62

nmol/l

2.54

220

2158

Other and unspecified degenerative diseases of nervous system

150

1.07

0.04

1.6

1.7

47.94

44.01

nmol/l

0.27

141

Maternal care for other conditions predominantly related to pregnancy

886

1.02

0.04

1.3

1.2

62.66

56.98

nmol/l

0.47

878

1155

10395

1.00

0.04

1.8

40.85

39.88

nmol/l

0.73

1120

10150

Parapsoriasis

170

0.94

0.04

1.6

1.7

52.56

40.59

nmol/l

0.50

160

Occupant of special all-terrain or other motor vehicle designed primarily for off-road use, injured in transport accident

372

0.97

0.04

1.9

1.8

36.00

37.10

nmol/l

0.13

362

Cellulitis of external ear

119

0.92

0.04

1.7

51.18

40.58

nmol/l

0.42

114

Smoking dependency

106

1076

0.98

0.04

1.9

1.8

43.14

40.00

nmol/l

0.59

1039

Idiopathic gout

104

1055

0.99

0.03

2.0

1.8

36.13

42.87

nmol/l

2.63

1006

Chorioretinal inflammation

270

0.96

0.03

2.1

1.8

44.50

39.17

nmol/l

0.52

260

Rare circulating lymphoid malignancy, including Hilmo

270

1.04

0.03

2.4

1.8

42.57

42.07

nmol/l

0.03

255

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1450

9462

1.00

0.03

1.7

42.01

41.70

nmol/l

0.18

1389

9266

Contact with other hot metals

199

0.95

0.03

2.1

1.8

31.84

39.15

nmol/l

1.09

192

Hepatomegaly and splenomegaly, not elsewhere classified

102

1.08

0.03

2.8

1.6

33.45

39.08

nmol/l

0.67

Intestinal stricture

298

2961

1.01

0.03

1.9

1.7

43.63

42.55

nmol/l

0.35

288

2848

Infection due to other mycobacteria

108

0.92

0.03

1.6

1.8

48.80

41.72

nmol/l

—

103

Cutaneous lupus erythematosus

122

1.07

0.02

1.7

43.15

43.71

nmol/l

0.02

115

Other secondary coxarthrosis

271

1.03

0.02

1.8

1.7

35.14

40.87

nmol/l

1.13

260

Other diseases of arteries and capillaries

711

0.98

0.02

2.0

1.7

42.01

41.44

nmol/l

0.09

682

Disorders of choroid and retina

1080

7691

1.00

0.02

1.7

45.44

41.10

nmol/l

5.66

1046

7479

Malignant neoplasm of other connective and soft tissue, including Hilmo

339

0.97

0.02

2.0

1.8

37.33

40.45

nmol/l

0.43

323

Malignant neoplasm of tonsil

178

0.95

0.02

1.2

1.9

51.59

41.08

nmol/l

0.59

170

Reimbursement for rheumatic diseases

629

6243

1.00

0.02

1.7

43.97

41.71

nmol/l

1.27

619

6063

Chronic iridocyclitis

451

1.02

0.02

2.0

1.8

42.41

38.95

nmol/l

0.48

437

Glomerular diseases

235

2363

0.99

0.02

1.7

1.8

43.92

40.78

nmol/l

0.64

229

2286

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

230

2240

0.99

0.02

1.7

1.8

39.83

39.50

nmol/l

0.07

225

2178

Type 1 diabetes, wide definition

386

3841

1.00

0.02

1.7

1.8

51.33

39.64

nmol/l

9.06

380

3756

Motor neuron disease (with DMD)

113

1.06

0.02

1.5

50.58

40.47

nmol/l

0.63

107

Mental and behavioural disorders due to tobacco

106

1070

0.99

0.01

1.9

1.8

43.14

39.86

nmol/l

0.63

1034

Alcohol abuse, main dg, excluding more controls

255

2562

1.00

0.01

1.7

39.16

39.65

nmol/l

0.15

250

2512

Myasthenia gravis

137

0.95

0.01

1.7

32.38

41.61

nmol/l

1.48

128

Dermatitis herpetiformis

147

0.95

0.01

2.1

1.8

55.07

41.95

nmol/l

0.99

141

Carcinoma in situ of colon

167

0.96

0.01

1.4

1.8

50.94

42.77

nmol/l

0.72

156

Acute epiglottitis

187

0.96

0.01

1.6

1.7

33.83

39.16

nmol/l

0.75

177

Malignant neoplasm of tongue

217

0.97

0.01

1.5

1.9

41.19

40.34

nmol/l

0.07

206

Pneumonitis due to solids and liquids

748

0.99

0.01

1.9

1.8

45.41

41.25

nmol/l

0.75

719

Amiodarone users

102

1012

1.01

0.01

1.4

1.8

54.89

42.60

nmol/l

4.43

969

Iron deficiency anaemia secondary to blood loss (chronic)

113

1138

0.99

0.01

2.2

1.7

43.65

42.35

nmol/l

0.22

107

1094

Marginal zone B-cell lymphoma, including Hilmo

106

0.94

0.01

1.8

1.9

44.50

42.63

nmol/l

—

101

Hypertensive Renal Disease

264

1.02

0.00

1.7

1.6

47.04

46.42

nmol/l

0.04

252

Mixed specific developmental disorders

227

0.98

0.00

1.8

1.7

29.38

35.71

nmol/l

1.14

221

Aneurysms, operations, SAH

143

1428

1.00

0.00

1.9

1.8

43.29

42.54

nmol/l

0.11

137

1372

Schizophrenia or delusion, excluding more controls

488

4829

1.00

0.00

1.8

1.7

39.05

38.67

nmol/l

0.11

475

4753

132

1154

1.00

0.00

1.7

49.56

48.99

nmol/l

0.09

124

1087

Benign neoplasm: Tonsil

106

1.04

0.00

1.5

1.7

36.18

39.77

nmol/l

0.40

100

Motor neuron disease

106

1.04

0.00

1.5

1.6

52.45

41.48

nmol/l

0.64

100

Other degenerative diseases of the basal ganglia

1.03

0.00

1.2

1.7

41.80

45.01

nmol/l

—

Myeloid leukaemia

216

1.02

0.00

2.9

1.8

43.23

40.95

nmol/l

0.11

206

Primary angle-closure glaucoma

216

1.02

0.00

1.1

1.7

50.27

41.42

nmol/l

0.69

204

Periodontal disease, other/unspecified

224

0.98

0.00

1.6

1.7

48.05

40.95

nmol/l

0.61

217

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

203

0.98

0.00

1.5

1.8

39.60

40.30

nmol/l

0.06

193

Background retinopathy and retinal vascular changes

188

1.01

0.00

1.5

1.8

39.42

39.88

nmol/l

0.03

182

Hypothermia

212

0.99

0.00

1.7

1.8

45.00

40.15

nmol/l

0.48

202

Idiopathic thrombocytopenic purpura

248

1.01

0.00

1.1

1.7

43.08

39.17

nmol/l

0.33

238

6-mercaptopurine

490

1.00

0.00

1.7

41.00

37.70

nmol/l

0.35

477

Disorders of oesophagus in diseases classified elsewhere

151

0.99

0.00

2.0

1.7

48.60

40.77

nmol/l

0.46

143

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

185

1.03

0.00

1.3

1.6

39.63

39.51

nmol/l

0.01

180

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

169

1.01

0.00

1.9

1.7

41.18

36.63

nmol/l

0.48

163

Haemolytic anaemias

299

1.00

0.00

1.5

1.7

46.37

40.02

nmol/l

0.66

286

Exposure to uncontrolled fire in building or structure

124

0.97

0.00

1.6

1.7

38.83

39.76

nmol/l

0.05

119

Contact with other specified venomous plants

0.00

0.0

1.2

—

21.80

—

Chronic bullous disease of childhood

0.00

0.0

1.5

—

36.17

—

Hereditary erythropoietic porphyria

0.00

0.0

3.0

—

42.00

—

Myiasis

0.00

0.0

1.2

—

50.17

—

Traumatic amputation of forearm

0.00

0.0

1.2

—

29.20

—

Brucellosis

0.00

0.0

1.4

—

38.25

—

Keratoderma in diseases classified elsewhere

0.00

0.0

1.0

—

52.20

—

Intracranial injury with prolonged coma

0.00

0.0

1.1

—

35.50

—

Sequelae of other and unspecified effects of external causes

0.94

0.00

1.7

29.14

38.88

nmol/l

—

Miliaria crystallina

0.00

0.0

1.5

—

41.63

—

Encephalocele

0.00

0.0

1.3

—

32.86

—

Malignant neoplasm of trachea, including Hilmo

0.00

0.0

1.2

—

34.60

—

GM2 gangliosidosis

0.00

0.0

1.2

—

59.00

—

Disorders of accommodation

0.00

0.0

1.4

—

28.60

—

Arenaviral haemorrhagic fever

0.00

0.0

1.3

—

38.17

—

Intrauterine hypoxia

0.00

0.0

1.2

—

27.00

—

Bartonellosis

0.00

0.0

2.1

—

37.22

—

Lymphocyte function antigen-1 [LFA-1] defect

0.00

0.0

2.3

—

40.29

—

Traumatic shock

0.00

0.0

2.2

—

36.40

—

Chagas' disease

0.00

0.0

1.0

—

56.40

—

Scleritis and episcleritis (ICD-9) only

0.00

0.0

1.2

—

40.00

—

Agent resistant to multiple antibiotics

0.00

0.0

1.4

—

38.38

—

Diphyllobothriasis and sparganosis

0.00

0.0

1.7

—

33.50

—

Occupant of streetcar injured in transport accident

0.00

-0.00

0.0

1.2

—

37.00

—

Immunodeficiency following hereditary defective response to Epstein-Barr virus

0.00

-0.00

0.0

1.4

—

39.40

—

Crushing injury of neck

0.00

-0.00

0.0

1.8

—

35.00

—

Pseudomembranous colitis, drug-induced

0.00

-0.00

0.0

2.2

—

34.40

—

Duodenal ulcer - Chronic or unspecified with haemorrhage, drug-induced

0.00

-0.00

0.0

2.3

—

40.83

—

Postpolio syndrome

0.00

-0.00

0.0

1.2

—

42.20

—

Benign neoplasm: Renal pelvis

0.00

-0.00

0.0

1.8

—

39.63

—

Eosinophilic cellulitis [Wells]

0.00

-0.00

0.0

1.0

—

55.33

—

Polydactyly

0.00

-0.00

0.0

1.4

—

28.75

—

Vibratory urticaria

0.00

-0.00

0.0

2.1

—

33.38

—

Conditions involving the integument and temperature regulation of fetus and newborn

0.00

-0.00

0.0

1.6

—

26.33

—

Alzheimer’s disease (undefined), excluding more controls

0.00

-0.00

0.0

1.0

—

48.71

—

Carcinoma in situ of other/unspecified male genital organs

0.00

-0.00

0.0

1.4

—

37.00

—

Tobacco use

680

1.00

-0.00

2.0

1.8

45.60

39.91

nmol/l

0.62

659

Hereditary factor XI deficiency

0.00

-0.00

0.0

1.1

—

53.71

—

Complicated migraine, drug-induced

0.00

-0.00

0.0

1.8

—

35.00

—

Drug-induced nonautoimmune haemolytic anaemia

0.00

-0.00

0.0

1.2

—

27.40

—

Androgen resistance syndrome

0.00

-0.00

0.0

1.2

—

30.67

—

Non-neuropathic heredofamilial amyloidosis

0.00

-0.00

0.0

1.7

—

41.33

—

Other congenital malformations of posterior segment of eye (coloboma)

0.00

-0.00

0.0

2.2

—

36.11

—

Delta-beta thalassaemia

0.00

-0.00

0.0

2.0

—

36.17

—

Iodine-deficiency-related goitre

0.00

-0.00

0.0

1.4

—

55.60

—

Fusion of the labia

0.00

-0.00

0.0

1.0

—

48.50

—

Drug-induced tics and other tics of organic origin

0.00

-0.00

0.0

1.0

—

47.38

—

Disorders of fatty-acid metabolism

0.00

-0.00

0.0

1.5

—

33.33

—

Increased secretion of glucagon

0.00

-0.00

0.0

1.1

—

27.22

—

Mixed disorder of acid-base balance

0.00

-0.00

0.0

1.2

—

32.33

—

Duodenal ulcer - Acute without haemorrhage or perforation, drug-induced

0.00

-0.00

0.0

1.6

—

40.22

—

Disorders of glycine metabolism

0.00

-0.00

0.0

1.2

—

50.20

—

Blindness (ICD-9)

0.00

-0.00

0.0

1.4

—

38.22

—

Use of benzatropine

0.00

-0.00

0.0

1.0

—

47.86

—

Other conditions originating in the perinatal period

0.00

-0.00

0.0

2.2

—

40.40

—

Phlebitis and thrombophlebitis of unspecified site, drug-induced

0.00

-0.00

0.0

2.8

—

44.50

—

Disorders of olfactory nerve

0.00

-0.00

0.0

1.2

—

43.40

—

Cyst of iris, ciliary body and anterior chamber

0.00

-0.00

0.0

2.0

—

42.56

—

Disorder of amino-acid metabolism, other/unspecified

0.00

-0.00

0.0

1.3

—

32.57

—

Other conditions of integument specific to fetus and newborn

0.00

-0.00

0.0

1.5

—

26.50

—

Enophthalmos

0.00

-0.00

0.0

2.0

—

34.29

—

Other inflammatory disorders of orbit (ICD-8 only)

0.00

-0.00

0.0

1.3

—

26.83

—

Birth injury to scalp

0.00

-0.00

0.0

1.0

—

35.50

—

Other migraine, drug-induced

0.00

-0.00

0.0

2.1

—

35.43

—

Follicular keratosis (Darier-White)

0.00

-0.00

0.0

1.2

—

40.60

—

Noonan syndrome

0.00

-0.00

0.0

1.4

—

28.89

—

Phlebitis and thrombophlebitis of femoral vein, drug-induced

0.00

-0.00

0.0

2.0

—

39.40

—

Follicular keratosis (Darier-White)

0.00

-0.00

0.0

1.7

—

37.89

—

Rat-bite fevers

0.00

-0.00

0.0

1.2

—

38.20

—

Fetal alcohol syndrome (dysmorphic)

0.00

-0.00

0.0

1.3

—

28.71

—

Malignant immunoproliferative diseases

0.90

-0.00

2.0

1.7

35.29

45.32

nmol/l

—

Other and unspecified disorders of skin and subcutaneous tissue related to radiation

0.00

-0.00

0.0

2.3

—

39.67

—

Other rickettsioses

0.00

-0.00

0.0

2.2

—

40.00

—

Acute myringitis

0.93

-0.00

1.4

1.5

44.14

40.07

nmol/l

—

Wrist or foot drop (acquired)

0.00

-0.00

0.0

1.0

—

46.00

—

Diphyllobothriasis and sparganosis

0.00

-0.00

0.0

1.6

—

33.57

—

Total (external) ophthalmoplegia

0.00

-0.00

0.0

2.3

—

36.00

—

Rat-bite fevers

0.00

-0.00

0.0

1.3

—

36.00

—

Strongyloidiasis

0.00

-0.00

0.0

1.1

—

50.38

—

Trichomoniasis

0.00

-0.00

0.0

1.2

—

41.11

—

Mantle cell lymphoma, including Hilmo

130

1.00

-0.00

2.4

1.9

50.62

41.95

nmol/l

0.67

124

Bacterial agents resistant to antibiotics

0.00

-0.00

0.0

1.3

—

38.67

—

Traumatic anuria

0.00

-0.00

0.0

1.2

—

33.80

—

Assault by unspecified chemical or noxious substance

0.00

-0.00

0.0

2.0

—

26.50

—

Toxic liver disease with cholestasis, drug-induced

0.00

-0.00

0.0

1.7

—

47.57

—

Epiphyseal arrest

0.00

-0.00

0.0

1.2

—

33.33

—

Lethal midline granuloma

0.00

-0.00

0.0

2.2

—

29.00

—

Ischaemic infarction of muscle

0.00

-0.00

0.0

1.2

—

26.00

—

Irritant contact dermatitis due to drugs in contact with skin

0.00

-0.00

0.0

1.7

—

31.43

—

Congenital syphilis

0.00

-0.00

0.0

1.0

—

49.43

—

Unspecified contact dermatitis due to drugs in contact with skin

0.00

-0.00

0.0

1.4

—

31.63

—

Perioral dermatitis, drug-induced

0.00

-0.00

0.0

2.0

—

29.40

—

Flexion deformity

0.00

-0.00

0.0

1.1

—

40.75

—

Secondary lactase deficiency

0.00

-0.00

0.0

1.2

—

46.89

—

Heart failure and hypertrophic cardiomyopathy

170

1.00

-0.00

1.9

37.76

41.43

nmol/l

0.24

161

Coccidioidomycosis

0.00

-0.00

0.0

2.1

—

38.43

—

Corneal degeneration

0.94

-0.00

2.0

1.8

35.33

44.12

nmol/l

—

Q fever

0.00

-0.00

0.0

2.8

—

34.83

—

Plasmodium malariae malaria

0.00

-0.00

0.0

1.0

—

52.20

—

Trichuriasis

0.00

-0.00

0.0

1.4

—

32.40

—

Plasmodium vivax malaria

0.00

-0.00

0.0

2.0

—

39.14

—

Other chronic figurate erythema

0.00

-0.00

0.0

1.0

—

55.00

—

Mandibular prognathia AND surgery (LeFortI or BSSO)

0.97

-0.00

2.5

1.6

28.00

37.61

nmol/l

—

Pemphigus erythematosus

0.00

-0.00

0.0

1.3

—

37.50

—

R07AX Other respiratory system products

0.00

-0.00

0.0

1.0

—

34.50

—

Bullous disorders in diseases classified elsewhere

0.00

-0.00

0.0

1.1

—

27.29

—

Other eccrine sweat disorders

0.00

-0.00

0.0

1.4

—

36.00

—

Histoplasmosis

0.00

-0.00

0.0

1.5

—

33.50

—

Leptospirosis

0.00

-0.00

0.0

1.2

—

28.17

—

Macular pucker, drug-induced

0.00

-0.00

0.0

2.3

—

42.33

—

Bladder disorders in in diseases classified elsewhere

0.00

-0.00

0.0

1.1

—

54.67

—

Neurological devices associated with adverse incidents

0.00

-0.00

0.0

2.2

—

41.60

—

Crushing injury of shoulder and upper arm

0.00

-0.00

0.0

1.9

—

29.71

—

Abscess of tendon sheath

0.92

-0.00

1.2

1.4

42.33

43.52

nmol/l

—

Multiple sites

0.00

-0.00

0.0

1.4

—

32.25

—

Hypoplasia of dental enamel, prenatal

0.00

-0.00

0.0

1.4

—

33.00

—

Scleritis and episcleritis in diseases classified elsewhere

0.00

-0.00

0.0

1.8

—

35.00

—

Progressive external ophthalmoplegia

0.00

-0.00

0.0

1.9

—

33.63

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Sex hormone binding globulin [Moles/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS